KR102011956B1 - 항생제 내성을 갖는 클렙시엘라(Klebsiella)속 균을 용균하는 박테리오파지 - Google Patents
항생제 내성을 갖는 클렙시엘라(Klebsiella)속 균을 용균하는 박테리오파지 Download PDFInfo
- Publication number
- KR102011956B1 KR102011956B1 KR1020170077538A KR20170077538A KR102011956B1 KR 102011956 B1 KR102011956 B1 KR 102011956B1 KR 1020170077538 A KR1020170077538 A KR 1020170077538A KR 20170077538 A KR20170077538 A KR 20170077538A KR 102011956 B1 KR102011956 B1 KR 102011956B1
- Authority
- KR
- South Korea
- Prior art keywords
- bacteriophage
- ymc15
- atg
- present
- klebsiella
- Prior art date
Links
- 241001515965 unidentified phage Species 0.000 title claims abstract description 105
- 239000003242 anti bacterial agent Substances 0.000 title claims abstract description 23
- 241000588748 Klebsiella Species 0.000 title abstract description 52
- 229940088710 antibiotic agent Drugs 0.000 title abstract description 17
- 230000002101 lytic effect Effects 0.000 title description 16
- 230000003115 biocidal effect Effects 0.000 claims abstract description 56
- 241000588747 Klebsiella pneumoniae Species 0.000 claims description 36
- YZBQHRLRFGPBSL-RXMQYKEDSA-N carbapenem Chemical compound C1C=CN2C(=O)C[C@H]21 YZBQHRLRFGPBSL-RXMQYKEDSA-N 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 10
- 239000004480 active ingredient Substances 0.000 claims description 9
- 239000000645 desinfectant Substances 0.000 claims description 8
- 241000702202 Siphoviridae Species 0.000 claims description 4
- 230000022534 cell killing Effects 0.000 claims description 3
- 201000010099 disease Diseases 0.000 abstract description 19
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 19
- 230000002265 prevention Effects 0.000 abstract description 5
- 239000006166 lysate Substances 0.000 abstract description 3
- 241000894006 Bacteria Species 0.000 description 20
- 239000008194 pharmaceutical composition Substances 0.000 description 17
- 239000000203 mixture Substances 0.000 description 15
- 108090000623 proteins and genes Proteins 0.000 description 15
- 235000013305 food Nutrition 0.000 description 14
- 229940096118 ella Drugs 0.000 description 10
- 208000015181 infectious disease Diseases 0.000 description 9
- 102000004169 proteins and genes Human genes 0.000 description 9
- OOLLAFOLCSJHRE-ZHAKMVSLSA-N ulipristal acetate Chemical compound C1=CC(N(C)C)=CC=C1[C@@H]1C2=C3CCC(=O)C=C3CC[C@H]2[C@H](CC[C@]2(OC(C)=O)C(C)=O)[C@]2(C)C1 OOLLAFOLCSJHRE-ZHAKMVSLSA-N 0.000 description 9
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 7
- 239000000796 flavoring agent Substances 0.000 description 7
- 239000002609 medium Substances 0.000 description 7
- 239000000725 suspension Substances 0.000 description 7
- 108020004414 DNA Proteins 0.000 description 6
- -1 Levoflocacin Chemical compound 0.000 description 6
- 206010035664 Pneumonia Diseases 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- 239000002775 capsule Substances 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 230000009089 cytolysis Effects 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 5
- 108700026244 Open Reading Frames Proteins 0.000 description 5
- 241000456882 Salmonella virus FSLSP030 Species 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000003755 preservative agent Substances 0.000 description 5
- 238000001179 sorption measurement Methods 0.000 description 5
- LITBAYYWXZOHAW-XDZRHBBOSA-N (2s,5r,6r)-6-[[(2r)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid;(2s,3s,5r)-3-methyl-4,4,7-trioxo-3-(triazol-1-ylmethyl)-4$l^{6}-thia-1-azabicyclo[3.2.0]hept Chemical compound C([C@]1(C)S([C@H]2N(C(C2)=O)[C@H]1C(O)=O)(=O)=O)N1C=CN=N1.O=C1C(=O)N(CC)CCN1C(=O)N[C@H](C=1C=CC=CC=1)C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 LITBAYYWXZOHAW-XDZRHBBOSA-N 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 4
- 101100351191 Autographa californica nuclear polyhedrosis virus PCNA gene Proteins 0.000 description 4
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 4
- 101150050790 ORF49 gene Proteins 0.000 description 4
- 241001641016 Salmonella phage 35 Species 0.000 description 4
- 241001640996 Salmonella phage 37 Species 0.000 description 4
- 101710173665 Uncharacterized 5.8 kDa protein Proteins 0.000 description 4
- 101710172361 Uncharacterized protein ycf17 Proteins 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 230000000968 intestinal effect Effects 0.000 description 4
- 229940104641 piperacillin / tazobactam Drugs 0.000 description 4
- 239000003826 tablet Substances 0.000 description 4
- WZPBZJONDBGPKJ-UHFFFAOYSA-N Antibiotic SQ 26917 Natural products O=C1N(S(O)(=O)=O)C(C)C1NC(=O)C(=NOC(C)(C)C(O)=O)C1=CSC(N)=N1 WZPBZJONDBGPKJ-UHFFFAOYSA-N 0.000 description 3
- 208000035143 Bacterial infection Diseases 0.000 description 3
- 206010014561 Emphysema Diseases 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 3
- 206010040047 Sepsis Diseases 0.000 description 3
- 238000012300 Sequence Analysis Methods 0.000 description 3
- 229960004821 amikacin Drugs 0.000 description 3
- LKCWBDHBTVXHDL-RMDFUYIESA-N amikacin Chemical compound O([C@@H]1[C@@H](N)C[C@H]([C@@H]([C@H]1O)O[C@@H]1[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O1)O)NC(=O)[C@@H](O)CCN)[C@H]1O[C@H](CN)[C@@H](O)[C@H](O)[C@H]1O LKCWBDHBTVXHDL-RMDFUYIESA-N 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000000845 anti-microbial effect Effects 0.000 description 3
- 229960003644 aztreonam Drugs 0.000 description 3
- WZPBZJONDBGPKJ-VEHQQRBSSA-N aztreonam Chemical compound O=C1N(S([O-])(=O)=O)[C@@H](C)[C@@H]1NC(=O)C(=N/OC(C)(C)C(O)=O)\C1=CSC([NH3+])=N1 WZPBZJONDBGPKJ-VEHQQRBSSA-N 0.000 description 3
- 208000022362 bacterial infectious disease Diseases 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- 210000002421 cell wall Anatomy 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000003937 drug carrier Substances 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 238000007918 intramuscular administration Methods 0.000 description 3
- 229960002260 meropenem Drugs 0.000 description 3
- DMJNNHOOLUXYBV-PQTSNVLCSA-N meropenem Chemical compound C=1([C@H](C)[C@@H]2[C@H](C(N2C=1C(O)=O)=O)[C@H](O)C)S[C@@H]1CN[C@H](C(=O)N(C)C)C1 DMJNNHOOLUXYBV-PQTSNVLCSA-N 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- MMRINLZOZVAPDZ-LSGRDSQZSA-N (6r,7r)-7-[[(2z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(1-methylpyrrolidin-1-ium-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;chloride Chemical compound Cl.S([C@@H]1[C@@H](C(N1C=1C([O-])=O)=O)NC(=O)\C(=N/OC)C=2N=C(N)SC=2)CC=1C[N+]1(C)CCCC1 MMRINLZOZVAPDZ-LSGRDSQZSA-N 0.000 description 2
- GNWUOVJNSFPWDD-XMZRARIVSA-M Cefoxitin sodium Chemical compound [Na+].N([C@]1(OC)C(N2C(=C(COC(N)=O)CS[C@@H]21)C([O-])=O)=O)C(=O)CC1=CC=CS1 GNWUOVJNSFPWDD-XMZRARIVSA-M 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- 241000639569 Erwinia phage PEp14 Species 0.000 description 2
- 239000004386 Erythritol Substances 0.000 description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 2
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 2
- 229930182566 Gentamicin Natural products 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 101000976889 Haemophilus phage HP1 (strain HP1c1) Uncharacterized 19.2 kDa protein in cox-rep intergenic region Proteins 0.000 description 2
- 101000768938 Haemophilus phage HP1 (strain HP1c1) Uncharacterized 8.9 kDa protein in int-C1 intergenic region Proteins 0.000 description 2
- 101700012268 Holin Proteins 0.000 description 2
- JUZNIMUFDBIJCM-ANEDZVCMSA-N Invanz Chemical compound O=C([C@H]1NC[C@H](C1)SC=1[C@H](C)[C@@H]2[C@H](C(N2C=1C(O)=O)=O)[C@H](O)C)NC1=CC=CC(C(O)=O)=C1 JUZNIMUFDBIJCM-ANEDZVCMSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- 101710159527 Maturation protein A Proteins 0.000 description 2
- 101710091157 Maturation protein A2 Proteins 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010034133 Pathogen resistance Diseases 0.000 description 2
- 101710118890 Photosystem II reaction center protein Ycf12 Proteins 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 108091075982 RecT family Proteins 0.000 description 2
- 241001518594 Salmonella phage BP12C Species 0.000 description 2
- 241000456879 Salmonella phage FSL SP-019 Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 101710172711 Structural protein Proteins 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 101710166729 Tail fiber protein Proteins 0.000 description 2
- 101710204224 Tape measure protein Proteins 0.000 description 2
- 101710198378 Uncharacterized 10.8 kDa protein in cox-rep intergenic region Proteins 0.000 description 2
- 101710110895 Uncharacterized 7.3 kDa protein in cox-rep intergenic region Proteins 0.000 description 2
- 101710134973 Uncharacterized 9.7 kDa protein in cox-rep intergenic region Proteins 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- 229960000723 ampicillin Drugs 0.000 description 2
- 229940043312 ampicillin / sulbactam Drugs 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 229960001139 cefazolin Drugs 0.000 description 2
- MLYYVTUWGNIJIB-BXKDBHETSA-N cefazolin Chemical compound S1C(C)=NN=C1SCC1=C(C(O)=O)N2C(=O)[C@@H](NC(=O)CN3N=NN=C3)[C@H]2SC1 MLYYVTUWGNIJIB-BXKDBHETSA-N 0.000 description 2
- 229960002100 cefepime Drugs 0.000 description 2
- 229960002682 cefoxitin Drugs 0.000 description 2
- 229960000484 ceftazidime Drugs 0.000 description 2
- NMVPEQXCMGEDNH-TZVUEUGBSA-N ceftazidime pentahydrate Chemical compound O.O.O.O.O.S([C@@H]1[C@@H](C(N1C=1C([O-])=O)=O)NC(=O)\C(=N/OC(C)(C)C(O)=O)C=2N=C(N)SC=2)CC=1C[N+]1=CC=CC=C1 NMVPEQXCMGEDNH-TZVUEUGBSA-N 0.000 description 2
- 230000030833 cell death Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- NWOYIVRVSJDTLK-YSDBFZIDSA-L disodium;(2s,5r,6r)-6-[[(2r)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate;(1r,4s)-3,3-dimethyl-2,2,6-trioxo-2$l^{6}-thiabicyclo[3.2.0]heptane-4-carboxylate Chemical compound [Na+].[Na+].O=S1(=O)C(C)(C)[C@H](C([O-])=O)C2C(=O)C[C@H]21.C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C([O-])=O)(C)C)=CC=CC=C1 NWOYIVRVSJDTLK-YSDBFZIDSA-L 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 229960002770 ertapenem Drugs 0.000 description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 2
- 235000019414 erythritol Nutrition 0.000 description 2
- 229940009714 erythritol Drugs 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- CEAZRRDELHUEMR-UHFFFAOYSA-N gentamicin Chemical compound O1C(C(C)NC)CCC(N)C1OC1C(O)C(OC2C(C(NC)C(C)(O)CO2)O)C(N)CC1N CEAZRRDELHUEMR-UHFFFAOYSA-N 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 244000144972 livestock Species 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000000877 morphologic effect Effects 0.000 description 2
- 210000000214 mouth Anatomy 0.000 description 2
- 210000003097 mucus Anatomy 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000007505 plaque formation Effects 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000010865 sewage Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 101710115267 ATP synthase protein MI25 Proteins 0.000 description 1
- 101000621943 Acholeplasma phage L2 Probable integrase/recombinase Proteins 0.000 description 1
- 101000748061 Acholeplasma phage L2 Uncharacterized 16.1 kDa protein Proteins 0.000 description 1
- 101000818123 Acholeplasma phage L2 Uncharacterized 17.2 kDa protein Proteins 0.000 description 1
- 101000818089 Acholeplasma phage L2 Uncharacterized 25.6 kDa protein Proteins 0.000 description 1
- 101000827329 Acholeplasma phage L2 Uncharacterized 26.1 kDa protein Proteins 0.000 description 1
- 101000768957 Acholeplasma phage L2 Uncharacterized 37.2 kDa protein Proteins 0.000 description 1
- 101000818108 Acholeplasma phage L2 Uncharacterized 81.3 kDa protein Proteins 0.000 description 1
- 101000823746 Acidianus ambivalens Uncharacterized 17.7 kDa protein in bps2 3'region Proteins 0.000 description 1
- 101000916369 Acidianus ambivalens Uncharacterized protein in sor 5'region Proteins 0.000 description 1
- 101000769342 Acinetobacter guillouiae Uncharacterized protein in rpoN-murA intergenic region Proteins 0.000 description 1
- 101000823696 Actinobacillus pleuropneumoniae Uncharacterized glycosyltransferase in aroQ 3'region Proteins 0.000 description 1
- 101000786513 Agrobacterium tumefaciens (strain 15955) Uncharacterized protein outside the virF region Proteins 0.000 description 1
- 101000618005 Alkalihalobacillus pseudofirmus (strain ATCC BAA-2126 / JCM 17055 / OF4) Uncharacterized protein BpOF4_00885 Proteins 0.000 description 1
- 101000618348 Allochromatium vinosum (strain ATCC 17899 / DSM 180 / NBRC 103801 / NCIMB 10441 / D) Uncharacterized protein Alvin_0065 Proteins 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 102100020724 Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 Human genes 0.000 description 1
- 101000748781 Anthoceros angustus Uncharacterized 3.0 kDa protein in psbT-psbN intergenic region Proteins 0.000 description 1
- 101000812031 Anthoceros angustus Uncharacterized 5.9 kDa protein in rps16-psbA intergenic region Proteins 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 101100214868 Autographa californica nuclear polyhedrosis virus AC54 gene Proteins 0.000 description 1
- 101100074342 Autographa californica nuclear polyhedrosis virus LEF-11 gene Proteins 0.000 description 1
- 101000781117 Autographa californica nuclear polyhedrosis virus Uncharacterized 12.4 kDa protein in CTL-LEF2 intergenic region Proteins 0.000 description 1
- 101000770875 Autographa californica nuclear polyhedrosis virus Uncharacterized 14.2 kDa protein in PK1-LEF1 intergenic region Proteins 0.000 description 1
- 101000781183 Autographa californica nuclear polyhedrosis virus Uncharacterized 20.4 kDa protein in IAP1-SOD intergenic region Proteins 0.000 description 1
- 101000847476 Autographa californica nuclear polyhedrosis virus Uncharacterized 54.7 kDa protein in IAP1-SOD intergenic region Proteins 0.000 description 1
- 101000967489 Azorhizobium caulinodans (strain ATCC 43989 / DSM 5975 / JCM 20966 / LMG 6465 / NBRC 14845 / NCIMB 13405 / ORS 571) Uncharacterized protein AZC_3924 Proteins 0.000 description 1
- 101000708323 Azospirillum brasilense Uncharacterized 28.8 kDa protein in nifR3-like 5'region Proteins 0.000 description 1
- 101000770311 Azotobacter chroococcum mcd 1 Uncharacterized 19.8 kDa protein in nifW 5'region Proteins 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 101000823761 Bacillus licheniformis Uncharacterized 9.4 kDa protein in flaL 3'region Proteins 0.000 description 1
- 101000819719 Bacillus methanolicus Uncharacterized N-acetyltransferase in lysA 3'region Proteins 0.000 description 1
- 101000789586 Bacillus subtilis (strain 168) UPF0702 transmembrane protein YkjA Proteins 0.000 description 1
- 101000748761 Bacillus subtilis (strain 168) Uncharacterized MFS-type transporter YcxA Proteins 0.000 description 1
- 101000792624 Bacillus subtilis (strain 168) Uncharacterized protein YbxH Proteins 0.000 description 1
- 101000736075 Bacillus subtilis (strain 168) Uncharacterized protein YcbP Proteins 0.000 description 1
- 101000736076 Bacillus subtilis (strain 168) Uncharacterized protein YcbR Proteins 0.000 description 1
- 101000790792 Bacillus subtilis (strain 168) Uncharacterized protein YckC Proteins 0.000 description 1
- 101000765620 Bacillus subtilis (strain 168) Uncharacterized protein YlxP Proteins 0.000 description 1
- 101000819705 Bacillus subtilis (strain 168) Uncharacterized protein YlxR Proteins 0.000 description 1
- 101000786247 Bacillus subtilis (strain 168) Uncharacterized protein YqaT Proteins 0.000 description 1
- 101000916131 Bacillus subtilis (strain 168) Uncharacterized protein YqxA Proteins 0.000 description 1
- 101000916134 Bacillus subtilis (strain 168) Uncharacterized protein YqxJ Proteins 0.000 description 1
- 101000948218 Bacillus subtilis (strain 168) Uncharacterized protein YtxJ Proteins 0.000 description 1
- 101000718627 Bacillus thuringiensis subsp. kurstaki Putative RNA polymerase sigma-G factor Proteins 0.000 description 1
- 101000641200 Bombyx mori densovirus Putative non-structural protein Proteins 0.000 description 1
- 101000754349 Bordetella pertussis (strain Tohama I / ATCC BAA-589 / NCTC 13251) UPF0065 protein BP0148 Proteins 0.000 description 1
- 101000774107 Borrelia burgdorferi (strain ATCC 35210 / B31 / CIP 102532 / DSM 4680) Uncharacterized protein BB_0266 Proteins 0.000 description 1
- 101000631235 Borrelia burgdorferi (strain ATCC 35210 / B31 / CIP 102532 / DSM 4680) Uncharacterized protein BB_0268 Proteins 0.000 description 1
- 201000004813 Bronchopneumonia Diseases 0.000 description 1
- 241000671907 Burkholderia phage AH2 Species 0.000 description 1
- 241000997471 Burkholderia phage BcepNazgul Species 0.000 description 1
- 101000827633 Caldicellulosiruptor sp. (strain Rt8B.4) Uncharacterized 23.9 kDa protein in xynA 3'region Proteins 0.000 description 1
- 101000736909 Campylobacter jejuni Probable nucleotidyltransferase Proteins 0.000 description 1
- 108090000565 Capsid Proteins Proteins 0.000 description 1
- 101710167800 Capsid assembly scaffolding protein Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- PTHCMJGKKRQCBF-UHFFFAOYSA-N Cellulose, microcrystalline Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC)C(CO)O1 PTHCMJGKKRQCBF-UHFFFAOYSA-N 0.000 description 1
- 102100023321 Ceruloplasmin Human genes 0.000 description 1
- 101000748745 Chlamydomonas reinhardtii Uncharacterized 6.2 kDa protein in psaC-petL intergenic region Proteins 0.000 description 1
- 101000626907 Chlamydomonas reinhardtii Uncharacterized 7.3 kDa protein in petA 5'region Proteins 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 101000947628 Claviceps purpurea Uncharacterized 11.8 kDa protein Proteins 0.000 description 1
- 101000947633 Claviceps purpurea Uncharacterized 13.8 kDa protein Proteins 0.000 description 1
- 241000218158 Clematis Species 0.000 description 1
- 101000686796 Clostridium perfringens Replication protein Proteins 0.000 description 1
- 101000947615 Clostridium perfringens Uncharacterized 38.4 kDa protein Proteins 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 102100039200 Constitutive coactivator of PPAR-gamma-like protein 2 Human genes 0.000 description 1
- 102100031725 Cortactin-binding protein 2 Human genes 0.000 description 1
- 101001017206 Coxiella burnetii (strain RSA 493 / Nine Mile phase I) Histone-like protein Hq1 Proteins 0.000 description 1
- 101000792449 Cyanophora paradoxa Uncharacterized 3.4 kDa protein in atpE-petA intergenic region Proteins 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 101150026402 DBP gene Proteins 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 102000004594 DNA Polymerase I Human genes 0.000 description 1
- 108010017826 DNA Polymerase I Proteins 0.000 description 1
- 101710159129 DNA adenine methylase Proteins 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 102100037840 Dehydrogenase/reductase SDR family member 2, mitochondrial Human genes 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 102100024101 DnaJ homolog subfamily C member 28 Human genes 0.000 description 1
- 102100031780 Endonuclease Human genes 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 241001370343 Enterobacter phage Enc34 Species 0.000 description 1
- 101000747774 Enterobacteria phage 82 Uncharacterized protein in rusA 3'region Proteins 0.000 description 1
- 101000953091 Enterobacteria phage P4 Uncharacterized protein ORF88 Proteins 0.000 description 1
- 101000948901 Enterobacteria phage T4 Uncharacterized 16.0 kDa protein in segB-ipI intergenic region Proteins 0.000 description 1
- 101000964391 Enterococcus faecalis UPF0145 protein Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 101000805958 Equine herpesvirus 4 (strain 1942) Virion protein US10 homolog Proteins 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- 101100173936 Escherichia coli (strain K12) flmA gene Proteins 0.000 description 1
- 101000790442 Escherichia coli Insertion element IS2 uncharacterized 11.1 kDa protein Proteins 0.000 description 1
- 101000788129 Escherichia coli Uncharacterized protein in sul1 3'region Proteins 0.000 description 1
- 241000068902 Escherichia phage K1-ind(3) Species 0.000 description 1
- 101000788370 Escherichia phage P2 Uncharacterized 12.9 kDa protein in GpA 3'region Proteins 0.000 description 1
- 101000788354 Escherichia phage P2 Uncharacterized 8.2 kDa protein in gpA 5'region Proteins 0.000 description 1
- 101000748786 Euglena longa Uncharacterized 7.2 kDa protein in rps2-rps9 intergenic region Proteins 0.000 description 1
- 101000792446 Euglena longa Uncharacterized 8.7 kDa protein in rpl22-rpl23 intergenic region Proteins 0.000 description 1
- 101000748747 Euglena longa Uncharacterized 9.2 kDa protein in rpl23-rpl2 intergenic region Proteins 0.000 description 1
- 108060002716 Exonuclease Proteins 0.000 description 1
- 239000001512 FEMA 4601 Substances 0.000 description 1
- 101000770304 Frankia alni UPF0460 protein in nifX-nifW intergenic region Proteins 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 101000797344 Geobacillus stearothermophilus Putative tRNA (cytidine(34)-2'-O)-methyltransferase Proteins 0.000 description 1
- 101000748410 Geobacillus stearothermophilus Uncharacterized protein in fumA 3'region Proteins 0.000 description 1
- 101000787096 Geobacillus stearothermophilus Uncharacterized protein in gldA 3'region Proteins 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 101000626903 Guillardia theta Uncharacterized 6.1 kDa protein Proteins 0.000 description 1
- 101000792437 Guillardia theta Uncharacterized 7.8 kDa protein Proteins 0.000 description 1
- 101000626971 Guillardia theta Uncharacterized 8.1 kDa protein Proteins 0.000 description 1
- 101000772675 Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) UPF0438 protein HI_0847 Proteins 0.000 description 1
- 101000631019 Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) Uncharacterized protein HI_0350 Proteins 0.000 description 1
- 101000912350 Haemophilus phage HP1 (strain HP1c1) DNA N-6-adenine-methyltransferase Proteins 0.000 description 1
- 101000933958 Haemophilus phage HP1 (strain HP1c1) Major capsid protein Proteins 0.000 description 1
- 101000743338 Haemophilus phage HP1 (strain HP1c1) Probable head completion/stabilization protein Proteins 0.000 description 1
- 101001066788 Haemophilus phage HP1 (strain HP1c1) Probable portal protein Proteins 0.000 description 1
- 101001052021 Haemophilus phage HP1 (strain HP1c1) Probable tail fiber protein Proteins 0.000 description 1
- 101000854890 Haemophilus phage HP1 (strain HP1c1) Probable terminase, ATPase subunit Proteins 0.000 description 1
- 101000743335 Haemophilus phage HP1 (strain HP1c1) Probable terminase, endonuclease subunit Proteins 0.000 description 1
- 101000748063 Haemophilus phage HP1 (strain HP1c1) Uncharacterized 11.1 kDa protein in rep-hol intergenic region Proteins 0.000 description 1
- 101000758973 Haemophilus phage HP1 (strain HP1c1) Uncharacterized 11.3 kDa protein in lys 3'region Proteins 0.000 description 1
- 101000758963 Haemophilus phage HP1 (strain HP1c1) Uncharacterized 12.7 kDa protein in lys 3'region Proteins 0.000 description 1
- 101000976893 Haemophilus phage HP1 (strain HP1c1) Uncharacterized 14.1 kDa protein in cox-rep intergenic region Proteins 0.000 description 1
- 101000818057 Haemophilus phage HP1 (strain HP1c1) Uncharacterized 14.9 kDa protein in rep-hol intergenic region Proteins 0.000 description 1
- 101000818121 Haemophilus phage HP1 (strain HP1c1) Uncharacterized 18.2 kDa protein in rep-hol intergenic region Proteins 0.000 description 1
- 101000786896 Haemophilus phage HP1 (strain HP1c1) Uncharacterized 19.2 kDa protein in rep-hol intergenic region Proteins 0.000 description 1
- 101000708358 Haemophilus phage HP1 (strain HP1c1) Uncharacterized 23.3 kDa protein in lys 3'region Proteins 0.000 description 1
- 101000786921 Haemophilus phage HP1 (strain HP1c1) Uncharacterized 26.0 kDa protein in rep-hol intergenic region Proteins 0.000 description 1
- 101000948764 Haemophilus phage HP1 (strain HP1c1) Uncharacterized 58.7 kDa protein in lys 3'region Proteins 0.000 description 1
- 101000768945 Haemophilus phage HP1 (strain HP1c1) Uncharacterized 7.9 kDa protein in int-C1 intergenic region Proteins 0.000 description 1
- 101000748060 Haemophilus phage HP1 (strain HP1c1) Uncharacterized 8.3 kDa protein in rep-hol intergenic region Proteins 0.000 description 1
- 101000977016 Haemophilus phage HP1 (strain HP1c1) Uncharacterized 8.9 kDa protein in int-C1 intergenic region Proteins 0.000 description 1
- 101710115484 Head-tail joining protein Proteins 0.000 description 1
- 101000626607 Herpetosiphon aurantiacus Putative type II restriction enzyme HgiDII Proteins 0.000 description 1
- 101000623276 Herpetosiphon aurantiacus Uncharacterized 10.2 kDa protein in HgiBIM 5'region Proteins 0.000 description 1
- 101000623175 Herpetosiphon aurantiacus Uncharacterized 10.2 kDa protein in HgiCIIM 5'region Proteins 0.000 description 1
- 101000626850 Herpetosiphon aurantiacus Uncharacterized 10.2 kDa protein in HgiEIM 5'region Proteins 0.000 description 1
- 101000748192 Herpetosiphon aurantiacus Uncharacterized 15.4 kDa protein in HgiDIIM 5'region Proteins 0.000 description 1
- 101000785414 Homo sapiens Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 Proteins 0.000 description 1
- 101001053999 Homo sapiens DnaJ homolog subfamily C member 28 Proteins 0.000 description 1
- 101000833492 Homo sapiens Jouberin Proteins 0.000 description 1
- 101001028836 Homo sapiens M-phase-specific PLK1-interacting protein Proteins 0.000 description 1
- 101000651236 Homo sapiens NCK-interacting protein with SH3 domain Proteins 0.000 description 1
- 101000652805 Homo sapiens Protein shisa-8 Proteins 0.000 description 1
- 101000820589 Homo sapiens Succinate-hydroxymethylglutarate CoA-transferase Proteins 0.000 description 1
- 101000667300 Homo sapiens WD repeat-containing protein 19 Proteins 0.000 description 1
- 101100064352 Human herpesvirus 8 type P (isolate GK18) DUT gene Proteins 0.000 description 1
- 101100100297 Human herpesvirus 8 type P (isolate GK18) TRM3 gene Proteins 0.000 description 1
- 101100283436 Human herpesvirus 8 type P (isolate GK18) gM gene Proteins 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 108010061833 Integrases Proteins 0.000 description 1
- 102100024407 Jouberin Human genes 0.000 description 1
- 101000782488 Junonia coenia densovirus (isolate pBRJ/1990) Putative non-structural protein NS2 Proteins 0.000 description 1
- 238000002768 Kirby-Bauer method Methods 0.000 description 1
- 241000588749 Klebsiella oxytoca Species 0.000 description 1
- 101000578717 Klebsiella pneumoniae Mannose-1-phosphate guanylyltransferase Proteins 0.000 description 1
- 101000957786 Klebsiella pneumoniae Phosphomannomutase Proteins 0.000 description 1
- 101000827627 Klebsiella pneumoniae Putative low molecular weight protein-tyrosine-phosphatase Proteins 0.000 description 1
- 101001015100 Klebsiella pneumoniae UDP-glucose:undecaprenyl-phosphate glucose-1-phosphate transferase Proteins 0.000 description 1
- 101000790838 Klebsiella pneumoniae UPF0053 protein in cps region Proteins 0.000 description 1
- 101000790837 Klebsiella pneumoniae Uncharacterized 18.9 kDa protein in cps region Proteins 0.000 description 1
- 101000790844 Klebsiella pneumoniae Uncharacterized 24.8 kDa protein in cps region Proteins 0.000 description 1
- 101000790840 Klebsiella pneumoniae Uncharacterized 49.5 kDa protein in cps region Proteins 0.000 description 1
- 101000811523 Klebsiella pneumoniae Uncharacterized 55.8 kDa protein in cps region Proteins 0.000 description 1
- 101000790842 Klebsiella pneumoniae Uncharacterized 65.4 kDa protein in cps region Proteins 0.000 description 1
- 101000768313 Klebsiella pneumoniae Uncharacterized membrane protein in cps region Proteins 0.000 description 1
- 101000818409 Lactococcus lactis subsp. lactis Uncharacterized HTH-type transcriptional regulator in lacX 3'region Proteins 0.000 description 1
- 101000904276 Lactococcus phage P008 Gene product 38 Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 108091071262 Lambda family Proteins 0.000 description 1
- 101000878851 Leptolyngbya boryana Putative Fe(2+) transport protein A Proteins 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- GSDSWSVVBLHKDQ-JTQLQIEISA-N Levofloxacin Chemical compound C([C@@H](N1C2=C(C(C(C(O)=O)=C1)=O)C=C1F)C)OC2=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-JTQLQIEISA-N 0.000 description 1
- 239000006142 Luria-Bertani Agar Substances 0.000 description 1
- 101000756286 Lymantria dispar multicapsid nuclear polyhedrosis virus Uncharacterized 10.9 kDa protein in LEF8-FP intergenic region Proteins 0.000 description 1
- 101000759330 Lymantria dispar multicapsid nuclear polyhedrosis virus Uncharacterized protein in LEF8-FP intergenic region Proteins 0.000 description 1
- 102100037185 M-phase-specific PLK1-interacting protein Human genes 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 101000626970 Marchantia polymorpha Uncharacterized 3.3 kDa protein in psbT-psbN intergenic region Proteins 0.000 description 1
- 101000626905 Marchantia polymorpha Uncharacterized 3.8 kDa protein in ycf12-psaM intergenic region Proteins 0.000 description 1
- 101000748779 Marchantia polymorpha Uncharacterized 6.4 kDa protein in atpA-psbA intergenic region Proteins 0.000 description 1
- 101000788536 Marchantia polymorpha Uncharacterized mitochondrial protein ymf22 Proteins 0.000 description 1
- 101000788487 Marchantia polymorpha Uncharacterized mitochondrial protein ymf25 Proteins 0.000 description 1
- 101000788489 Marchantia polymorpha Uncharacterized mitochondrial protein ymf26 Proteins 0.000 description 1
- 101000788491 Marchantia polymorpha Uncharacterized mitochondrial protein ymf27 Proteins 0.000 description 1
- 101000747938 Marchantia polymorpha Uncharacterized mitochondrial protein ymf31 Proteins 0.000 description 1
- 101000747949 Marchantia polymorpha Uncharacterized mitochondrial protein ymf32 Proteins 0.000 description 1
- 101000747945 Marchantia polymorpha Uncharacterized mitochondrial protein ymf34 Proteins 0.000 description 1
- 101000758828 Methanosarcina barkeri (strain Fusaro / DSM 804) Uncharacterized protein Mbar_A1602 Proteins 0.000 description 1
- 101000804418 Methanothermobacter thermautotrophicus (strain ATCC 29096 / DSM 1053 / JCM 10044 / NBRC 100330 / Delta H) Uncharacterized protein MTH_1463 Proteins 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 101001122401 Middle East respiratory syndrome-related coronavirus (isolate United Kingdom/H123990006/2012) Non-structural protein ORF3 Proteins 0.000 description 1
- 101001130841 Middle East respiratory syndrome-related coronavirus (isolate United Kingdom/H123990006/2012) Non-structural protein ORF5 Proteins 0.000 description 1
- MSFSPUZXLOGKHJ-UHFFFAOYSA-N Muraminsaeure Natural products OC(=O)C(C)OC1C(N)C(O)OC(CO)C1O MSFSPUZXLOGKHJ-UHFFFAOYSA-N 0.000 description 1
- 101001055788 Mycolicibacterium smegmatis (strain ATCC 700084 / mc(2)155) Pentapeptide repeat protein MfpA Proteins 0.000 description 1
- 101000774651 Naja atra Zinc metalloproteinase-disintegrin-like kaouthiagin-like Proteins 0.000 description 1
- 101100521838 Nicotiana tabacum pbf1 gene Proteins 0.000 description 1
- 108050000938 Nucleoside 2-deoxyribosyltransferases Proteins 0.000 description 1
- 102000008973 Nucleoside 2-deoxyribosyltransferases Human genes 0.000 description 1
- 101150101223 ORF29 gene Proteins 0.000 description 1
- 101150020791 ORF37 gene Proteins 0.000 description 1
- 101150016564 ORF39 gene Proteins 0.000 description 1
- 101150075249 ORF40 gene Proteins 0.000 description 1
- 101150006817 ORF43 gene Proteins 0.000 description 1
- 101150104094 ORF52 gene Proteins 0.000 description 1
- 101150098690 ORF54 gene Proteins 0.000 description 1
- 101710087110 ORF6 protein Proteins 0.000 description 1
- 101150092861 ORF71 gene Proteins 0.000 description 1
- 101100389785 Orgyia pseudotsugata multicapsid polyhedrosis virus ETM gene Proteins 0.000 description 1
- 101100069690 Orgyia pseudotsugata multicapsid polyhedrosis virus GTA gene Proteins 0.000 description 1
- 101100306237 Orgyia pseudotsugata multicapsid polyhedrosis virus LEF-8 gene Proteins 0.000 description 1
- 101000740670 Orgyia pseudotsugata multicapsid polyhedrosis virus Protein C42 Proteins 0.000 description 1
- 101100096140 Orgyia pseudotsugata multicapsid polyhedrosis virus SOD gene Proteins 0.000 description 1
- 101000783504 Orgyia pseudotsugata multicapsid polyhedrosis virus Uncharacterized 15.4 kDa protein Proteins 0.000 description 1
- 101000666843 Orgyia pseudotsugata multicapsid polyhedrosis virus Uncharacterized 24.0 kDa protein Proteins 0.000 description 1
- 101000770899 Orgyia pseudotsugata multicapsid polyhedrosis virus Uncharacterized 24.3 kDa protein Proteins 0.000 description 1
- 101000781204 Orgyia pseudotsugata multicapsid polyhedrosis virus Uncharacterized 36.6 kDa protein Proteins 0.000 description 1
- 101000770870 Orgyia pseudotsugata multicapsid polyhedrosis virus Uncharacterized 37.2 kDa protein Proteins 0.000 description 1
- 101000805098 Orgyia pseudotsugata multicapsid polyhedrosis virus Uncharacterized 73.1 kDa protein Proteins 0.000 description 1
- 101000768120 Oryza nivara Uncharacterized protein ycf76 Proteins 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 101100378791 Paenarthrobacter nicotinovorans aldh gene Proteins 0.000 description 1
- 101100156835 Paenarthrobacter nicotinovorans xdh gene Proteins 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 108010013639 Peptidoglycan Proteins 0.000 description 1
- 101000769182 Photorhabdus luminescens Uncharacterized protein in pnp 3'region Proteins 0.000 description 1
- 101100481711 Pneumococcus phage Dp-1 TMP gene Proteins 0.000 description 1
- 101710159752 Poly(3-hydroxyalkanoate) polymerase subunit PhaE Proteins 0.000 description 1
- 101000764206 Porphyra purpurea Uncharacterized protein in rpl9-rpl11 intergenic region Proteins 0.000 description 1
- 101710149744 Portal protein B Proteins 0.000 description 1
- 101710130262 Probable Vpr-like protein Proteins 0.000 description 1
- 101710130420 Probable capsid assembly scaffolding protein Proteins 0.000 description 1
- 101710197985 Probable protein Rev Proteins 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 101710146616 Prohead protease Proteins 0.000 description 1
- 101710188053 Protein D Proteins 0.000 description 1
- 102100040307 Protein FAM3B Human genes 0.000 description 1
- 241000417109 Providencia phage Redjac Species 0.000 description 1
- 101000961392 Pseudescherichia vulneris Uncharacterized 29.9 kDa protein in crtE 3'region Proteins 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 101000731030 Pseudomonas oleovorans Poly(3-hydroxyalkanoate) polymerase 2 Proteins 0.000 description 1
- 241000954595 Pseudomonas phage MP1412 Species 0.000 description 1
- 241001610516 Pseudomonas phage vB_PaeS_PAO1_Ab18 Species 0.000 description 1
- 101001065485 Pseudomonas putida Probable fatty acid methyltransferase Proteins 0.000 description 1
- 101000708297 Pseudomonas stutzeri Uncharacterized 8.5 kDa protein in nirQ 3'region Proteins 0.000 description 1
- 101710089184 Putative uncharacterized protein ycf15 Proteins 0.000 description 1
- 241000588746 Raoultella planticola Species 0.000 description 1
- 241000588756 Raoultella terrigena Species 0.000 description 1
- HELXLJCILKEWJH-SEAGSNCFSA-N Rebaudioside A Natural products O=C(O[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@@]1(C)[C@@H]2[C@](C)([C@H]3[C@@]4(CC(=C)[C@@](O[C@H]5[C@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@H](O)[C@@H](CO)O5)(C4)CC3)CC2)CCC1 HELXLJCILKEWJH-SEAGSNCFSA-N 0.000 description 1
- 102000018120 Recombinases Human genes 0.000 description 1
- 108010091086 Recombinases Proteins 0.000 description 1
- 101710124818 Recombination-associated protein RdgC Proteins 0.000 description 1
- 101710132893 Resolvase Proteins 0.000 description 1
- 101000711023 Rhizobium leguminosarum bv. trifolii Uncharacterized protein in tfuA 3'region Proteins 0.000 description 1
- 101000974028 Rhizobium leguminosarum bv. viciae (strain 3841) Putative cystathionine beta-lyase Proteins 0.000 description 1
- 101000756519 Rhodobacter capsulatus (strain ATCC BAA-309 / NBRC 16581 / SB1003) Uncharacterized protein RCAP_rcc00048 Proteins 0.000 description 1
- 101000748499 Rhodobacter capsulatus Uncharacterized 104.1 kDa protein in hypE 3'region Proteins 0.000 description 1
- 101000748505 Rhodobacter capsulatus Uncharacterized 16.1 kDa protein in hypE 3'region Proteins 0.000 description 1
- 101000827754 Rhodobacter capsulatus Uncharacterized 5.8 kDa protein in puhA 5'region Proteins 0.000 description 1
- 101000948219 Rhodococcus erythropolis Uncharacterized 11.5 kDa protein in thcD 3'region Proteins 0.000 description 1
- 101000948156 Rhodococcus erythropolis Uncharacterized 47.3 kDa protein in thcA 5'region Proteins 0.000 description 1
- 101000917565 Rhodococcus fascians Uncharacterized 33.6 kDa protein in fasciation locus Proteins 0.000 description 1
- 101000768117 Saccharum officinarum Uncharacterized protein ycf70 Proteins 0.000 description 1
- 101000790284 Saimiriine herpesvirus 2 (strain 488) Uncharacterized 9.5 kDa protein in DHFR 3'region Proteins 0.000 description 1
- 241000456876 Salmonella phage FSL SP-124 Species 0.000 description 1
- 101000814063 Salmonella phage P22 Uncharacterized 6.6 kDa protein in eae-abc2 intergenic region Proteins 0.000 description 1
- 101000953980 Salmonella phage P22 Uncharacterized 7.7 kDa protein in gp5-gp4 intergenic region Proteins 0.000 description 1
- 101000953981 Salmonella phage P22 Uncharacterized 7.8 kDa protein in ral-gp17 intergenic region Proteins 0.000 description 1
- 101000736813 Salmonella phage P22 Uncharacterized 8.6 kDa protein in ral-gp17 intergenic region Proteins 0.000 description 1
- 101000953093 Salmonella phage P22 Uncharacterized 9.0 kDa protein in gp15-gp3 intergenic region Proteins 0.000 description 1
- 101000788145 Salmonella typhimurium (strain LT2 / SGSC1412 / ATCC 700720) Uncharacterized protein YpfL Proteins 0.000 description 1
- 241001541326 Salmonella virus Chi Species 0.000 description 1
- 241000456873 Salmonella virus FSLSP088 Species 0.000 description 1
- 241001010516 Salmonella virus SPN19 Species 0.000 description 1
- 241001558040 Salmonella virus iEPS5 Species 0.000 description 1
- 101000992423 Severe acute respiratory syndrome coronavirus 2 Putative ORF9c protein Proteins 0.000 description 1
- 241000009028 Staphylococcus phage SA1 Species 0.000 description 1
- 241000543700 Staphylococcus virus Twort Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 108091081024 Start codon Proteins 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 101000936719 Streptococcus gordonii Accessory Sec system protein Asp3 Proteins 0.000 description 1
- 101000936711 Streptococcus gordonii Accessory secretory protein Asp4 Proteins 0.000 description 1
- 101000929863 Streptomyces cinnamonensis Monensin polyketide synthase putative ketoacyl reductase Proteins 0.000 description 1
- 101000788499 Streptomyces coelicolor Uncharacterized oxidoreductase in mprA 5'region Proteins 0.000 description 1
- 101000788468 Streptomyces coelicolor Uncharacterized protein in mprR 3'region Proteins 0.000 description 1
- 101001102841 Streptomyces griseus Purine nucleoside phosphorylase ORF3 Proteins 0.000 description 1
- 101000708364 Streptomyces griseus Uncharacterized 31.2 kDa protein in rplA-rplJ intergenic region Proteins 0.000 description 1
- 101000708557 Streptomyces lincolnensis Uncharacterized 17.2 kDa protein in melC2-rnhH intergenic region Proteins 0.000 description 1
- 101000953979 Streptomyces lividans Uncharacterized 6.6 kDa protein Proteins 0.000 description 1
- 101000845085 Streptomyces violaceoruber Granaticin polyketide synthase putative ketoacyl reductase 1 Proteins 0.000 description 1
- 102100021652 Succinate-hydroxymethylglutarate CoA-transferase Human genes 0.000 description 1
- 101710128479 Tail assembly protein G Proteins 0.000 description 1
- 101000649826 Thermotoga neapolitana Putative anti-sigma factor antagonist TM1081 homolog Proteins 0.000 description 1
- 101000711771 Thiocystis violacea Uncharacterized 76.5 kDa protein in phbC 3'region Proteins 0.000 description 1
- 101000764204 Trieres chinensis Uncharacterized 3.3 kDa protein in rpl11-trnW intergenic region Proteins 0.000 description 1
- 101000792450 Trieres chinensis Uncharacterized 4.7 kDa protein in ycf33-trnY intergenic region Proteins 0.000 description 1
- 101000748762 Trieres chinensis Uncharacterized 5.4 kDa protein in trnK-psbC intergenic region Proteins 0.000 description 1
- 101000626900 Trieres chinensis Uncharacterized 5.5 kDa protein in ccsA-rps6 intergenic region Proteins 0.000 description 1
- 101000768114 Triticum aestivum Uncharacterized protein ycf70 Proteins 0.000 description 1
- 101710095001 Uncharacterized protein in nifU 5'region Proteins 0.000 description 1
- 101000711318 Vibrio alginolyticus Uncharacterized 11.6 kDa protein in scrR 3'region Proteins 0.000 description 1
- 101000827562 Vibrio alginolyticus Uncharacterized protein in proC 3'region Proteins 0.000 description 1
- 101000778915 Vibrio parahaemolyticus serotype O3:K6 (strain RIMD 2210633) Uncharacterized membrane protein VP2115 Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 102100039744 WD repeat-containing protein 19 Human genes 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 101000736254 Zea mays Uncharacterized protein ycf70 Proteins 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- 235000012241 calcium silicate Nutrition 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 108010068385 carbapenemase Proteins 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 229960004261 cefotaxime Drugs 0.000 description 1
- AZZMGZXNTDTSME-JUZDKLSSSA-M cefotaxime sodium Chemical compound [Na+].N([C@@H]1C(N2C(=C(COC(C)=O)CS[C@@H]21)C([O-])=O)=O)C(=O)\C(=N/OC)C1=CSC(N)=N1 AZZMGZXNTDTSME-JUZDKLSSSA-M 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 239000000571 coke Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 229940097362 cyclodextrins Drugs 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 239000003405 delayed action preparation Substances 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000013024 dilution buffer Substances 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 239000000890 drug combination Substances 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000000635 electron micrograph Methods 0.000 description 1
- 238000001493 electron microscopy Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- HELXLJCILKEWJH-UHFFFAOYSA-N entered according to Sigma 01432 Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC(C1OC2C(C(O)C(O)C(CO)O2)O)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O HELXLJCILKEWJH-UHFFFAOYSA-N 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 102000013165 exonuclease Human genes 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 230000037433 frameshift Effects 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 101150055782 gH gene Proteins 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000001361 intraarterial administration Methods 0.000 description 1
- 238000007917 intracranial administration Methods 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 239000007951 isotonicity adjuster Substances 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229960003376 levofloxacin Drugs 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000001320 lysogenic effect Effects 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000006186 oral dosage form Substances 0.000 description 1
- 101150055367 orf47 gene Proteins 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229960002292 piperacillin Drugs 0.000 description 1
- WCMIIGXFCMNQDS-IDYPWDAWSA-M piperacillin sodium Chemical compound [Na+].O=C1C(=O)N(CC)CCN1C(=O)N[C@H](C=1C=CC=CC=1)C(=O)N[C@@H]1C(=O)N2[C@@H](C([O-])=O)C(C)(C)S[C@@H]21 WCMIIGXFCMNQDS-IDYPWDAWSA-M 0.000 description 1
- 230000004260 plant-type cell wall biogenesis Effects 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 235000019203 rebaudioside A Nutrition 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 229960003865 tazobactam Drugs 0.000 description 1
- LPQZKKCYTLCDGQ-WEDXCCLWSA-N tazobactam Chemical compound C([C@]1(C)S([C@H]2N(C(C2)=O)[C@H]1C(O)=O)(=O)=O)N1C=CN=N1 LPQZKKCYTLCDGQ-WEDXCCLWSA-N 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- 239000003860 topical agent Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 210000002845 virion Anatomy 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 235000012431 wafers Nutrition 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 238000012070 whole genome sequencing analysis Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/127—Antibiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/00021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/00031—Uses of virus other than therapeutic or vaccine, e.g. disinfectant
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/00032—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Biotechnology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Agronomy & Crop Science (AREA)
- General Chemical & Material Sciences (AREA)
- Environmental Sciences (AREA)
- Plant Pathology (AREA)
- Pest Control & Pesticides (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Dentistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
본 발명은 항생제에 대한 내성을 갖는 클렙시엘라(Klebsiella)속 균을 용균시키는 박테리오파지에 관한 것으로, 구체적으로는 서열번호 2 또는 3으로 표시되는 유전체를 포함하는 YMC15/11/N54_KPN_BP 박테리오파지 (기탁번호: [KCTC18572P])를 제공한다.
본 발명에서 제공하는 항생제 내성 클렙시엘라속 균에 대하여 특이적 사멸능을 가지므로, 항생제 내성 클렙시엘라속 균에 의해 유발되는 질환의 예방 및 치료 목적으로 활용할 수 있다.
본 발명에서 제공하는 항생제 내성 클렙시엘라속 균에 대하여 특이적 사멸능을 가지므로, 항생제 내성 클렙시엘라속 균에 의해 유발되는 질환의 예방 및 치료 목적으로 활용할 수 있다.
Description
본 발명은 항생제에 대한 내성을 갖는 클렙시엘라(Klebsiella)속 균을 용균시키는 박테리오파지에 관한 것이다.
클렙시엘라(Klebsiella)속 균에 해당하는 클렙시엘라 뉴모니아(Klebsiella pneumoniae)는 그람 음성의 피막을 가진 혐기성 세균으로 입, 피부, 장 등의 정상세균총에서 발견된다. 병원 밖 클렙시엘라 세균에 의해 유발되는 가장 흔한 감염질환은 폐렴이 있으며, 전형적으로 기관지폐렴 및 기관지염의 형태로 나타난다. 크렙시엘라 뉴모니아는 감염 및 출혈을 통해 인간 폐를 파괴할 수 있고, 때로는 점액성 객담을 생성하기도 한다. 상기 세균은 전형적으로 구강 인두에 대량으로 서식하는 미생물 흡입에 의해 기도로 들어가 감염을 유발하는 것으로 알려져 있다.
상기 클렙시엘라속 균의 감음은 대부분 면역력이 약한 사람에게서 두드러지게 나타나며, 항균치료를 수행하더라도 약 50%의 높은 사망률을 나타내고 있다. 특히, 클렙시엘라 뉴모니아는 구강 등의 흡입 이외에도 비뇨기관, 쓸개관, 및 수술에 의한 상처부위에서도 감염을 유발할 수 있다. 최근, 클렙시엘라 뉴모니아가 병원 내 감염에 있어서 매우 중요한 병원균으로 인식되고 있다.
항생제 오남용 및 이로 인한 내성균 출현 등으로 대표되는 기존 합성 항생제의 문제점이 세계적으로 크게 이슈화되어 있는 상황에서 이에 대한 해결책을 제시해 줄 수 있는 대상으로 주목을 받고 있는 것이 바로 박테리오파지(Bacteriophage) 및 박테리오파지 유래의 리신(Lysin) 단백질이다. 박테리오파지 및 리신 단백질은 기존 항생 물질과는 완전히 다른 계열이라 할 수 있으며 이에 따라 전혀 다른 항균(antibacterial) 작용 기작(mode of action)을 갖고 있다. 따라서 기존 항생제의 사용에서 나타나던 여러 부작용(side effect)이나 문제점을 개선할 수 있을 것으로 기대를 모으고 있다.
박테리오파지는 박테리아를 감염시킬 수 있으며 보통 파지(phage)라고 줄여서 부르기도 한다. 박테리오파지는 핵산으로 이루어진 유전물질 중심부를 단백질 외피가 싸고 있는 단순한 구조의 유기체이며, 핵산은 단일 사슬이거나 이중 사슬인 DNA 또는 RNA로 되어있다. 박테리오파지는 생존에 숙주(host)가 반드시 필요하며, 모든 박테리아에는 특정 박테리오파지가 존재한다고 알려져 있다. 박테리오파지는 박테리아의 세포벽(cell wall)의 펩티도글리칸(peptidoglycan) 층(layer)을 공격하여 세포벽을 파괴함으로써 박테리아를 사멸시킬 수 있다. 박테리오파지는 1915년 영국의 세균학자 Twort와 1917년 프랑스의 dHerelle에 의해 독립적으로 규명되었으며 세균을 잡아먹는다는 뜻에서 박테리오파지라고 명명되었다. 박테리오파지의 항 박테리아 활성(antibacterial activity) 때문에 발견 직후부터 인체와 동물의 질병 치료에 사용되었다. 그러나 Flemming에 의해 페니실린이 발견된 이후, 계속된 다양한 항생제의 등장 및 보급화로 인하여 서구에서는 관심이 점차 줄어들게 되었다. 그러나 러시아와 독일 등의 동구권 나라들은 박테리오파지 연구를 계속 해왔으며 관련하여 다수의 제품들이 산업화된 바도 있다. 하지만, 2000년대에 이르러 항생제 내성균 문제가 부각되면서 서구에서도 다시 박테리오파지에 대하여 관심을 갖게 되었으며 그 후 약 7~8년이 흐른 최근, 산업화 사례들이 속속 보고되고 있다. 즉, 박테리오파지가 세계적으로 새롭게 재조명되기 시작한 시기는 2000년대 초반으로, 실질적 산업화 노력이 약 7 ~ 8 여년 정도 진행된 신규한 분야로서, 생명공학기술의 발전과 맞물려 최근 매우 활발히 관련 개발이 진행되고 있는 분야라 할 수 있다.
박테리오파지의 가장 큰 특징으로는, 감염성 박테리아 속에 침투한 다음 박테리아의 세포벽을 파괴하여 박테리아의 사멸을 유도한다는 것이며, 이러한 박테리오파지에 의한 세포 사멸의 기작은 세균의 세포벽 합성을 방해하는 방식의 기존 합성 항생제의 기작과는 완전히 다르다. 따라서 기존 합성 항생제에 대한 감수성에 관계없이 자신의 항균 활성을 발휘할 수 있다. 이로 인하여 특히 기존 항생제에 대하여 이미 내성을 획득한 내성균에 대해서도 항균 효과가 있다. 또한, 박테리아에 대해서는 매우 특이적인 항균 활성을 가지고 있기 때문에 인간을 포함한 동물을 구성하는 세포인 진핵세포(eukaryotic cell)에는 영향을 주지 않는다는 장점을 갖고 있다.
본 발명의 일 목적은 항생제 내성 클렙시엘라속 균에 대하여 특이적인 감염 및 세포 사멸 능력을 갖는 신규한 박테리오파지를 제공하는 것이다.
본 발명의 다른 목적은 클렙시엘라속 균에 대하여 특이적인 세포 사멸 능력을 갖는 신규한 박테리오파지를 유효성분으로 포함하여, 상기 클렙시엘라속 균에 의해 유발되는 질환의 예방 또는 치료용 약학 조성물 및 개선용 식품 조성물을 제공하는 것이다.
본 발명의 또 다른 목적은 본 발명에 따른 상기 박테리오파지를 포함하는 항생제 및 소독제를 제공하는 것이다.
그러나 본 발명이 이루고자 하는 기술적 과제는 이상에서 언급한 과제에 제한되지 않으며, 언급되지 않은 또 다른 과제들은 아래의 기재로부터 당업계에서 통상의 지식을 가진 자에게 명확하게 이해될 수 있을 것이다.
본 발명의 발명자들은 항생제 내성 세균 감염증 치료의 대안 물질로 기존의 화학 용법 제제를 보완할 수 있는 박테리오파지를 검토하던 중 항생제 내성 클렙시엘라(Klebsiella)속 균을 선택적으로 사멸시킬 수 있는 박테리오파지를 분리하고, 분리된 박테리오파지의 형태적 및 유전적 특성을 분석하여 이를 타 박테리오파지와 구별하여 특정 지을 수 있는 유전체(genome)의 유전자 서열을 제공하며, 더 나아가 항생제 내성 클렙시엘라속 균에 특이적 사멸능을 갖는 분리된 박테리오파지를 이용하여 상기 항생제 내성 클렙시엘라속 균에 의해 유발되는 질환의 예방 및 치료 목적으로 이용함으로써 본 발명을 완성하였다.
구체적으로, 본 발명자들은 항생제 내성 클렙시엘라속 균에 대하여 선택적으로 사멸시키기 위해 노력한 결과, 병원체로부터 카바페넴 내성을 갖는 클렙시엘라 뉴모니아(Klebsiella pneumoniae)를 분리하였고, 상기 카바페넴 내성 클렙시엘라 뉴모니아를 특이적으로 사멸시킬 수 있는 신규한 박테리오파지를 선별하여, 이를 "YMC15/11/N54_KPN_BP"로 명명하였다. 이렇게 선별된 상기 박테리오파지를 2017년 5월 11일자로 한국생명공학연구원 미생물자원센터(기탁번호: [KCTC18572P])에 기탁하였다.
본 발명의 일 구현 예는 항생제 내성 클렙시엘라(Klebsiella)속 균에 대하여 특이적인 세포 사멸능을 갖고, 서열번호 2 또는 3으로 표시되는 유전체를 포함하는 박테리오파지일 수 있다.
본 발명에서 상기 클렙시엘라(Klebsiella)속 균은 장내세균과의 한 속으로, 협막을 지니며 점액을 생산하고, 탄소원으로서 구연산염을 이용하는 균으로, 자연계에 널리 존재하며 사람의 호흡기, 장관 및 비뇨기에서 검출된다. 일반적으로 상기 균은 비병원성이지만 다양한 질병의 2차 감염과 폐렴 등의 질환의 원인이 될 수 있다.
본 발명에서, 상기 클렙시엘라속 균은 클렙시엘라 뉴모니아(Klebsiella pneumoniae), 클렙시엘라 옥시토카(Klebsiella oxytoca), 클렙시엘라 플란티콜라(Klebsiella planticola) 및 클렙시엘라 테리게나(Klebsiella terrigena)로 구성된 군으로부터 선택되는 어느 한종일 수 있으며, 바람직하게는 클렙시엘라 뉴모니아(Klebsiella pneumoniae)일 수 있으나, 이에 제한되는 것은 아니다.
단, 본 발명에서 상기 클렙시엘라 뉴모니아(Klebsiella pneumoniae)는 간균으로도 불리우며, 아종으로 뉴모니아(Pneumoniae), 아자니아(azaenae) 및 리노스틸레로마티스(rhinoscleromatis)가 존재하며, 상기 균은 급성폐렴, 취비증, 비경종증을 유발할 수 있다. 또한, 항생 물질에 내성이 존재하고, 건조하지 않는 경우 실온에서 수개월 동안 생존할 수 있다.
본 발명에서 상기 "항생제 내성"은 특정 항생제에 내성을 보여 약효가 듣지 않는 것을 의미하며, 본 발명의 목적상 상기 항생제는 카바페넴(Carbapenem)의 구조를 갖는 항생제일 수 있다. 구체적으로, 아미카신(Amicacin), 앰피실린(Ampicillin), 엠피실린/설벡탐(Ampicillin/Sulbactam), 아즈트레오남(Aztreonam), 세즈타지딤(Ceftazidime), 세파졸린(Cefazolin), 에르타페넴(Ertapenem), 세페핌(Cefepime), 세폭시틴(Cefoxitin), 세포탁심(Cefotaxime), 젠타마이신(Gentamicine), 레보플록세신(Levoflocacin), 메로페넴(Meropenem), 피페라실린/타조박탐(Piperacillin/Tazobactam), 코트리목사(Cortrimoxa), 및 티게틸린(Tigecyline)으로 구성된 군으로부터 선택되는 어느 하나일 수 있으나, 이에 제한되는 것은 아니다. 본 발명의 목적상 상기 클렙시엘라 뉴모니아는 항생제 내성을 갖는 것일 수 있고, 상기 항생제 내성은 상기 카바페넴을 분해하여 효과의 발휘를 억제하는 카바페넴아제 효소(carbapenemase)를 생산함으로써 발생될 수 있다.
또한, 본 발명에서 상기 “박테리오파지”는 세균을 숙주세포로 하는 바이러스 일군의 총칭으로, 숙주에 감염된 후 증식하여 자손 파지를 방출하는 용균성을 갖는 회로 또는 숙주 염색체와 공존한 상태에서 숙주는 생존하고, 파지 DNA는 복제하는 회로를 갖는다. 본 발명의 목적상 상기 박테리오파지는 전체 게놈 크기가 59100bp 의 서열번호 1로 표시되는 유전체로 이루어진 것일 수 있고, 서열번호 2 또는 3으로 표시되는 유전체를 포함하는 것일 수 있다. 구체적으로, 상기 서열번호 2 또는 3은 상기 박테리오파지의 ORF(Open reading frame)로, 상기 클렙시엘라속 균에 흡착 및 용균의 기능을 수행하는 단백질 중에서도 특히 홀린(holin) 및 엔돌리신(endolysin)을 코딩하는 유전체를 표시하는 염기 서열일 수 있으며, 보다 상세하게는 상기 서열번호 2는 ORF48로 홀린을 코딩하는 유전체의 염기 서열이고, 서열번호 3은 ORF49로 엔돌리신을 코딩하는 유전체의 염기 서열이다.
또한, 본 발명에서 상기 박테리오파지는 시포비리데(siphoviridae)에 속하는 박테리오파지일 수 있다.
단, 본 발명에서 상기 “시포비리데(siphoviridae)”는 박테리오파지를 전자현미경을 통한 형태 관찰에 의해 분류 및 동정하는 방법에 의해 분류된 것으로, 수축성이 없는 수축성이 없는 긴 꼬리(a long non-contractile tail)를 갖는 복합형의 형태를 나타낸 것일 수 있다.
본 발명의 다른 구현 예는 본 발명에 따른 상기 박테리오파지 YMC15/11/N54_KPN_BP를 유효성분으로 포함하는 항생제 내성 클렙시엘라속 균 유발성 질환의 예방 또는 치료용 약학 조성물을 제공한다.
본 발명의 약학 조성물은 1 × 103 내지 1 × 1010 pfu/㎖의 박테리오파지를 포함하며, 바람직하게는 1 × 106 내지 1 × 109 pfu/㎖의 박테리오파지를 포함할 수 있다.
본 발명의 약학 조성물에 포함되는 박테리오파지 YMC15/11/N54_KPN_BP는 상술한 바와 같이, 항생제 내성 클렙시엘라속 균, 바람직하게는 카바페넴 내성 클렙시엘라속, 보다 바람직하게는 카바페넴 내성 클렙시엘라 뉴모니아를 특이적으로 사멸시킬 수 있는 용균능 및 흡착능이 존재하므로, 본 발명의 약학 조성물을 사용하는 경우 상기 항생제 내성 클렙시엘라속 균을 용균 및 사멸시켜 인체 내에서 상기 항생제 내성 클렙시엘라 속 균의 감염으로 인하여 유발되는 다양한 질환을 효과적으로 예방 또는 치료할 수 있다.
본 발명의 약학 조성물에서 상기 클렙시엘라속, 유전체, 박테리오파지, 항생제 내성, 시포비리데, 기탁번호, 및 클렙시엘라 뉴모니아에 대한 내용은 상기 박테리오파지에서 기재한 바와 중복되어, 이하 구체적인 기재를 생략한다.
본 발명에서 상기 클렙시엘라속 균 유발성 질환은 패혈증, 폐렴 및 폐기종으로 이루어진 군에서 선택되는 어느 하나인 것일 수 있다. 본 발명의 목적상 상기 항생제 내성 클렙시엘라속 균에 의해 유발되는 질환은 패혈증, 폐렴 및 폐기종으로 이루어진 군으로부터 선택되는 어느 하나일 수 있으나, 이에 제한되는 것은 아니다.
본 발명에서 상기 "치료"는 (ⅰ) 클렙시엘라속 균 에 의해 유발된 질환의 예방; (ⅱ) 클렙시엘라속 균 에 의해 유발된 질환의 억제; 및 (ⅲ) 클렙시엘라속 균 에 의해 유발된 질환의 경감을 의미한다.
본 발명에서 상기 약학 조성물은 캡슐, 정제, 과립, 주사제, 연고제, 분말 또는 음료 형태임을 특징으로 할 수 있으며, 상기 약학 조성물은 인간을 대상으로 하는 것을 특징으로 할 수 있다.
본 발명에서 상기 약학 조성물은 이들로 한정되는 것은 아니지만, 각각 통상의 방법에 따라 산제, 과립제, 캡슐, 정제, 수성 현탁액 등의 경구형 제형, 외용제, 좌제 및 멸균 주사 용액의 형태로 제형화하여 사용될 수 있다. 본 발명의 약학 조성물은 약학적으로 허용 가능한 담체를 포함할 수 있다. 약학적으로 허용되는 담체는 경구 투여 시에는 결합제, 활탁제, 붕해제, 부형제, 가용화제, 분산제, 안정화제, 현탁화제, 색소, 향료 등을 사용할 수 있으며, 주사제의 경우에는 완충제, 보존제, 무통화제, 가용화제, 등장제, 안정화제 등을 혼합하여 사용할 수 있으며, 국소투여용의 경우에는 기제, 부형제, 윤활제, 보존제 등을 사용할 수 있다. 본 발명의 약학 조성물의 제형은 상술한 바와 같은 약제학적으로 허용되는 담체와 혼합하여 다양하게 제조될 수 있다. 예를 들어, 경구 투여시에는 정제, 트로키, 캡슐, 엘릭서(elixir), 서스펜션, 시럽, 웨이퍼 등의 형태로 제조할 수 있으며, 주사제의 경우에는 단위 투약 앰플 또는 다수회 투약 형태로 제조할 수 있다. 기타, 용액, 현탁액, 정제, 캡슐, 서방형 제제 등으로 제형화될 수 있다.
한편, 제제화에 적합한 담체, 부형제 및 희석제의 예로는, 락토즈, 덱스트로즈, 수크로즈, 솔비톨, 만니톨, 자일리톨, 에리스리톨, 말디톨, 전분, 아카시아 고무, 알지네이트, 젤라틴, 칼슘 포스페이트, 칼슘 실리케이트, 셀룰로즈, 메틸 셀룰로즈, 미정질 셀룰로즈, 폴리비닐피롤리돈, 물, 메틸하이드록시벤조에이트, 프로필하이드록시벤조에이트, 탈크, 마그네슘 스테아레이트 또는 광물유 등이 사용될 수 있다. 또한, 충진제, 항 응집제, 윤활제, 습윤제, 향료, 유화제, 방부제 등을 추가로 포함할 수 있다.
본 발명에 상기 약학 조성물의 투여 경로는 이들로 한정되는 것은 아니지만 구강, 정맥내, 근육내, 동맥내, 골수내, 경막내, 심장내, 경피, 피하, 복강내, 비강내, 장관, 국소, 설하 또는 직장이 포함된다. 경구 또는 비경구 투하가 바람직하다.
본 발명에서 상기 "비경구"란, 피하, 피내, 정맥내, 근육내, 관절내, 활액낭내, 흉골내, 경막내, 병소내 및 두개골내 주사 또는 주입기술을 포함한다. 본 발명의 약학 조성물은 또한 직장 투여를 위한 좌제의 형태로 투여될 수 있다.
본 발명의 상기 약학 조성물은 사용된 특정 화합물의 활성, 연령, 체중, 일반적인 건강, 성별, 정식, 투여 시간, 투여 경로, 배출율, 약물 배합 및 예방 또는 치료될 특정 질환의 중증을 포함한 여러 요인에 따라 다양하게 변할 수 있고, 상기 약학 조성물의 투여량은 환자의 상태, 체중, 질병의 정도, 약무 형태, 투여 경로 및 기간에 따라 다르지만 당업자에 의해 적절하게 선택될 수 있고, 1일 0.0001 내지 50mg/kg 또는 0.001 내지 50mg/kg으로 투여할 수 있다. 투여는 하루에 한번 투여할 수도 있고, 수회 나누어 투여할 수도 있다. 상기 투여량은 어떠한 면으로든 본 발명의 범위를 한정하는 것은 아니다. 본 발명에 따른 의약 조성물은 환제, 당의정, 캡슐, 액제, 겔, 시럽, 슬러리, 현탁제로 제형화될 수 있다.
본 발명의 또 다른 구현 예는 본 발명에 따른 박테리오파지 YMC15/11/N54_KPN_BP를 유효성분으로 포함하는 항생제 내성 클렙시엘라속 균 유발성 질환의 예방 또는 개선용 식품 조성물을 제공한다.
본 발명의 식품 조성물은 1 × 103 내지 1 × 1010 pfu/㎖의 박테리오파지를 포함하며, 바람직하게는 1 × 106 내지 1 × 109 pfu/㎖의 박테리오파지를 포함할 수 있다.
본 발명의 식품 조성물에 포함되는 박테리오파지 YMC15/11/N54_KPN_BP는 상술한 바와 같이, 항생제 내성 클렙시엘라속 균, 바람직하게는 카바페넴 내성 클렙시엘라속, 보다 바람직하게는 카바페넴 내성 클렙시엘라 뉴모니아를 특이적으로 사멸시킬 수 있는 용균능 및 흡착능이 존재하므로, 본 발명의 약학 조성물을 사용하는 경우 상기 항생제 내성 클렙시엘라속 균을 용균 및 사멸시켜 인체 내에서 상기 항생제 내성 클렙시엘라 속 균의 감염으로 인하여 유발되는 다양한 질환을 효과적으로 예방 또는 개선할 수 있다.
본 발명에서 상기 클렙시엘라속 균 유발성 질환은 패혈증, 폐렴 및 폐기종으로 이루어진 군에서 선택되는 어느 하나인 것일 수 있으나, 이에 제한되는 것은 아니다.
본 발명의 식품 조성물에서 상기 클렙시엘라속, 유전체, 박테리오파지, 항생제 내성, 시포비리데, 기탁번호, 클렙시엘라 뉴모니아, 클렙시엘라속 유발성 질환 및 예방에 대한 내용은 상기 박테리오파지에서 기재한 바와 중복되어, 이하 구체적인 기재를 생략한다.
한편, 본 발명에서, “개선”은 본 발명의 식품 조성물을 이용하여 클렙시엘라속 균의 감염으로 인해 발생한 증상이 호전 또는 이롭게 변경되는 모든 행위라면 제한없이 포함할 수 있다.
본 발명의 상기 화합물을 유효성분으로 포함하는 식품 조성물은 각종 식품류, 예를 들어, 음료, 껌, 차, 비타민 복합제, 분말, 과립, 정제, 캡슐, 과자, 떡, 빵 등의 형태로 제조될 수 있다.
본 발명에서 상기 화합물이 식품 조성물에 포함될 때 그 양은 전체 중량의 0.1 내지 50%의 비율로 첨가할 수 있으나, 이에 제한되는 것은 아니다.
본 발명에서 상기 식품 조성물이 음료 형태로 제조되는 경우 지시된 비율로 상기 식품 조성물을 포함하는 것 외에 특별한 제한점은 없으며, 통상의 음료와 같이 다양한 향미제 또는 천연 탄수화물 등을 추가 성분으로서 함유할 수 있다. 구체적으로, 천연 탄수화물로서 포도당 등의 모노사카라이드, 과당 등의 디사카라이드, 슈크로스 등의 및 폴리사카라이드, 덱스트린, 시클로덱스트린 등과 같은 통상적인 당 및 자일리톨, 소르비톨, 에리트리톨 등의 당알콜 등을 포함할 수 있다. 상기 향미제로서는 천연 향미제(타우마틴, 스테비아 추출물(예를 들어 레바우디오시드 A, 글리시르히진등) 및 합성 향미제(사카린, 아스파르탐 등) 등일 수 있다.
본 발명에서, 그 외 본 발명의 상기 식품 조성물은 여러 가지 영양제, 비타민, 광물(전해질), 합성 풍미제 및 천연 풍미제 등의 풍미제, 착색제, 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알콜, 탄산 음료에 사용되는 탄산화제 등을 포함할 수 있다.
본 발명에서 상기 성분은 독립적 또는 조합하여 사용할 수 있다. 상기 첨가제의 비율은 본 발명의 핵심적인 요소에 해당하지 아니하지만, 본 발명의 식품 조성물 100 중량부 당 0.1 내지 약 50 중량부의 범위에서 선택될 수 있으나, 이에 제한되는 것은 아니다.
본 발명의 또 다른 구현 예는 본 발명에 따른 상기 박테리오파지 YMC15/11/N54_KPN_BP를 유효성분으로 포함하는 항생제를 제공한다.
본 발명에서 상기 항생제는, 대부분의 다른 항생 물질들은 대상체인 균주의 내성이 증가함에 따라 갈수록 사용범위가 줄어들 수 밖에 없는데에 반하여, 본 발명의 상기 항생제는 상기와 같은 문제점과 무관하게 사용될 수 있으므로 항생제로 사용될 수 있는 수명이 길어질 수 있다.
단, 본 발명에서 상기 "항생제"는 방부제, 살균제 및 항균제를 총칭하는 의미를 나타낸다.
본 발명의 또 다른 구현 예는 본 발명에 따른 상기 박테리오파지 YMC15/11/N54_KPN_BP를 유효성분으로 포함하는 소독제를 제공한다.
본 발명에서 상기 소독제는 항생제 내성 클렙시엘라속 균에 대하여 특이적 사멸능을 갖는 박테리오파지를 유효성분으로 하고 있으므로, 병원에서의 감염을 방지하기 위한 병원 및 보건용 도구 등의 소독제로 유용하게 사용될 수 있고, 일반 생활 소독제, 식품 및 조리 장소 및 설비의 소독제, 축산 산업의 축사 소독제로 유용하게 사용될 수 있다.
본 발명에 따른 신규한 박테리오파지는 항생제 내성 클렙시엘라속 균에 대하여 특이적 사멸능을 가지므로, 항생제 내성 클렙시엘라속 균에 의해 유발되는 질환의 예방 및 치료 목적으로 활용할 수 있다.
도 1은 본 발명의 일 실시예에 따른 항생제 내성을 갖는 클렙시엘라속 균에 대한 용균성 박테리오파지의 전자 현미경 사진을 나타낸 것이다.
도 2는 본 발명의 일 실시예에 따른 항생제 내성을 갖는 클렙시엘라속 균에 대한 용균성 박테리오파지의 흡창능을 그래프로 나타낸 것이다.
도 3은 본 발명의 일 실시예에 따른 항생제 내성을 갖는 클렙시엘라속 균에 대한 용균성 박테리오파지의 1단 증식 곡선을 나타낸 것이다.
도 4는 본 발명의 일 실시예에 따른 생체 외에서 박테리오파지의 항생제 내성을 갖는 클렙시엘라속 균에 대한 용균능을 그래프로 나타낸 것이다.
도 5는 본 발명의 일 실시예에 따른 항생제 내성을 갖는 클렙시엘라속 균에 대한 용균성 박테리오파지의 pH 안정성을 그래프로 나타낸 것이다.
도 6은 본 발명의 일 실시예에 따른 항생제 내성을 갖는 클렙시엘라속 균에 대한 용균성 박테리오파지의 온도 안정성을 그래프로 나타낸 것이다.
도 7은 본 발명의 일 실시예에 따른 항생제 내성을 갖는 클렙시엘라속 균에 대한 용균성 박테리오파지의 전체 유전체 서열분석 결과를 나타낸 것이다.
도 2는 본 발명의 일 실시예에 따른 항생제 내성을 갖는 클렙시엘라속 균에 대한 용균성 박테리오파지의 흡창능을 그래프로 나타낸 것이다.
도 3은 본 발명의 일 실시예에 따른 항생제 내성을 갖는 클렙시엘라속 균에 대한 용균성 박테리오파지의 1단 증식 곡선을 나타낸 것이다.
도 4는 본 발명의 일 실시예에 따른 생체 외에서 박테리오파지의 항생제 내성을 갖는 클렙시엘라속 균에 대한 용균능을 그래프로 나타낸 것이다.
도 5는 본 발명의 일 실시예에 따른 항생제 내성을 갖는 클렙시엘라속 균에 대한 용균성 박테리오파지의 pH 안정성을 그래프로 나타낸 것이다.
도 6은 본 발명의 일 실시예에 따른 항생제 내성을 갖는 클렙시엘라속 균에 대한 용균성 박테리오파지의 온도 안정성을 그래프로 나타낸 것이다.
도 7은 본 발명의 일 실시예에 따른 항생제 내성을 갖는 클렙시엘라속 균에 대한 용균성 박테리오파지의 전체 유전체 서열분석 결과를 나타낸 것이다.
이하, 본 발명을 하기의 실시예에 의해 상세히 설명한다. 단, 하기 실시예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기 실시예에 의해 한정되는 것은 아니다.
실시예
[실시예 1] 임상검체 분리 및 항생제 내성 균주 선별
세브란스 병원 환자들로부터 환자의 분변 내 클렙시엘라 뉴모니아(Klebsiella pneumoniae) 균을 배양하여 분리하였다. 그 뒤, 감수성 결과는 Clinical and Laboratory Standards Institute (CLSI, 2009)를 기준으로 판독하였다. 감수성 시험은 뮬러-힌튼(Mueller-Hinton) 아가를 사용하여 외기 37에서 하룻밤 동안 배양하는 CLSI 디스크 확산 시험방법을 사용하였다. 클렙시엘라 뉴모니아 균에 대한 시험 항생제는 아미카신(Amicacin), 앰피실린(Ampicillin), 엠피실린/설벡탐(Ampicillin/Sulbactam), 아즈트레오남(Aztreonam), 세즈타지딤(Ceftazidime), 세파졸린(Cefazolin), 에르타페넴(Ertapenem), 세페핌(Cefepime), 세폭시틴(Cefoxitin), 세포탁심(Cefotaxime), 젠타마이신(Gentamicine), 레보플록세신(Levoflocacin), 메로페넴(Meropenem), 피페라실린/타조박탐(Piperacillin/Tazobactam), 코트리목사(Cortrimoxa), 및 티게틸린(Tigecyline)을 사용하였다. 수집된 클렙시엘라 뉴모니아(Klebsiella pneumoniae) 53개 주의 항생제 내성 프로파일은 하기 표 1에 나타내었다. 단, 하기 표 1에서 S, I 및 R은 항균제에 대한 감수성을 평가한 결과로, 'S'는 민감(Susceptible), 'I'는 중간(Intermediate), 'R'은 내성(Resistant)를 의미한다.
숙주 균주 | 아미카신 | 엠피실린 | 엠피실린/설벡탐 | 아즈트레오남 | 세즈타지딤 | 세파졸린 | 에르타페넴 | 세페핌 | 세폭시틴 | 세포탁심 | 젠타마이신 | 레보플록사신 | 메로페넴 | 피페라실린/타조박탐 | 코트리목사졸 | 티게틸린 |
YMC15/09/P488 | ≤2 (S) | ≥32 (R) | ||||||||||||||
YMC15/09/P546 | ≤2 (S) | ≥32 (R) | ≥32 (R) | ≥64 (R) | ≥64 (R) | ≥64 (R) | ≥8 (R) | ≥64 (R) | ≥64 (R) | ≥64 (R) | ≥16 (R) | ≥8 (R) | ≥16 (R) | ≥128 (R) | ≥320 (R) | ≥8 (R) |
YMC15/09/U2874 | ≤2 (S) | ≥32 (R) | ≥32 (R) | ≥64 (R) | ≥64 (R) | ≥64 (R) | ≥8 (R) | ≥64 (R) | ≥64 (R) | ≥64 (R) | ≤1 (S) | =8 (R) | ≥16 (R) | ≥16 (R) | 40 (S) | ≥8 (R) |
YMC15/09/N45 | ≥8 (R) | ≥16 (R) | ||||||||||||||
YMC15/09/P756 | ≤2 (S) | ≥32 (R) | ≥32 (R) | ≥64 (R) | ≥64 (R) | ≥64 | ≥8 (R) | ≥64 (R) | ≥64 (R) | ≥64 (R) | ≤1 (S) | ≥8 (R) | ≥16 (R) | ≥128 (R) | ≤40 (S) | ≥8 (R) |
YMC15/09/N55 | ≥8 (R) | ≥16 (R) | ||||||||||||||
YMC15/09/T741 | ≤2 (S) | ≥32 (R) | ≥32 (R) | ≥64 (R) | ≥64 (R) | ≥64 (R) | ≥8 (R) | ≥64 (R) | ≥64 (R) | ≥64 (R) | ≤1 (S) | ≥8 (R) | 10 (R) | ≥128 (R) | ≤40 (S) | ≥8 (R) |
YMC15/09/U4318 | ≤2 (S) | ≥32 (R) | ≥32 (R) | ≥64 (R) | ≥64 (R) | ≥64 | ≥8 (R) | ≥64 (R) | ≥64 (R) | ≥64 (R) | ≤1 (S) | ≥8 (R) | ≥16 (R) | ≥128 (R) | ≤40 (S) | ≥8 (R) |
YMC15/09/P860 | ||||||||||||||||
YMC15/09/C1052 | ||||||||||||||||
YMC15/10/N12 | 6 (R) | 6 (R) | ||||||||||||||
YMC15/10/U1383 | ≤2 (S) | ≥32 (R) | ≥32 (R) | ≥64 (R) | ≥64 (R) | ≥64 | ≥8 (R) | ≥64 (R) | ≥64 (R) | ≥64 (R) | ≤1 (S) | ≥8 (R) | ≥16 (R) | ≥128 (R) | ≤40 (S) | ≥8 (R) |
YMC15/10/P776 | ≤2 (S) | ≥32 (R) | ≥32 (R) | ≥64 (R) | ≥64 (R) | ≥64 | ≥8 (R) | ≥64 (R) | ≥64 (R) | ≥64 (R) | ≥16 (R) | ≥8 (R) | ≥16 (R) | ≥128 (R) | ≥320 (R) | ≥8 (R) |
YMC15/10/N150 | ||||||||||||||||
YMC15/11/N1073 | ||||||||||||||||
YMC15/11/G57 | ≤2 (S) | ≥32 (R) | ≥32 (R) | ≥64 (R) | ≥64 (R) | ≥64 | 25 (S) | 2 (S) | ≥64 (R) | ≥64 (R) | ≤1 (S) | 4 (I) | 29 (S) | ≥128 (R) | ≤20 (S) | ≤0.5 (S) |
YMC15/11/B4059 | ≤2 (S) | ≥32 (R) | ≥32 (R) | ≥64 (R) | ≥64 (R) | ≥64 | ≥8 (R) | ≥64 (R) | ≥64 (R) | ≥64 (R) | ≥16 (R) | ≥8 (R) | ≥16 (R) | ≥128 (R) | ≥320 (R) | ≥8 (R) |
YMC15/11/U2284 | ≤2 (S) | ≥32 (R) | ≥32 (R) | ≥64 (R) | ≥64 (R) | ≥64 | =8 (R) | ≥64 (R) | ≥64 (R) | ≥64 (R) | ≥16 (R) | ≥8 (R) | ≥16 (R) | ≥128 (R) | ≥320 (R) | ≥8 (R) |
YMC15/11/N45 | ≥8 (R) | ≥16 (R) | ||||||||||||||
YMC15/11/N53 | ≥8 (R) | ≥16 (R) | ||||||||||||||
YMC15/11/N54 | ≤2 (S) | ≥32 (R) | ≥32 (R) | ≥64 (R) | ≥64 (R) | ≥64 | ≥8 (R) | ≥64 (R) | ≥64 (R) | ≥64 (R) | ≥16 (R) | ≥8 (R) | ≥16 (R) | ≥128 (R) | ≥320 (R) | ≥8 (R) |
YMC15/11/N96 | ≥8 (R) | ≥16 (R) | ||||||||||||||
YMC15/11/N98 | ≥8 (R) | ≥16 (R) | ||||||||||||||
YMC15/11/N101 | ≥8 (R) | ≥16 (R) | ||||||||||||||
YMC15/11/N107 | ≥8 (R) | ≥16 (R) | ||||||||||||||
YMC15/11/N115 | ≥8 (R) | ≥16 (R) | ||||||||||||||
YMC15/11/N137 | ≤2 (S) | ≥32 (R) | ≥32 (R) | ≥64 (R) | ≥64 (R) | ≥64 | ≥8 (R) | ≥64 (R) | ≥64 (R) | ≥64 (R) | ≤1 (S) | ≥8 (R) | ≥16 (R) | ≥128 (R) | ≤40 (S) | ≥8 (R) |
YMC15/11/R3218 | ≤2 (S) | ≥32 (R) | ≥32 (R) | ≥64 (R) | ≥64 (R) | ≥64 | ≥8 (R) | ≥64 (R) | ≥64 (R) | ≥64 (R) | ≥16 (R) | ≥8 (R) | ≥16 (R) | ≥128 (R) | ≥320 (R) | ≥8 (R) |
YMC15/11/N154 | ≥8 (R) | ≥16 (R) | ||||||||||||||
YMC15/11/R3705 | ≤2 (S) | ≥32 (R) | ≥32 (R) | ≥64 (R) | ≥64 (R) | ≥64 | ≥8 (R) | ≥64 (R) | ≥64 (R) | ≥64 (R) | ≥16 (R) | ≥8 (R) | ≥16 (R) | ≥128 (R) | ≥320 (R) | ≥8 (R) |
YMC15/11/G223 | ≤2 (S) | ≥32 (R) | ≥32 (R) | ≥64 (R) | ≥64 (R) | ≥64 | ≥8 (R) | ≥64 (R) | ≥64 (R) | ≥64 (R) | ≥16 (R) | ≥8 (R) | ≥16 (R) | ≥128 (R) | ≥320 (R) | ≥8 (R) |
YMC15/12/P746 | ≤2 (S) | ≥32 (R) | ≥32 (R) | ≥64 (R) | ≥64 (R) | ≥64 | ≥8 (R) | ≥64 (R) | ≥64 (R) | ≥64 (R) | ≤1 (S) | ≥8 (R) | ≥16 (R) | ≥128 (R) | ≤40 (S) | ≥8 (R) |
YMC15/12/C910 | ||||||||||||||||
YMC16/01/R859 | ≤2 (S) | ≥32 (R) | ≥32 (R) | ≥64 (R) | ≥64 (R) | ≥64 | ≥8 (R) | ≥64 (R) | ≥64 (R) | ≥64 (R) | ≥16 (R) | ≥8 (R) | ≥16 (R) | ≥128 (R) | ≥320 (R) | ≥8 (R) |
YMC16/01/N136 | ≥8 (R) | ≥16 (R) | ||||||||||||||
YMC16/01/N133 | ≤2 (S) | ≥8 (R) | ≥16 (R) | |||||||||||||
YMC16/01/N141 | ≥8 (R) | ≥16 (R) | ||||||||||||||
YMC16/01/N164 | ≥8 (R) | ≥16 (R) | ||||||||||||||
YMC16/01/N233 | ≥8 (R) | ≥16 (R) | ||||||||||||||
YMC16/01/N359 | ≥8 (R) | ≥16 (R) | ||||||||||||||
YMC16/01/R3917 | ||||||||||||||||
YMC16/01/R3958 | ≤2 (S) | ≥32 (R) | ≥32 (R) | ≥64 (R) | ≥64 (R) | ≥64 | ≥8 (R) | ≥64 (R) | ≥64 (R) | ≥64 (R) | ≥16 (R) | ≥8 (R) | ≥16 (R) | ≥128 (R) | ≥320 (R) | ≥8 (R) |
YMC16/02/B372 | ≤2 (S) | ≥32 (R) | ≥32 (R) | ≥64 (R) | ≥64 (R) | ≥64 | ≥8 (R) | ≥64 (R) | ≥64 (R) | ≥64 (R) | ≤1 (S) | ≥8 (R) | ≥16 (R) | ≥128 (R) | ≥320 (R) | ≥8 (R) |
YMC16/02/N11 | ≥8 (R) | ≥16 (R) | ||||||||||||||
YMC16/02/N162 | ≥8 (R) | ≥16 (R) | ||||||||||||||
YMC16/02/N394 | ||||||||||||||||
YMC16/02/N393 | ||||||||||||||||
YMC16/02/N499 | ≥8 (R) | ≥16 (R) | ||||||||||||||
YMC16/02/N726 | ≥8 (R) | ≥16 (R) | ||||||||||||||
YMC16/03/N942 | ≥8 (R) | ≥16 (R) | ||||||||||||||
YMC16/04/R1602 | ≤2 (S) | ≥64 (R) | ≥64 (R) | ≥32 (R) | 8 (I) | ≥8 (R) | ≥16 (R) | ≥128 (R) | ||||||||
YMC16/05/N235 | ||||||||||||||||
YMC16/05/N151 | ≥8 (R) | ≥16 (R) |
상기 표 1에서 보는 바와 같이, 수집된 클렙시엘라 뉴모니아(Klebsiella pneumoniae) 중 53개 주에서 항생제 내성을 가지며, 특히, 클렙시엘라 뉴모니아 YMC15/11/N54는 카바페넴 분해 효소인 bla KPC 유전자를 갖는 다재내성 균주임을 확인하였다.
[실시예 2] 박테리오파지 검체 수집
2-1 파지 은행 구축을 위한 검체 수집
세브란스 병원의 하수 처리시설에서 최초 침전지 거친 후 부유물질 및 침사물이 제거된 원수를 확보하였다. 이는 화학 처리 시설 전 단계의 하수로 제한하였다. 수집한 시료에 1L 당 염화나트륨 58g을 첨가한 후 10,000g에서 10분간 원심 분리하여 220nm 밀리포어 필터로 여과하였다. 얻어진 여과액에 폴리에틸렌글리콜(PEG, 분자량 8000)을 10% W/V으로 첨가하고 4에서 12시간 동안 냉장 보관하였다. 12시간 냉장 보관된 여과액을 12,000g에서 20분간 원심 분리하여 침전물을 파지 희석 완충액 (SM 완충액)에 재부유한 뒤, 동일한 양의 클로로포름을 첨가하여 냉동 보관하였다. 이를 3회 반복하여 300mL의 박테리오파지 부유액을 채취하였다.
2-2 용균성 파지 선별 및 용균역가 측정
용균성 파지의 분리 정제는 스팟 테스트(Spot Test)법 (Mazzocco A et al. In Bacteriophages, Clokie and Kropinski AM, eds. Humana Press. 2009)으로 실행하였다. 확보된 균주를 맥콘키 한천배지에서 접종 후 외기 35에서 하룻밤 동안 배양하였다. 배양 후, 투명한 플라크 형성을 보고 파지에 감수성인 균주를 선별하였다. 감수성인 균주를 맥콘키 한천 배지에 접종하여 35에서 12시간 동안 배양하였다. 살린 1ml 튜브에 McFarland 0.5 탁도로 각 균주의 현탁액 제조하고 H 탑 아가 (3 ml), 감수성 박테리아 100 ㎕ 및 파지 용액 (각각 1 ㎕, 10 ㎕ 및 50 ㎕)을 섞어 LB 아가에 도포한 후, 35에서 12시간 동안 배양하였다. 플라크 관찰한 후에 파스퇴르 파이펫으로 플라크를 채취하여 SM 완충 용액에 희석하고, 다시 감수성인 균주 현탁액을 이용하여 3회 반복 정제하였다. 이렇게 얻어진 순수한 박테리오파지는 SM 완충 용액에 희석하고 다시 감수성인 균주 현탁액을 이용하여 3회 반복 정제하였다. 이렇게 얻어진 순수한 박테리오파지는 SM 완충 용액에 희석하여 보관하였다.
실시예 1에서 확인한 항생제 내성 클렙시엘라 뉴모니아(Klebsiella pneumoniae) 53주 각각을 맥콘키 한천배지에서 접종하여 배양한 후, 상기 과정에 의해 정제된 박테리오파지 YMC15/11/N54_KPN_BP를 도말된 각각의 내성 균주에 5 ㎕로 접종하여 플라그 형성을 확인하고, 역가 범위를 확인하여, 용균성을 하기 표 2에 나타내었다.
단, 상기 표 2에서 + 및 -는 수집된 균주에 대한 플라크 활성을 평가한 것으로, '+'는 투명한 플라크(clear plaque)를 의미하고, '-'는 용균이 일어나지 않은 것을 의미한다.
숙주 균주 | 용균 여부 | 숙주 균주 | 용균 여부 |
YMC15/09/P488 | + | YMC15/11/R3218 | + |
YMC15/09/P546 | + | YMC15/11/N154 | + |
YMC15/09/U2874 | + | YMC15/11/R3705 | + |
YMC15/09/N45 | - | YMC15/11/G223 | + |
YMC15/09/P756 | + | YMC15/12/P746 | + |
YMC15/09/N55 | + | YMC15/12/C910 | + |
YMC15/09/T741 | + | YMC16/01/R859 | + |
YMC15/09/U4318 | + | YMC16/01/N136 | + |
YMC15/09/P860 | + | YMC16/01/N133 | + |
YMC15/09/C1052 | + | YMC16/01/N141 | + |
YMC15/10/N12 | + | YMC16/01/N164 | + |
YMC15/10/U1383 | + | YMC16/01/N233 | + |
YMC15/10/P776 | + | YMC16/01/N359 | + |
YMC15/10/N150 | + | YMC16/01/R3917 | + |
YMC15/11/N1073 | + | YMC16/01/R3958 | + |
YMC15/11/G57 | + | YMC16/02/B372 | + |
YMC15/11/B4059 | + | YMC16/02/N11 | + |
YMC15/11/U2284 | + | YMC16/02/N162 | - |
YMC15/11/N45 | + | YMC16/02/N394 | + |
YMC15/11/N53 | + | YMC16/02/N393 | + |
YMC15/11/N54 | + | YMC16/02/N499 | - |
YMC15/11/N96 | + | YMC16/02/N726 | - |
YMC15/11/N98 | + | YMC16/03/N942 | + |
YMC15/11/N101 | + | YMC16/04/R1602 | + |
YMC15/11/N107 | + | YMC16/05/N235 | + |
YMC15/11/N115 | + | YMC16/05/N151 | + |
YMC15/11/N137 | + |
상기 표 2에서 보는 바와 같이, 박테리오파지 YMC15/11/N54_KPN_BP는 항생제 내성 클렙시엘라 뉴모니아 53주 중 49주(약 92%)를 용균 시키는 것을 확인할 수 있었다.
[실시예 3] 항생제 내성 클렙시엘라 뉴모니아균에 대한 용균성 박테리오파지의 전자 현미경 분석
상기 실시예 2의 방법에 의해 정제된 박테리오파지를 감수성 균주 배양 배지(20ml LB 배지)에 접종 및 배양한 뒤 220nm 밀리포어 필터로 여과하고, 상청액에 폴리에틸렌글리콜(MW 8,000)을 10%(w/v)의 양으로 첨가한 후 밤새 냉장 보관하였다. 이후 12,000g의 조건으로 20분 동안 원심 분리한 뒤, 에너지 여과 투과 전자현미경(Energy-Filtering Transmission Electron Microscope)을 이용하여 박테리오파지의 형태를 분석하여, 그 결과를 도 1에 나타내었다.
도 1에서 보는 바와 같이, 본 발명에 따른 상기 YMC15/11/N54_KPN_BP 박테리오파지를 모양으로 분류하는 기준으로 보았을 때, 파지가 수축성이 없는 긴 꼬리(a long non-contractile tail)를 갖고, 시스(sheath)가 없으므로 시포비리대(Siphoviridae)에 속하는 것으로 분류하였다.
[실시예 4] 박페리오파지의 흡착능 및 1단 증식 곡선(One-step growth curve) 분석
항생제 내성을 갖는 클렙시엘라 뉴모니아균을 OD 값이 0.5가 되도록 배양한 뒤, 클렙시엘라 뉴모니아균에 상기 실시예 2에서 정제된 박테리오파지 YMC15/11/N54_KPN_BP를 MOI 0.001로 넣고 상온에서 배양한 뒤, 100ul 시료를 1, 2, 3, 4, 5분에 1ml씩 채취하여 LB 배지에 희석한 뒤 플라그 분석을 통해 상기 박테리오파지의 흡착능을 평가하여, 그 결과를 도 2에 나타내었다.
또한, 항생제 내성을 갖는 클렙시엘라 뉴모니아균을 OD 값이 0.3이 되도록 배양한 뒤, 4에서 5분 동안 7,000g로 원심 분리하여 세포를 침전시킨 후, 0.5ml의 LB 배지에 희석시키고, 상기 실시예 2에서 정제된 박테리오파지를 MOI 0.001(titer 108 pfu/cells)를 넣고 37에서 5분 동안 배양하였다. 배양된 혼합 시료를 13,000g에서 1분 동안 원심 분리하여 얻어진 펠렛을 10ml의 LB 배지에 희석시키고 37℃℃에서 배양하였다. 배양 도중 10분 마다 시료를 채취하여 플라그 분석을 통해 상기 박테리오파지의 1단 증식 곡선을 평가하여, 그 결과를 도 3에 나타내었다.
도 2에서 보는 바와 같이, 상기 YMC15/11/N54_KPN_BP 박테리오파지의 접종 후 5분 이내에 박테리오파지의 99% 정도가 클렙시엘라 뉴모니아균에 흡착하였다.
또한, 도 3에서 보는 바와 같이, 1단 증식 곡선 결과 71 PFU/감염 세포의 높은 버스트 사이즈를 나타내었다.
상기 결과를 통해 본 발명에 따른 상기 YMC15/11/N54_KPN_BP 박테리오파지는 항생제 내성을 갖는 클렙시엘라 뉴모니아균에 매우 빠른 시간 내에 흡착할 수 있고, 현저하게 높은 버스트 사이즈를 나타내 항생제 내성 균주의 용균 효과를 발휘하는 것을 알 수 있다.
[실시예 5] 생체 외 항생제 내성 클렙시엘라 속 균에 대한 박테리오파지의 용균능 검증
항생제 내성 클렙시엘라 뉴모니아균 1 X 109 CFU/ml에 준비된 박테리오파지 YMC15/11/N54_KPN_BP를 1 X 108 CFU/ml(MOI: 0.1), 1 X 109 PFU/ml(MOI: 1), 1 X 1010 PFU/ml(MOI: 10)의 양으로 각각 처리하고 시간 별로 OD 값(파장 600nm)을 측정하였다. 단, 음성 대조군으로는 PBS+SM 버퍼를 처리하여, 그 값을 도 4에 나타내었다.
도 4에서 보는 바와 같이, 음성 대조군과 비교할 때, 클렙시엘라 뉴모니아균에 대하여 박테리오파지를 처리한 경우 OD 값이 감소하였고, MOI 값이 증가할수록 OD 값은 더욱 감소하였다.
상기 결과를 통해, 본 발명에 따른 박테리오파지는 항생제 내성 클렙시엘라 뉴모니아균에 대하여 용균성을 갖는 것을 알 수 있다.
[실시예 6] 항생제 내성 클렙시엘라 속 균에 대한 박테리오파지의 안정성 평가
본 발명에 따른 YMC15/11/N54_KPN_BP 박테리오파지가 온도 및 알칼리에서 파괴되지 않고 안정성을 유지하는지 확인하였다.
상기 실시예 2의 방법에 의해 정제된 박테리오 파지 1 ㎕를 4, 5, 6, 7, 8, 9 및 10의 pH로 맞춘 SM 버퍼 40 ㎕에 넣은 뒤, 37℃에서 1시간 동안 배양한 뒤 항생제 내성 클렙시엘라 뉴모니아균과 함께 상기 실시예 4의 방법으로 플라크 분석을 실시하여 그 결과를 도 5에 나타내었다.
또한, 상기 박테리오파지 용액을 각각 40℃, 50℃, 60℃ 및 70℃에서 배양하는 1시간 동안 10분 단위로 각각의 샘플을 클렙시엘라 뉴모니아균과 함께 상기 실시예 4의 방법으로 플라크 분석을 실시하여 그 결과를 도 6에 나타내었다.
도 5에서 보는 바와 같이, 본 발명에 따른 상기 파지는 pH 7에 해당하는 중성에서 가장 안정성을 나타내었고, 14일 동안 상기 파지는 알칼리성에서 좀 더 안정성을 나타내었다.
또한, 도 6에서 보는 바와 같이, 상기 파지는 40℃에서는 20분까지 약 40%의 PFU를 유지하였으나, 그 이상의 온도에서는 활성도를 나타내지 않았다.
[실시예 7] 항생제 내성 클렙시엘라 속 균에 대한 박테리오파지의 전체 게놈 서열 분석
본 발명에 따른 상기 YMC15/11/N54_KPN_BP 박테리오파지의 특성을 규명하기 위하여 전체 유전자 서열 분석을 Illumina sequencer(Roche)를 통하여 통상의 기술자에게 자명한 전체 게놈 서열 분석 방법을 기초로 분석하여, 그 결과를 도 7 및 하기 표 3에 나타내었다.
유전체 번호 | 범위(Range) | 개시코돈 | 스트랜드(strand) | 길이(bp) | 추정 기능 (Putative function) |
주석 출처 (Annotation source) |
E-value | NCBI blastP identity (%) | NCBI-Bank accession number | |
시작 | 종료 | |||||||||
ORF1 | 939 | 1136 | ATG | + | 186 | |||||
ORF2 | 1139 | 1504 | ATG | + | 366 | |||||
ORF3 | 1779 | 1991 | ATG | + | 213 | putative DNA binding protein | Salmonella phage 35 | 1.00E-14 | 53% | AKJ74148.1 |
ORF4 | 1779 | 1991 | ATG | + | 213 | - | ||||
ORF5 | 2154 | 2807 | ATG | + | 654 | putative tail component K-like protein | Salmonella phage 35 | 9.00E-08 | 43% | AKJ74149.1 |
ORF6 | 2797 | 3048 | ATG | + | 252 | |||||
ORF7 | 3057 | 3182 | ATG | + | 126 | |||||
ORF8 | 3199 | 3405 | ATG | + | 207 | |||||
ORF9 | 3402 | 3701 | GTG | + | 300 | |||||
ORF10 | 3713 | 4057 | ATG | + | 345 | |||||
ORF11 | 4205 | 4735 | ATG | 531 | ||||||
ORF12 | 5087 | 5200 | ATG | 114 | ||||||
ORF13 | 5214 | 7805 | ATG | - | 2592 | |||||
ORF14 | 7802 | 8083 | ATG | - | 282 | |||||
ORF15 | 8314 | 8706 | ATG | + | 393 | RecT protein | Salmonella phage 37 | 2.00E-04 | 64% | YP_009221371.1 |
ORF16 | 8818 | 9111 | ATG | + | 294 | - | - | - | - | |
ORF17 | 9104 | 10453 | ATG | + | 1350 | exonuclease | Burkholderia phage AH2 | 1.00E-86 | 38% | YP_006561159.1 |
ORF18 | 10500 | 11138 | ATG | + | 639 | |||||
ORF19 | 11205 | 13247 | ATG | + | 2043 | DNA polymerase I | Salmonella phage FSL SP-124 | 0.00E+00 | 78% | JX296113.1 |
ORF20 | 13286 | 13582 | ATG | + | 297 | VRR-NUC domain-containing protein | Salmonella phage SPN19 | 2.00E-51 | 79% | KU927500.1 |
ORF21 | 13629 | 15116 | ATG | + | 1488 | Salmonella phage FSL SP-030 | complete genome | 2.00E-163 | 75% | KC139519.1 |
ORF22 | 15100 | 15669 | ATG | + | 570 | endonuclease | Staphylococcus phage SA1 | 5.00E-95 | 87% | GU169904.1 |
ORF23 | 15659 | 17734 | ATG | + | 2076 | RecT family recombinase | Salmonella phage FSL SP-030 | 0 | 79% | YP_006990312.1 |
ORF24 | 17737 | 17997 | ATG | + | 261 | head-tail joining protein lambda W | Salmonella phage FSL SP-019 | 8.00E-34 | 80% | AGF89268.1 |
ORF25 | 17997 | 19661 | ATG | + | 1665 | putative lambda family portal protein B | Salmonella phage BP12C | 0 | 77% | KM366098.1 |
ORF26 | 19685 | 20998 | ATG | + | 1314 | prohead protease ClpP | Salmonella phage FSL SP-019 | 5.00E-173 | 65% | AGF89266.1 |
ORF27 | 21011 | 21400 | ATG | + | 390 | decorator protein D | Salmonella phage FSLSP030 | 1.00E-58 | 76% | YP_008239846.1 |
ORF28 | 21413 | 22477 | ATG | + | 1065 | capsid protein E | Salmonella phage FSL SP-030 | 0 | 83% | KC139519.1 |
ORF29 | 22528 | 22797 | ATG | + | 270 | tail length tape measure protein | Salmonella phage 35 | 1.00E-45 | 62% | AKJ74091.1 |
ORF30 | 22799 | 23164 | ATG | + | 366 | |||||
ORF31 | 23164 | 23784 | ATG | + | 621 | |||||
ORF32 | 23781 | 24284 | ATG | + | 504 | |||||
ORF33 | 24298 | 25437 | ATG | + | 1140 | |||||
ORF34 | 25544 | 26002 | ATG | + | 459 | tail assembly chaperone | Salmonella phage Chi | 4.00E-53 | 57% | YP_009101119.1 |
ORF35 | 26044 | 26241 | ATG | + | 198 | pre-tape measure frameshift protein | Enterobacter phage Enc34 | 7.00E-25 | 71% | YP_007007021.1 |
ORF36 | 26234 | 30547 | ATG | + | 4314 | tape measure protein | Salmonella phage BP12C | 0% | 66% | YP_009300926.1 |
ORF37 | 30551 | 33337 | ATG | + | 2787 | conserved tail assembly protein | ||||
ORF38 | 33341 | 34189 | GTG | + | 849 | XRE family transcriptional regulator | Pseudomonas phage vB_PaeS_PAO1_Ab18 | 1.00E-38 | 30% | YP_009125171.1 |
ORF39 | 34198 | 34425 | ATG | + | 228 | tail assembly structural protein | Pseudomonas phage MP1412 | 1.00E-08 | 44% | YP_006561081.1 |
ORF40 | 34422 | 34628 | ATG | + | 207 | )conserved tail assembly protein | Burkholderia phage BcepNazgul | 1.00E-07 | 35% | NP_918977.1 |
ORF41 | 34628 | 36913 | ATG | + | 2286 | virion structural protein | Pseudomonas phage PaMx11 | 2.00E-111 | 33% | YP_009196285.1 |
ORF42 | 36916 | 37698 | ATG | + | 783 | tail fiber protein | Providencia phage Redjac | 1.00E-13 | 35% | YP_006905987.1 |
ORF43 | 37745 | 40354 | ATG | + | 2610 | |||||
ORF44 | 40359 | 41453 | ATG | + | 1095 | |||||
ORF45 | 41515 | 41673 | ATG | + | 159 | |||||
ORF46 | 41803 | 42129 | ATG | + | 327 | |||||
ORF47 | 42086 | 42229 | ATG | + | 144 | |||||
ORF48 | 42229 | 42561 | ATG | + | 333 | |||||
ORF49 | 42574 | 43158 | ATG | + | 585 | endolysin; PP_00051 | Erwinia phage PEp14 | 2.00E-73 | 66% | YP_005098432.1 |
ORF50 | 43158 | 43547 | ATG | + | 390 | |||||
ORF51 | 43544 | 43807 | ATG | + | 264 | |||||
ORF52 | 43831 | 44031 | ATG | - | 201 | |||||
ORF53 | 44025 | 44798 | ATG | - | 774 | nucleoside 2-deoxyribosyltransferase | Salmonella phage FSLSP088 | 3.00E-24 | 45% | YP_008239933.1 |
ORF54 | 44795 | 45094 | ATG | - | 300 | |||||
ORF55 | 45091 | 45387 | ATG | - | 297 | |||||
ORF56 | 45389 | 45598 | ATG | - | 210 | |||||
ORF57 | 45601 | 45948 | ATG | - | 348 | |||||
ORF58 | 45952 | 46464 | ATG | - | 513 | |||||
ORF59 | 46540 | 47253 | ATG | - | 714 | |||||
ORF60 | 47250 | 47570 | ATG | - | 321 | |||||
ORF61 | 47572 | 48321 | ATG | - | 750 | putative head morphogenesis protein | ||||
ORF62 | 48321 | 49559 | ATG | - | 1239 | |||||
ORF63 | 49620 | 50726 | ATG | - | 1107 | putative C-specific methylase | Escherichia phage K1-ind(3) | 1.00E-107 | 55% | ADA82477.1 |
ORF64 | 50819 | 51211 | GTG | - | 393 | |||||
ORF65 | 51189 | 51452 | ATG | - | 264 | |||||
ORF66 | 51456 | 51671 | ATG | - | 216 | |||||
ORF67 | 51674 | 52384 | GTG | - | 711 | putative DNA adenine methylase | Salmonella phage FSLSP030 | 6.00E-104 | 63% | YP_008239882.1 |
ORF68 | 52377 | 52697 | ATG | - | 321 | |||||
ORF69 | 52694 | 53014 | ATG | - | 321 | |||||
ORF70 | 53011 | 53493 | ATG | - | 483 | |||||
ORF71 | 53483 | 53890 | ATG | - | 408 | |||||
ORF72 | 53887 | 54654 | ATG | - | 768 | |||||
ORF73 | 54811 | 55083 | ATG | - | 273 | endolysin | Salmonella phage 37 | 2.00E-22 | 48% | YP_009221448.1 |
ORF74 | 55085 | 55312 | ATG | - | 228 | tail fiber protein | Salmonella phage 35 | 2.00E-14 | 59% | AKJ74137.1 |
ORF75 | 55314 | 56384 | ATG | - | 1071 | putative recombination-associated protein RdgC | Salmonella phage iEPS5 | 2.00E-162 | 65% | AGF87999.1 |
ORF76 | 56374 | 56706 | ATG | - | 333 | |||||
ORF77 | 56703 | 57014 | ATG | - | 312 | |||||
ORF78 | 57014 | 57247 | ATG | - | 234 | |||||
ORF79 | 57240 | 57686 | ATG | - | 447 | |||||
ORF80 | 57699 | 58043 | ATG | - | 345 | viral integrase family 4 | Salmonella phage 37 | 3.00E-24 | 45% | YP_009221453.1 |
ORF81 | 58021 | 58482 | ATG | - | 462 | |||||
ORF82 | 58542 | 58919 | ATG | - | 378 | RecT family protein | Salmonella phage 37 | 1.00E-28 | 50% | YP_009221455.1 |
도 7 및 상기 표 3에서 보는 바와 같이, 상기 박테리오파지의 전체 유전자는 59100bp/ GC:56.33%의 linear dsDNA로, 82개의 ORF로 구성되어 있었다. 또한, 본 발명의 상기 ORF 중 용원성 유전자(lysogenic gene) 또는 독성 관련 유전자(toxin related gene)은 존재하지 않았다.
또한, 본 발명에 따른 YMC15/11/N54_KPN_BP 박테리오파지가 용균 효과를 나타내는 단백질을 코딩하는 유전자의 서열은 서열번호 2로 표시되는 ORF48 및 서열번호 3으로 표시되는 ORF49에 해당하였다.
상기 ORF48은 에스케리키아 파지(Escherichia phage) SerU-LTllb의 holin과 34%의 유사성을 보였고, ORF49가 코딩하는 엔돌리신(Endolysin)은 에위니아 파지(Erwinia phage) Pep14의 엔돌리신과 66%의 유사성을 보였으나, 본 발명에 따른 상기 박테리오파지의 전체 서열은 기존의 박테리오파지의 서열과 대조한 결과 유사성을 갖는 박테리오파지는 존재하지 않았다.
상기 결과를 통해 본 발명에 따른 YMC15/11/N54_KPN_BP 박테리오파지는 기존에 발견되지 않은 신규한 박테리오파지에 해당함을 알 수 있다.
이상에서 본 발명에 대하여 상세하게 설명하였지만 본 발명의 권리범위는 이에 한정되는 것은 아니고, 청구범위에 기재된 본 발명의 기술적 사상을 벗어나지 않는 범위 내에서 다양한 수정 및 변형이 가능하다는 것은 당 기술분야의 통상의 지식을 가진 자에게는 자명할 것이다.
<110> Industry-Academic Cooperation Foundation, Yonsei University
<120> LYTIC BACTERIOPHAGE SPECIFIC FOR KLEBSIELLA GENUS RESISTANT TO
<130> DPB172741
<160> 3
<170> KoPatentIn 3.0
<210> 1
<211> 59100
<212> DNA
<213> Unknown
<220>
<223> Klebsiella pneumoniae bacteriophage YMC15/11/N54_KPN_BP
<400> 1
atggccaccg tggcgccgca ggaattttac ctcaaggatt gccgggcatg gccaccggtc 60
aggcccatgg cgccgacctg gctggcgcgg cccgccgccg ggtttcagcc tgccagcttt 120
ttcaagtaag cgcgcaccgc taaaaatttt cagcccgcta ggtttgccaa gtaaggaagc 180
ccaaaatttt tatagaaaat ccggatttcg gcgtccccat ggatcccgaa aaaggtgcga 240
tttctgtaaa ccattgattt tattggttcc gcggggatgg cgccgatggg gcggaaaggc 300
cagcaagcca ggcgtggcgc gggttgcatg ggtatagatc cccgttgggt gacggcgtgg 360
cggcgcgccc tggggtgacg cggaaagcaa aaatgaaata aatctgcatc gaggggttgc 420
acacggaatg agtgcaagtt atgtttatcg aacccggcgg ggatacgcga acaacgaaac 480
aacataaacg aggtaaacga aatgaaaaag attaaacgtc tggcactgtc ctggtctgtc 540
tcccgcggtc gtgacactta cggctacaac atttgccgcc ttgatgacac atcaaccgga 600
gaccgcttta aatgcatggg cggcgggtat gacatggtag ggacggtgtt cggtgactgg 660
ctggccgcaa actatcagcc tgaattgttg gcgctgaaag atcgcgctgg ggccgtgtgg 720
gaagaggcgg gcggccgtaa atcggcggac cgcgcggacc gcctatacgg catggtatac 780
cgggaaaaag atagcgtagt tatccttgat ggcgcttgcg ggcttgattg catgatccgc 840
attgctgagg ctatcgggct ggaagtggag cgcgattata tcgctaaagg ccgccgccgg 900
ggtgagactg tgggctggta tgtaagcgag gccgaataat gataacaata atgtttatcg 960
gttatttcat tatcggcgtt tatatcgggg cggacgtccg ccgcgtttta aagcgttgcc 1020
gtattgagcg ccgcccgtgt tttggtcgca tgactattta tttgcgtgaa cgtaagaccg 1080
gacggttgat cggctgttct aataacattt tcactttaat tttgcagggg tcttgatcat 1140
gagaattaaa atagaatcgc ataaatatgc gccggaatta aaccgcgttt atttaaccgg 1200
aaaaaattca tcgagcgcgg cggtactccg cgccccgtcg gtaacgtccg taaaagatgc 1260
ccgcgcggcg ttattcccta aagcgcttcc attccgccgg gttgtaaccg tggaatcata 1320
ttatgatgat cctcgttttt acgggcttgg ccgccgctat tccggaaccg tggattcata 1380
cgaacatctt aaaaacgtga tcgctaacat taaagcccgt aacactgggg ggccgctgtt 1440
agatgggtcg attctcccgc cagtgaaagt gcgtattgtc tcaataaaag ctatgggggc 1500
ttaattatgt ttacctcaaa cgttgaaaac cgtctggcat tgccagccgt cattaccgcg 1560
cccggcgact acatcacccg gtccggatgc cgcgtcacaa tcatcggggt atcgcctgtt 1620
aatagccatt ataccttccc ttgcaagggg tcagtatggg ttaaattccg cggggcgatg 1680
cggccgcgtg gatataacgt ctggatgcgg tccggtcatt tacacgccgt gggcgatcat 1740
ccgctggata tcgtcgggcc gtgggaggac ttgaaaccat gaatagtgac gcaaaaaagg 1800
ccgtcgtaaa gttctccgcg tgcggcctta tcgctggctt taccgtgatc gccattatcg 1860
cgggcgacgg gggcggcctg ttccgcccga tactttacac cgtggctgga ggggtatgct 1920
gtgggctgat atggcccaca caggaccagg gcgacgccct gctggactgg atcaaagaag 1980
ggcggcgata agccgccttt cttattggcg ctgatacccg aaccgcgaaa accggggtga 2040
cgcggacagc aaaaatgaaa taaatccggc taaggggttg cactcgttcc gtgtgcatat 2100
tatgtttatc ggacccggcg gggatacgca aacaacaata aacgaggttc aaaatgacat 2160
acgacgaaat caccgcaaaa attaacgctt tcaacctgaa agatgggatc acgattcgtt 2220
atacctccga cacggacgga tcaaccctgg ttgaactccg cgacgatagc ggcgctttga 2280
tctggtgtgc ctggtccttt gaggctgatt ttgctttctg cctggatcgc gagctggacc 2340
gctacggcgt gaacaaatca gcggaggcgt attgcgtcgc tgataaccgc cgcccgtccc 2400
acgtaaaccg cgcggactac gcaacggacg ccgaatacag cgccgcgaag gtggcgtttt 2460
atgcgcatat actccgatcc ctgtggtccg tacgcgggaa cagcatttac cgtcgccagg 2520
taaagaaaac cattaaatca ctgcgagact ggaaagcggt cgcacgcaag gacgcggacg 2580
ccgccggggt ggcggcggta ttcggtaacg ccctcatggt taaacccgtc aaaatcacta 2640
cggcgggcgg aatgaccctt atcgcctcgc aatccgatat aaagatctac ccggctttaa 2700
tgcgcctaac ggcattgtgg gatatgcgcc acggcctaac ccgtgacacg cattacaacc 2760
attctctgcc gttccactgc atcgcgggga ttgaatatgc gggctaacga tattcgccgg 2820
gcgcaagccc gttacaccat ggaaaaatgg cacgggaatt tagtcgccaa aggctttaaa 2880
gcggctggcg atctgctgta tagccgaaat gatgccgatc taacgtggga tgacaaggcc 2940
cgcgcctgga cggtgactat ctggaccacc gaggggcggg accgtctcaa agtgctaact 3000
attcgcaaaa atccggtttt accggcgtta cttaaatctt ttttctaggg gtatctatgt 3060
tcgcattccg tgatgttctg gaagtcgttt taccggcggt aatgttcgcc gtggcgcttg 3120
tcgtcatttc cagtgattac cgtcgtaaac tccgcgccag cggtcgtaaa ttcaaaaagt 3180
aagaaggggg gaattattat ggcttcggta tggtttttag tggtgacact gtgcaccgtt 3240
aaccctggcg cgctggcgtc ggattgtgat gactatgtga tcgacgggga tttgtcgtat 3300
agcgattgca tcaagtccat cgcacagttc ccggagaagg ctgcattgtt cgcggtcagc 3360
tgtaagcgcg gggaaccgct ggacggcgta gggggtgaga tgtgagtaac tttaaaacgg 3420
atgtaaaagg gtcagtagtc ctactgtaca aggacgataa cctacaaaag ccggtcgcta 3480
ctgtgaacag cgcggatgac gtggaggata tgcgcgggca aatcagagac gcggttatgg 3540
cggcctatca tatcggcgtt atggagggtt tcaatgaggc taaaagtgaa ccgctgaggg 3600
atgacccgag agttatcaag gcgctacaac gcgccacaaa agccgggcgg gaacagcacg 3660
ccgcgcaact ccgcgcgcta ctgaatgaag gtcttaacta gggggaagaa aaatgaaaaa 3720
acgtctgacc gttctgattt gtaatgatat gcgcgacccg tacgatccga ttgtggtaac 3780
ggtgagcggg gcgacgcctg aagaagtccg cgccagtgcg ataatcgcgc atgctgaggc 3840
ggaaatggcc gactttgacg gcgaccctat gacggcggcg gatctgtggg cggtatcgcg 3900
ggcttacatc ttcgcggcta tccccgggac cgtggatttt tactatgtcg ggatgccatc 3960
ggacacggtc gacaattacg atcacgtgat gggtgagatc ctgcatgtga tgggtgagag 4020
cctggacacg tcgcccctat gcaacatggg cgattaaccg cccgccgtat tcccgcccca 4080
taaggcccgc catttgagcg ggtcttttta cgtctgcctt atacccgaac ctacgtatcg 4140
cagcctatcg ccctggccgc tggcatagcc cccggagtga ccagtggatg aaaagaagtt 4200
gcactcaccc cgtttcataa aatacccctt tacgccgtcc taacagcctt tttgaaatca 4260
gattaattgc acgcggtgca ggtgcatccc tgcccggtgg cgggcgcgtt atatcgtgct 4320
gtgggctttc tgtattgcac acggggcgtg tgttataggc gctgcccttg tgtgaccgta 4380
tcaatgcacc tgatgcatgt tcaatgaggc cgcttatcgt agtgatatgg cctgtttttg 4440
tgtcggggtg gtggtgtgac cgtgtgacct ggtgacggta tgccaattct gccgccgcta 4500
cggggggtag acggggcgat cgtgggggta tgtagtaggg gtataccatg atcggggttg 4560
cggctgtctc cgtggcgctg gcgaaggaat ccggatcgaa ttcaaaaagg tacttcccgg 4620
gggtcctggc gtgccggggg tgcgcagagc cgcggtggaa gaaaatgcgg cgaaaccccc 4680
atagccccac ttcggaaatt cctgatttac aggggttttt tcgagttttg cccataggga 4740
agacgtgatt ttgcgttcca ggggtggtgc cctaaattcc gttttagccc cgcaaccgat 4800
tgattgcatt acatttttgg gcggtgctct tacaggatca ggtgtcgtca cggaaggtgg 4860
tttattacaa attacaagtt tactacaaga cgaacaactt gtaataaacc ggtaagctgc 4920
tgttatttat atcttttcct caatatttat tacaagttac aagaaaacaa ggaaatccat 4980
ataagattaa aagtaaaacg taatcggtat gcatattatg tatatgtata agtaacctca 5040
acttgtaata aataataatc gcgaaaaatg atttgcattc aaacacttgc aaattattac 5100
aagtttgccg ccccccgaaa actggtcaaa aacggccatt tttggggaca aaaaacgcga 5160
tttttcgaca aaaaagaaag gggccgaagc ccctttttag cgatttttct tgctcacact 5220
tcgtcatcgt cttcatcgtc gaacggattt ttcggtttcc cgattttctt ttcgacttcg 5280
gcattgtgtt ttttgagcgt agtttgcgcc cattttgtat tcagcgtacc gttttcctgg 5340
aacgcattac gcacacgttt tctgacgaac actcttccgc ttttactatt gaaacagagt 5400
accccagctt gagtaaaacc gagttccatg agcaggtttt tcatgcgtga agtcttcggc 5460
atctcgatgc cctcggcttc cataaatgcg tcgttcaatg atggtgaaaa gataatgtct 5520
ttgcacacgc ccagtgtcac gccgcccttg atcatgtccg ctataaattc gcctgcgccg 5580
tcgttcgctg catcgcgcat ttcgcggaaa gcattagtat ccaacggggc atggccttta 5640
tggttaaacc cctccgagat ctcccattcc atgaaccact ttttgatggc cgcgctgtga 5700
ttttcgatag cccgataaac gttagagaag aacttctcgc gttccttagc cgagccgtaa 5760
acgcggtcca tgtccatgtg gttttcagcc tgcgtggaga cgaccaggta gcggcgctgg 5820
ttctcatcca gcggaagcgc gttgatgtgg ttggtgaaca tcaatttcga actggtattc 5880
accacgtcac gcggctttac gcctttccct tcaacctgga agcggtcgtt cgagataaat 5940
tccttctgtt tgtcgaccgc gctgtaccga tcacccttgt catacacctc ttccacgatt 6000
ttcagaatgt ggccttccgc ccagtcggtg aaacgaccat tcatgaccga gtttgacacg 6060
tacccgatgt tctgggcgcc gagcatttcc cgcatgagca cgccgatggt cgatttaccc 6120
gaaccgtgag caccgcggat cagaagagag tagttaattc gctttgtcgg gtgctgaacg 6180
acgtgcgcca gccagtccat gacgtaattt cgctctttcg tgtccggaaa caatacgacg 6240
aacaggtctt tgacgatcga gatggccttt ttatccagtt ttgacagctt ttccgctggt 6300
ttagggatac tttcaggcga aaaagtgttt aaacgtagca aaccggcgtc gtcatagaag 6360
aattccggcc ctaaaagtcc ctctttttgg gtccatttcg attcaggcat atccccgtgc 6420
atttcggggt agtacataac atcgtgaata atagggattt ttacgacgtc cgtggcgaac 6480
ttattcggcg ataaaccgcc ttccacgtcg ccgatatcac gcccatggga cgaatcaaac 6540
gcgctttttg acagtaaaat cccggtttta cggctaacaa aggcgtcctg ggcctgggca 6600
aagacgtatt ctttcagcca agtcggggta tccgcacggg aaaagtcgaa actgaggtac 6660
tctttaacgg ctttgttagt cagcgcgctt tcgttcaggc gtttgtaggc tttcttggcc 6720
gcgtcaatag tcggctggcg ctcaatgccg aaaacccgca gcttacggaa gtcgtctgcc 6780
caggctttcc agtccgccat ggtggtgact tcgttgaatg cctcggtgaa ctcggaaacc 6840
tgttcccggg cttccttctc ttcgatttcg tggaccgttt tgatgatggt gccgattgtc 6900
accagcgtct gggcatcatg ggtaaagcct ttttcccact tgtactcgaa ttctgactcg 6960
tcatagttat ccgcctgcat ggaccagtcg cgggcgatct ctttcgcttc atcctgatcg 7020
cggcatgaca cctgcagcgc tgccattacc cggatccagt tttcatagtt ttccgggtca 7080
gggtatttca tgacgatatc gcgcagctcg tcgtaggtgc cgtcccactt ggtgacggtg 7140
gccattgccg cccagtcgtc atcgtccgct tcgccttccg ccgcccgccc gttaatggcc 7200
cgtgcgactt tcatccatcc ctgtttttcg gcataggcgt cgaacgcgtc ggcgatatcg 7260
cgggcgatct ccagcgttat ttccggcagg tccatggcgg ccgcgcagtt caccggggta 7320
tcatcggtga tccaggtgta ttccttgcgc gtatccgggt ggataccgaa ggcgacgaac 7380
tgctggccat cacccaggat ttcgactgca tggcgctgtc cgaagtcatc ttcccaggtg 7440
gcggacttga cctttttgaa cggctcgtcg gtatggcaaa gcaccagttt tttcggttga 7500
cggccaacac gaaccgggcc ggcgccgatt ttcttttcga caacggccat catgtgctta 7560
accccgtctt tgtcgtagac gtcaatgtct accgcggggg tgtgcttggt caggatgccg 7620
atgccagatg acgcgtattt cttcacgaaa ccgttaatct ggccacgggt attctcgatt 7680
ttctgccagt cttcgaacgc aggccgtttt cctgcttttg gcctgggcga gtcaggcgga 7740
atgatgggaa cgacggtgaa gccgttttcc cacagcacta ttccgtattc gttccagtag 7800
ttcattcaag aatttcccct gtatccgggt cgatttttat ccagtccggg ttagtgaacc 7860
aatgtggtcg gatgccagaa gttttagctg cctcacaaat tttgacggcc atctgtccgg 7920
aaacggtgtt gcggatattc cagatcatag tgtcgtaatt tacgccagcc gccttcgcca 7980
gtttggtaag gttgccgtcc gggtctacct ccagggcagc gatacccgcg agataacgcg 8040
gtctcaggga gtggtcttta atagcccacg gtggaaattt catagatgat cctcgcgtgt 8100
gtgtgcgtgt aagtaaaacg gatattagtc tcgcgctgct acaaagtaaa ggggacgata 8160
cccggcgacc cccggccatt tcacaaagat ccccgaaaaa accaatgggt accgaaaaat 8220
atttttgcga aagtgttgac acgggatgcg gcaatggcca tactccaaac cgtcaacacg 8280
acaaacccaa attaaccgaa cgaggattta actatgtcag gtatttttga acagctgctg 8340
gccgaacaac aaaaaaccaa ctccctgctg gaacagctgc tggcgaatgg cggtgtttca 8400
tccgctgcag caggtgaaga cgctggcgcc ggtaagacca ccgccaaagg taaaaccacc 8460
gccaaaggca aatccactgc tgcggcagac aagccgaaac acaccaaaga cgaagtagtc 8520
gctgcggtcg tagcggtgaa agaccgcttt ggcgcaccgg aagccaaaaa gatcaccgct 8580
aaattcggcc tggccaaaat cgccgaagcg aaagaagaac acttcgacgc gatctttgac 8640
ctgtgtgaag ccaaactggc cgaaccggaa gaggatgaag gcaactccga agaagacgac 8700
gtttaatctt cgatcgtgta actcggcccc tgcgggggcc gttttagcag agaggttatt 8760
gtgaataagt tcggaacggc aatagcgatg acgcccggcg gcggagagga agtgcctatg 8820
tgggctgagt tccgcttcga aattggcgac cgtaacccct tattcagagt aacttccccc 8880
gcgcgtggcc agaacggccg gcggattaac ggggaattcc gtttcgtcgt tacccacgtt 8940
gggtccgggt atcgttttac cgatttcagt ttcgacctgt tagcgaaaac ccggtataac 9000
ctgaaacgga ataactacgg aagggccggc gcaatggcgg ttaaaaagac aatcgatgaa 9060
gtaggcgttg aacgaatttt acgcgccata aaaggctacc atgatgagta agtctttcct 9120
ggttcgtgtt atgcaggagt ttgccggcgg cgggcattct atcttcgcgc cgtcagcctc 9180
tgcgatgtgg acggcctgcg gcggaagcct gctggccaac cttttcgaag aggacgagtg 9240
cagctatgaa gcggcggaag gaaccgtcgc ccatggcatc gccgagcagt ggctgaaaac 9300
ggacatccga ccgacgcatc ttatcggaac cacgcaggtc atcgaggaaa aaggcgttcg 9360
gcatgagatt gtcgtcaccc actccatgat cgactacgtt caggattatg ttgactggtg 9420
tcggttcgaa gaaggcatga tgctgacgga aatccgggtc tggttcaccg acctgatgcc 9480
gccagccaac gctgacgagc tggaggaaga cccggacgcc gaagtagtgc cgtttctccc 9540
gcagggcggt accgcggata acatcatcat tcgtgaccgg gtgctgattg tcaccgacct 9600
gaaatacggc accggcgtcc aggttttcgc ggaaggcaac ccccaggcgt tgctctatgc 9660
atacggggcg taccgcgcat tcagcgacga gtacgagttt gaccgggtca tcatccggat 9720
cgcacagccg aggcttgagc atttcgacgt ttgggaagtg acagtcgacg aattgctgga 9780
cttcgccgag tttatccgcg agcgtgcagc ggccgcctgg tcactcaaag ccaaacgcaa 9840
ggcgacgttg aaaggatgcc gatggtgccg ggccgcgcat aattgcgcag cggtggcgta 9900
catgatggaa tgcgccgtcg gtgccgacct cgaattcctg gacactgaat tcggagatta 9960
tgagatgtcg cagttacgct ccgccctggc ggaagaatac aaaatgcgga aggcaaagtt 10020
cggcgatctg tccgttgccg agatggccaa gatcctgccg taccgcaaag tgattgaaaa 10080
ctggttcgcc cgcctggacc tggaacttga gcgggccgcg aaagacggta aggcggttcc 10140
cgggcataag ctggtggaat cacgctctaa ccgtgcgcat accaacgtcg aaaaggccaa 10200
ggagctttat gatttcctcg gccttgacga aaaagactat atgaaaacgg aattgcgctc 10260
gccggcgcag atggaagaag tccttcggga taaacttgga ctgtcacgcg ccggcgcgcc 10320
aatggtcatc gaaagcgtcg tatggaagcc ggaaggcaag ccgaccctgg taccgctcac 10380
tgataagcgg ccaccactgg atcggaaata ttccggcgcc tatgatgacg aagatgacga 10440
tgatgaagtg taaatcggta agatggtaaa cccgtaaatt cgtaacccgg agtagagaaa 10500
tggctgaaaa attaattccc gcgaagaaag ttaaaaacgg cgttctgtat aagagcggtc 10560
acatcaaagt ttccaacgta cgcgcttcat atccgcacct gggcgcccca tacggcggag 10620
acggcgaagg cgagccgaaa tacggtatcg ttgggctttt gccgaagaaa acgcacaaag 10680
agatttacca gctgctgaaa gagcagatcg aagtcgccaa aaagaatcac aaagctggtc 10740
cgctcaaagt ggcgccggcc atgttgttcc tgaaagacgg cgatgtcgat ttcccggaca 10800
aaccggaatg cgctggcatg tgggttctct ctgcgcgcga aagcaaaaag cccgaagtct 10860
ttaacatcga gcgcgaggaa ttaacgacta aggctgagat tgaagaagag atttacggcg 10920
gttgctgggt atccatggtt atccgaccct ggacccagga taacaaatac ggcaaacgcg 10980
taaacgctaa cctgatctct gttttaaagc gtaaagatga cgaaccgttc ggcgaaggtc 11040
gtgttgatac ctccgacgcg tgggatgacg acgaagactg ggaagacgac gaagactggg 11100
aagacgacga cgccggcgac gaagacgacg acgtttaacc cccagcccgt cgggcattga 11160
aaccggaagc ccgcctagtg cgggctttct tataagagga caccatggcc gatattatta 11220
accttgacta cgaaagccgg gcgcgtgcca atctcaaaac gcaaggcctg gaccaatatt 11280
cccgctgccc ggatgcgaaa gtgctgatgg cggcgtattc ccttaacaac ggtaaggtgc 11340
agcacgccga cctatcccgt ggcgcgaaga tgccggcgga gctgaaagaa gcactgcttg 11400
acccctacgt ggagaaatgg gcattcaacg cacaattcga aagggtgatg acccgccgtg 11460
ttcttggtct gaaaaccccg tacaaatcgt ggcgatgcac gatggttctg gcgtacatgc 11520
tcggcttcac tggcgacctt ctgcagatag gtaagcaggt cgggctgaaa gaagaccagc 11580
tgaaagacac ggacggcaag cggctgataa aaatgttctg cgtgcctcaa cgtgtcacca 11640
aaaataaccc ttttgaatgg cgtaacgagc taacggatcc cgaagagtgg tgggggttct 11700
gccggtataa cattcgcgac gttgatactg aaatgctgat caaaaatcgg cttatcaagt 11760
accccatact gccgcaggaa tgggacttat acgccctgga ccagcttatc aatgaccgcg 11820
gcgtaatgat cgacaccgaa ttcgcgcagg ccgcactgga cctggctgaa cgccggaagc 11880
cgcaaatcat agaagagatg aaggatatca ccggccttca aaaccctaac tctgtatccc 11940
agctagtgcc atggcttaaa gagcgagggt acccgtttga cgatgtgcgc caggacacgg 12000
tgaaaaaagt tatccgtgaa caggaagaaa acggcgtcga tgatgaagcg ataaccgttc 12060
tgaaagcccg ccttaacagc gccaaaaact caatcgccaa atataaaacc atgatcgact 12120
gcgccgggga ggacgggcgt ttccgttact ccctgcagtt cgccggcgcc agccgaacaa 12180
atcgctgggc cggacgccgc ctgcagacgc agaacctcgc gcgcaccccg aaatttcttg 12240
agaaagtgga agacctgacg atcgcgaacc ggttcatcgc gaaccgggaa ctggataacc 12300
tggcgctgtt cgccggggaa ccgatggacg cgcttgtcgg ctgcatccgg tcagcaatca 12360
tccccgcgcc gcagcataaa tttatcgtcg ccgacctttc atccatcgaa tcggtagtta 12420
tcggatggtt gaccgactgc aaatggttca tggatacact ggcggcaaag catgacctgt 12480
atcagtcatt tgctgcccac tggctcggaa taccgtacga agacaccctt cctcaccgca 12540
gtaaagccaa acccgctacc ctcggtgcag gttatcgcct tggtggcggc cacctcggcg 12600
atgacgggaa gaaaaccggg ctgtggggat acgcggagaa tatgggcgtt cacatgaccc 12660
agaaagaagc cgcggattcg gtgaaagcgt tccgcgaact ttgcccggaa atagtgaacg 12720
cctggacgca gctggaaaac tgtgtcttcc aggttatccg tacgcaccgt ccggttaagt 12780
ggaaatgcct gaccatcgaa tacaccaagc cattcctgac tattcagctg ccgtcaggcc 12840
gtaagatgta ctacttccgc ccgcgcatcg ctgaacgcca gatgacggtt cagagcggcc 12900
cacgtaaagg cgagaagtac agcacactga acttccagta cgaagggaag attgaaaaat 12960
ccggcggttc gtcctggggc aaagtgttca gccacggggg gaaacttgtg gaaaacatcg 13020
ttcaggccct ggcgcgtgac gtcctcgccg aagggatgaa gaaggcacac cggatgggat 13080
ttaagatcgt catgcacatc cacgatgaga tcgtcaccga agtcccggaa gatagtccgt 13140
taacccttgc tgacctgatc ggctgcatgg cggctgaact gccatgggcg cccggattgc 13200
cgcttggcgc cgccggatgg gaagggtatt tttatcgcaa ggactaattt gcatagaaat 13260
caaagacttg ccggagaaac cgctaatgcc cgaatgggga acccctgtcg tcagggaatc 13320
gaaggtcgaa ggccgctgct gcgagtatgc gcagggccgc ggctggtggg tgtcgaagtt 13380
cacggcacct gggaaaaagg ccgttccgga ccgcgttttt atccggaacg gcgttgtgct 13440
ttttgtggaa ttcaagcgcc cgggcgaaga accaacgctg cagcagcgaa accgccatcg 13500
gcagatgaaa gccaaagggg ctaacgtgac atgggtggac aattttgaag actttaagaa 13560
ctaccttatc tcctttgagt aaggcaatcg cgtattgcca gcgcaacgtg attcaccagc 13620
ggtcggacat gcacggctat caggacgagg gcgtcgactt catcaaagaa acgccgttct 13680
gtggcctgtt cgtcgacctc ggcctgggca agaccgtgat ggccgccact gccgcactag 13740
accgtatcgt agacgggaag gtcaacaaag tgctgatcgt cgggccaaaa cgcgttgcga 13800
aagtgggctg gccaagcgaa ttcgaggaat gggggcacct ctgtttctgg aagatatcgg 13860
tcatcgacgg tgatgcagcg caacgcgagc gcgccgcacg cgaggactgc catttctaca 13920
cggtgagcgt ggataacctc gcgtggctgt gtacgctgtt caaaaagaaa tggccatacg 13980
acatggttat cctggacgag tccagcatgt tcaagtcgca tacctcgcaa cggttcaagc 14040
tgttgcggcg ctgccggccg tacataaact acctggtgga gctgactgcc acccctgccg 14100
ccgaagggta catgggcatt ttcgcacaga cgtacctgct ggacgaaggc gagcgatttg 14160
gcaccacgat caccgggtat caggaaaact atttcatcca gaacaagtac aacttcaagt 14220
tcaagttacg caatggcgcc gaggaagaaa tcatccgtaa gatctccgac atcgtcatgg 14280
tgatgaaggc ggaagattat ctagacgtcg aaaagccaac gctggtaccg ctaccggtag 14340
aactagaccc gcattccgcg gacctgtacc gccagatgga agaagaatcc cttgtcgaaa 14400
tcatgcccga cgaattcgac gaatatctgg atgacccggt gacgattgaa gccgagcagg 14460
cggcggccct gcaggacaaa ttgctgcaac tggcgtccgg atttatctac gataccaaaa 14520
ttgtcgggat caccagtgac gacaaagtag tgaagcagaa agatgcttat cgaattcacg 14580
acctgaaatt cgatgcgctg gaagagttac ttgacagcac cctggagggg gaaaacgtct 14640
ttctggccta tcactttaag ccgaccctgg cccgcctgca ggagcggttc gggaaaaggg 14700
gtctggtcgt catggatgat gacggcaagg cgattaagaa gtggaacgcc ggaaagataa 14760
agctgctggc agcacacccc cagtccgccg gccatgggct taacctgcag cacggtggtc 14820
acatcatcgt atacgttgat aacccgtggt cgcttgaacg gtttctgcaa ttcaatggcc 14880
gcctggcgcg tcagggccag aagcacccgg taacggttta ccagatgaaa gcgatgatcc 14940
gccatccgaa aaccaaggag ctgatcgaca ctgtcgacgg caccgtcatc gaagcgctaa 15000
atactaaggg tgatgtgcaa gatgcttttt ttgatttgct aaaccgcatc aaaggccgca 15060
taactaagcg catgaaggct aagaaaacgg agctatggga tgacgaagac gactaagacc 15120
gccccgctgg cgacccgcaa tcggcgatcg aatgcgccgg acgctgatac cgaggcgatg 15180
attttccagg ggtgcaacat aacgcaactg gcgaagctgt tccgcatgga gcgccgggac 15240
atcacgccga agatcatgga tatcccgccc gtcggggagc gcggcgggta cccaatttac 15300
gccgtccacg aagtcgcgcc gtacctggta aaaccgctgt acgacgtcga gacgtatttg 15360
cgccgcatga acttcaaaga cctgcccaaa gagctgtcga aggagttctg gaacggccag 15420
cgcgcgaagc aggagtatga cctgcgcgca gggaacctgt ggccaacgga agacgtggtc 15480
agcgtattcg gcgaagcgat caaaacgctg cggatgagtc tgctgctgat ccccgacaca 15540
ttatcgcggc aggtagggct taccgaagcg cagcgcaacg tggtgcagtc atcggtggat 15600
tcaatactgg atgacctcgc gaataccctg gaaagacggt tcgcggagga agaagacgat 15660
gaagtttaaa tcgttaaacc acatcatccg gtcggtcgcc agccagctgc ggccaccaat 15720
gcgcatgacg gtcgctgagg cggccgccaa ataccgttac gtgaaccagc ccggcgcata 15780
tgtcgggcct tggcttaata tgaccacgcc atacatggtc gagccgatga acacgctgaa 15840
cagccgccat tacaacaaaa tggcgtttgt cggtccggcg cagagcggga aaacggatgc 15900
gctgatcctc aacggcatta cctattcggt gaaagtagac cccatggata tcatggtgtt 15960
ctgcccgact tctaccgccg cacgcgactt ctcaatgcga cgcgtggacc gactccatcg 16020
gcacagcccg gaagtaggcg ccatgctgat gaagaaccgt gatgccgata acaaattcga 16080
taaacactac accaccggga tcattctgac gcttagttac ccatcggtta cggaactggc 16140
ggggaggccg gtgggccgta tcatcatcac cgactatgac cgtatcgacg atgacatcgg 16200
cggcgacggt aacgcctttg acctcgcatc aaaacgtaca acgaccttcg ggtcgttcgc 16260
catgtgcgcg gcagaatcgt cgccgtcccg cccggtaaaa gacccaaact ggatcaagaa 16320
aacgccgcat gaagcgccac cgtgcgacgg catcgtcggg ctttacaacc gcggcgaccg 16380
ccggcgctgg aaatggccat gcccccattg cgaccagtat ttcgaaggaa cgttccagct 16440
gatgaagtgg gacaccaagt ccgccgatgg ccgaacgctc accaacctgg aaaaagcaga 16500
aacggccaga atggtctgcc catgctgcgg ctgcgaaatc gcgccggaag agaagtacga 16560
gatgaatttg tggggtatgt gggtaccgga aggatgtacg gtaaatgaga aagggcaact 16620
ggtcggcgag ccgattcggg cgacattcgc gtctttctgg ctgcgcggta cggcggcggc 16680
gtttatctca tggcagacgc tggtgctgaa ctacctcgat gcatccgacg actatgagcg 16740
cacgatgtcg gaagagtcgt tgaaaaagtt ctggaacaac gacatgggag aaccctatgt 16800
gccgaagtcg atcgagtcgg ttcgtgttcc ggaaatgctg aaagcccggg cagagccgtg 16860
ggcggaaaaa acggtcccgc ccgccgtacg ttttttggcg gcgacggtgg acgtccagaa 16920
acatcgcttt gaggtggcgg tattcggcgt ggcgccgggg tacccgttcg atatttacct 16980
gattgaccgg ttcaacatca tcaaatcaga gcgtctcgat atagacggcg agcgggagaa 17040
gttaagcccg gcggcgtacc tggaggactg ggatttgatc gagaagcagg tcatgatgaa 17100
gacctatccg ctggccgatg accccagtcg cgtgatgcag gtcaagatga cagcctgtga 17160
ctccggcggt gcagcaggcg taacggccaa tgcgtacgag tattatcgca agctgcgccg 17220
cgaggggaaa aacgggcgat tcatcctggt caaaggcgac cctatgccga aaagcccgcg 17280
tacccatatc gcgacaccgg actctaaccg gaaggacaaa aacgcgatcg cgcgcggcga 17340
cgttccggtg ctgatgataa actccaacat ggtgaaagac atgcttaacg gccgactgga 17400
tgtaacggtt cccggaaaag gcatgtatca tttccctacg tggcttccgg actacgcata 17460
cggcgagatg tgcgccgagc atcgcgacga aaaaggctgg caatgcccgc agggtacccg 17520
aaatgaaacg tgggacttga gttactatct gatcgggatg tgtatcagcg ggcgtgtcct 17580
cgcgatggaa gcaatagact gggataaccc gccagtctgg gctgacgagt gggataaaaa 17640
cccgctggtg gtcacaatag ataaacagga ggccatcgca gaaaaaccag atacaggtta 17700
tagttttgcg caactggccg aaatgttagc atgaggatga ccaccatgac cccagatgaa 17760
tgccgagcca agtaccaaca atggctgaat gacgctatgg acgcctataa ccagctgaac 17820
gtcggtggtt cggtgcgtgt tgtggtggac cagaacggcg aacgcgtaga gtatacggcg 17880
gccaaccgcc agagcctgtg ggcgtatatt ctgcgactgc agaacgcaat taactcaccc 17940
gacccgtgca gagccttctt cggcacgccg agtcgcccag cgaggtttat tttctgatga 18000
gcgaagtcaa gaaagccact cgcgcgagca agaaaaccgc ggttgctacg gtcgacgcct 18060
ctccggcgaa acctgcagcg ggcggcggcc ttgagggtgc tgaacgaaac acccgcgcaa 18120
ccttcaactg gaatcctgcg ataatttcgc cagaccagca gatcgcccgc gataaggata 18180
tggccgatgc ccgcgcacag gacatggtgc agaacgacgg ctatgccttt ggcgccgtgg 18240
cgatccaccg tgacagtatt gtcgggtcac agtacaagct gaacgccaag ccgaattccc 18300
tgatacttgg cgctcctgac ggttgggcgg aggaattcca ggctatcgtt gaatcgcggt 18360
tcaacatggc ggccgagtca ccggaaaact ggttcgacgc ccggcgcgtc aatacgttta 18420
ccggcctggt tcgcctcgcg gtcggcggat ttttgatgac cggggaagtg ctggggtccg 18480
ccgagtgggt caagtctacc ggacgtggcg cattaggccg ccggccattc ggtaccgcca 18540
ttcagtttat ctcgccctac cgactgtcga acccggacat gcagacggat accgaccgga 18600
tccgtaaggg cgtcgagatt gacgagtatg gcgccccgca ggcgtactgg ttccgcgaag 18660
ccttcccggg agactacacc aacattgaag gccagtggcg ctggaagcgc gagcctgcgc 18720
gattcgactg gggccgccgg cgtattatcc acatcatcga acagctgctg cccgggcaga 18780
cccgcgggat cagcgagatg gtgtcggcgt tgaagcagat gcggatgacc cgtaatttcc 18840
aggaagtcac cctgcagaac gccatcgtta acgcgacgta tgccgccgtt atcgaatccg 18900
aattgccgac gcatgaagtc ttctcgcagc tgggcatggg gcagaccgcc ttttcggaat 18960
acttcaacgc ctacatggcg agtatggccg agtatgtcgc cgcgtcgaag aacatcacga 19020
tcgacggcgt taaagtcccg cacctctttc ccggaacgaa gttcaacctg aaacccgccg 19080
gcacaccggg cggcgtcggt actgactatg aagaatcgct gctgcgcaat atcgccgcgg 19140
cgctcggtct ttcctatgag cagttcagcc gcgactacac gaagacgaac tacagttctg 19200
cgcgtgcgtc gatggcggaa acgtggaaat tcatggagag ccgtaagaag ctggtagccg 19260
accgtttcgc gtctatggtc tatacgctat ggctggaaga agagattaac gccggcaatg 19320
tgccgctgcc accgggcaag acctggcgtg acttttacga cccgatgttc cgtgatgcga 19380
tttgcaatgc tgaatggatc ggagccagcc gtggccagat tgacgagaag aaagaaaccg 19440
aagctgcgat cctgcgtatc aagaatggcc tgtcgacata cgaagccgaa attgcgcgcc 19500
tgggtggcga tttccgttcg gtgtttgagc agcgcgcgcg ggaagaaaat ctgattaaat 19560
cgctggattt ggatttttca ggtaaagttg tcgaaggcgc agagacgaca tcatcttcct 19620
cgtcggcgac cgataaccct gataaggaac agaaccaatg aatgcacatg ttcgatccag 19680
cttaatgcaa gcggttcagc gcatgaacgg gtcgccggta gctgtccgtg aaagcgacac 19740
caatttcctg ctgaatatcc agtcggtgtt ccagatgagc gccgacgagg acgactttga 19800
cctcgatgcc gaagaacgta tcgccacgga gcgcaatcgc aatctatgcg cggcttacgg 19860
catggcaccg tcgagcggaa ataaaccttt cgccttttcc ggcggcttcg ccatcatccc 19920
gatccacggc tccctgatta accgctatgg cggctattac tatggctacg tgacgggata 19980
caatttcatc cgctcgcaga tgaacgccgc actggcagat cctgacgtgg aagctattat 20040
tttcgacgtg aactctaacg gcggcgaagc agcgggctgt tttgagctgg cgaacgagat 20100
tttcgcatcc cgcgcagtga agccgtcatt cgctgtcgtg gactccaatg cgtactctgc 20160
ggcttacgcc ctgggcagcg cagcgacgaa aatggcggtc attccgtcgg gcggcgccgg 20220
gtccatcggg gttatctcga tgcacgtcga tatcagtaag atgttggaag acttcggcgt 20280
taaggttagt attattaaat ccggtgcgca caaagccgac ggcaacccgt tcgaatcgct 20340
ttccgatgag acaaaagccc gctggcaggc agatgtcgac accatgcgtg aagacttcgt 20400
caatcttgtc gcacaaaacc gaaatttaga tccgaaagtc gtgcgtgaca ccgaggcatt 20460
atgctataac gccccagaag cactggccct cggactaata gatgcggtca caacgccggc 20520
taaggcagtg gctgaattcc taaacgggcc gtccggtggc tcggatgaac aaccaggagc 20580
aaacgcgatg tttacccaag aacaaatgga cgctgcccgt caagatgcag cagccgaagc 20640
aactgccacg gctaccgcgg cagcgactac ggcggaacgt aatcgcattt ccggtattct 20700
gggatgcgaa gcggcgaaag gccgttcaaa actggcgtca catattgcgt tcaacaccgc 20760
aatgagtgtt gccgatgctg aaaccatgct gggcgcttct gcggtcgagc aggccccggc 20820
atccgcagcg gctaccaatc agccggagaa aggggcagac agcccgttca agacggtgat 20880
ggataacgct gaccacccga atatgggtgc ggaaaacgaa cagcaggctg aacccggcaa 20940
aggtgatggc ctgatggctg cgatggccgc tgtagctggc gactcgttca ctaagtaaga 21000
ggcgactaac atgtctttga tctccctgat ggcaagcctc ccgaactatc tcgctggcaa 21060
cggcgacctt ggttcgtggg aacccactca gctgtttgct ggtgaagctg atatcgtaac 21120
cgacggcggt gaagtcgcag tcgcgtttgc gcgttatcag gtcatcgcca aaaacgcagc 21180
tggcaaactg gtgccttatg acccgaccac tccggccaac ccggaagcga cggccatcgg 21240
tatcgctaac gaagctggtg tcgtgggaac ctacgcaccg tattacatcg gtggtgtgtt 21300
caaccacgaa gcactcgtat ggccagcagc agtcgacact ctgctgaaac gtcaggcggt 21360
gttcgaacgt acgaacatcc acatcggcaa cctgtactaa ggagcagcag aaatggctgg 21420
attgtacgaa actaccgtcc tgatgggagt gcaacgcaag gttaagtccc tgccggcgtt 21480
cttcctgcag tggttcccgc gccagattaa cttcgaggaa gaccagatcg cgttcgataa 21540
ggtcatccag gacgttaccc gcgtcgcgcc gtttgtcgca cctaccgcgc aaggccgtgt 21600
gatcaaggaa caaggttaca acaccaagac cttcaaaccg gcttacgtta aaccgaagca 21660
cgtcattgac ccgaacatga tcgttccgcg tcaacccggc gaagcgctcg gtaccggtag 21720
cctctctaac gagcagcgtc gtgaccgtgt tatcgcattc ctgctgatga agcaccgcgc 21780
gatgcatgaa aacacctggg agtggatggc cgcgcaggct gcgcagtacg gctatgttga 21840
cgtggaaggg caggattacc cgaaaacccg cgtagacttt ggccgtgatg cggcgctgac 21900
catgacttcc gactggaccg ccaccggcgt taccctgatg gacatgatcg ccgacctgcg 21960
cgatggccag cgtctggtgt ccgataagtc actttccggc acggtgatcc gcgattacgt 22020
gttcggcggc gacgcatggg accagttcgt taaagtcggc ggcgcagagc tgtggggcaa 22080
agacggcctg atggatggca atatccgcgg ttccgactcc aacctgaccc gtctgtggga 22140
cgatgtcgaa ggtgttcagc tcatgggtga actggtaggc atcaacggcg ccggccgtat 22200
gcgtttctgg gttaacactc agaaattccg cgactggaaa aatcaggaac agtacctgat 22260
gaaccagaag gccgtcatgg gcatctcgtc tgcgattgaa ggcgttaagt gcttcggtgc 22320
aatcatggat aaagcggccg gctatcgggc gctggaatac ttcccgaaaa tgtgggaaga 22380
agaggatccg agcgtggaat acctgatgac tcagggcgca ccgctgatgg tcccggcaga 22440
cccgaatgcg tcgttcctgc tgaccgtcgt tccgtaacca cctgcaggcc cgtcaataat 22500
ggcgggccaa tttaaaggac agagattatg ccacaacgta aagtagtcca gacggtcatc 22560
gttttccgcg acggccagcg tatccgcccg gcgatcggtg aaatcttcaa cttcacccag 22620
aaagagctgg aatccatcaa cagcatgaac ccgggcgccc ttgaccgtcc tgtcatcgaa 22680
gtcgatgcgg aagagcaggc ggcgaaagag aaagcgcctg cgcaggaaga aaagtctgac 22740
gcgaaagcca ccaccaaaaa aggcggtaag gccggcgcag cggacgaaga ggtctgatat 22800
ggcctctaac ttcgcggcaa tcaaagcgaa ggcacgcagg gacgttcacg cgtccctgtc 22860
tgtatctgcg cggtatgaaa gctattcgca ggaagtcatc gtcgacggtc ttagcgtgcg 22920
ctggcacaac aagcagcaac tggtcggcga tctggatagt ggcggttacg cccagattat 22980
cgatggcatc gagcgaatcg tttttatgca ggacgagctg caggagaaag gcgtcacgct 23040
ggaaggcggt gatgtgatta tcatcacggc ggaaggatac ggcaacgttg gcctggtgct 23100
acagacgcag gaaccgattg tcggtccggt cgaagtgatc tggcaggtgt cgaggaagaa 23160
ctgatgaccg ttaacgttat ttccgtgggc gacctggagc tgcgtgacta tctcaagcgg 23220
cttccggaaa taaccgaact ggcgatgcag atggccatta acaccgtcgc atcgcgcacc 23280
ggcatgtcgt tggtcaagaa aaacatgctg aacgaggtgg ccttcccatc cgggtatctc 23340
aaccccgacc gcctgaaagt caccaagcgc gccaccagaa ccaacctcga agccaccatc 23400
accggacgta aacgggcgac ctccctggcc cggttcgtga cgagtaacag tgttgtgaac 23460
agccggcgaa aggaaggggt atccgttcga gtgaagcgcg gtaagaccac gtacctgaaa 23520
aacgcctttc tcgtcaggct gaaaaaaggc gccagtcttt ccgaagacaa ctacaacatc 23580
ggccttgccg taaggctttc cgccggggag tcattatcga ataagcggac gcagcataaa 23640
tcatggctgg ttccgggcaa ggtggcgttg ctgtatggcc cttcggtaga ccaggtattc 23700
tcggaggtgg ccgagaaggt cgggtcgcaa attgctgaca tggtggcgac ggagtttttc 23760
cgtaatttcg agaggttatc atgagtaagc gcctcgatgt gctgaaagca ttaacggatt 23820
tcctggaagg catttccccg gataacgggt atccgtatga cttccgggga aaggtgtacc 23880
gcggtcggga ccgtttcggc gcggaatacg tggcaaagat gccgttcctg tctattctgg 23940
aagcgaaagc aaccgactac gggaagttcg ctaacgagga acagaccgtc cggatggatg 24000
actgggtgct gctggttcag gggtggtgcg cagatgacgc gcgcaaccca acggacccga 24060
tttacgacat cgtggcagtc gttgaaaagc gcctgtcaat gctcatctcg aaggatgaaa 24120
atggaaaccc ggaattcccg ggggtctatc ggttaaaggg aatgattgct acactgacac 24180
tcgcacagcc ggttgttcgt ccgcccgagg aaggactatc ggacacggcg tttttcttcc 24240
tgcctattag ggtaggacta aaagtagata ttcggaatcc ctaacaggag atgaaagatg 24300
caaagcgatt tccagaacga ctatacgatc ggacgtggga aaacctattt cgataagttc 24360
ttgccgaact ctaaccgcaa gactggcgaa atgtacttcg gcaacggccc ggaattcacg 24420
atcaccactg atacggaaaa cctggaccac tatgcgtcgg attacggcct gcgcgtaaaa 24480
gatgcctccg tcctgctgga agccggcatg accgggactt tcacctgcga caacatcgcg 24540
gcggagaacc tggcgctgtg gttccttggc gacctggtta acatgaccct gaccgaccag 24600
accggcgtca aggaagtgtt caagccggta ctgcgcggta agtattacca gatcggtacc 24660
agcgacgaca cccctaccgg cctgttcaac gtggataacg ttgtggtcgg cgtggcggat 24720
ggtgacgctg aaatcgtccc gggaaccggc gatattagcg gcctggcagg cgtgaccatc 24780
gttaccgccg ctggcaacta cgagctggac ctggcgcaag gccgtatcta catcgagccg 24840
gactccaccg agttcgcggg taacaagcag atgatcatcc agtgcgatat cgctgcgcag 24900
aaccgcaaca tggtgatcgg caagaccaat cagatttacg gcgccctgcg ttacatcgcg 24960
gacaacccgg tcggtaccaa caaaaactac tacttcccga aagtggcgct gcgcccggac 25020
ggggattatg cgctgaaagg cgacgactgg aacgtgatgt cgttctcgtt cgaagcgctg 25080
cagctgaaca acctcaccca gcgtctgtac attgacgtgc tgccgtctgc ggcaaccgtt 25140
gacccgacga cgctgcgtac cgtgtctgta tcgctggcga gcacttcggc ggcgtccggc 25200
ggtgcgggta tcgtggctac cgctacggtt cgtgacggca acggcaccgt ggttcagggt 25260
gaaaccgtga acttcacgac ggacaccggc gctaccgtta ccccggcgag cgcgtccacc 25320
gcgagcacgg gcctggcaac caccacgctg aaccgcgcga cggccggtac cgccaaagtt 25380
accgcaacgc tggcgaacgg caagtccgca gtatcgcaaa ctgcgacctt ctcgtaagag 25440
cagaccgcag tcacaccgga aagcgcctac gggcgctttt cttttatgct tttctgccga 25500
cgtgctacat taacgacgtc aaccaacgaa gaggataaac cccatgtcac tgtcagattt 25560
caccccggat accgaagaaa tcatcgttaa gcgcgctaaa aaaggcgata tgacattcga 25620
ggtccgcggc ctttccttcc aggacatttc gaagatcgtc cgcgtgcatt atgacgacct 25680
ggaagggctg tttgatattt acgaaaccca cggcggcggc gacctttcct acgtggccat 25740
gggcaaattc gccatgggtc tgattaacga tgcgcccggc ctggtagcgc acatcatcgc 25800
gctggcggca gacgacgaag ccaacctgga gaaagcccag cgcctgccgc tgaccgccca 25860
gattgacgcg ctgaaagccg ttggccgcct gaccttctcg gacgttgaag atataaaaaa 25920
gatgctacga aaggccatgg acctgatgag ggaaacaaag gcaagccgga cacccgcgtc 25980
tacagcaaaa gggaaaaagt aatccggttt cacaacgagc tgcgggaagg cgtgtccttc 26040
ctgatgtctc agggacaccc agacgcacgc cggtacccgc tggggtacct gtggtctgaa 26100
atcaagattg cccggcgccg cgtgaatatg cacctggtga cggaaagcac gttactgcag 26160
gcgctactgg cctccgtcat gaacgggaag aaaggtggcc cgcactacaa aaaactgatt 26220
aagggcttga gcgatggcta acagcaaaga cgtcgaacta aggatccggg cgagggattt 26280
cagccagaaa cccctgaaag ccgtggcctc cgcgattgaa gcaatggcga aggcgcagga 26340
cgaccagcgt aaagcggcgg aacggggaga agtctcgacg cgtcagctgg aagcctcgta 26400
caaaaaactt gagcaggccg ggcagcagct gttaaagctg aatgccctgg tggagctgta 26460
caaacgccag aacgccacga tggttgaagc ggcgcaaaag acggaagact tacgggccaa 26520
gcaggcgcag ttgcagcaag cgtatgattc atccacgaag gtaactaaaa aacaggaagc 26580
cgaacttgcc cgtatcaacc gtcaggttga gcgcgcagaa cgcgccgagg cgtcacgcgc 26640
cgcgcaggtg agccggacta ccaaagaact gcagcgatac ggtattgaga cgaaaaacct 26700
tggtgccgcg cagtccagca tcgttaacag cgtggcgagc gttaacaagg tactgcagca 26760
gcaggaaaac atcatcgcta ccgcgcctgc ggcggccgcc caaaataaag tcatacaggg 26820
actgcagcag caagcgcagc aggcactggc ggcggcaaaa gggtattcaa ccctgggccg 26880
ggtcgtacag accaccacgt cgcagatggg gccactggcg tcgcaaatcc agcaaatcgt 26940
aagcccgtca gacgctgcgc gccggacgct gtctggactg cagcagcagg tgacaaccct 27000
tgcgacggag atagcgaata gcggcaaaaa gattaccgat atcacaggga agatccgcca 27060
gctgaatgac gcgaataaaa gtgtttcggc catggcgcac cagatcgata tgtaccgtca 27120
gcaggtggca gcgatccggg cagcgcgggc ggaataccgc acagcaatgg gggcggtaca 27180
gggtttagcg cagcagatgc gaacggccac taccgacacg ggtgaattgt cggtccggat 27240
gcaggcggca cagcagagac ttgcggcggc cgcccggtca ttgcgggaca ccgggactgc 27300
tgcgcgcacg acacaatcgg ctttgcgggc ggcaggcatt gatacccgta atttgaatag 27360
cgccgagcag gcgctgatct ccacaagccg tcagaccacc agttctataa actccctaac 27420
gcaagcattg cggaataacg cgggcgccac gcgcgacggt tcaaaagcct tctctctttt 27480
ccgcgatgag ggacgaacta cgttatcaat gctgcagcgt atccgcggtg aggtcctggg 27540
gctggccacg gcctatgttg gtgtgcaggg ggcgcttaat caggcatccg gtgcggtgga 27600
tgcgtacaag atgcgtcagc aagccctggt taagatctcc accgttgttg gggaaagcca 27660
ggcggcactt aacgacgaat ggcaatatat gctcgggctt tccgacaagc tgggtattga 27720
tatcggagtg gtcgcgaact cgtatacccg gttcgcggta gcggcgaaag ccgtcggtct 27780
gtcgttgcag gattcaaaat tcatattcga aagcgtggcg aaagccggcc gtgttttcca 27840
cctctccgcg gatgacatga acggtatttt ccgcgcactg gaacagatgc tgtcgaaagg 27900
gcaggtttac gccgaagaac tgcgcggcca gctgggcgaa cgtttacccg gggcggtggc 27960
gctgttcgcg aaaggtatga acatgaccac gacgcagctg atgaaggcaa tggagaacgg 28020
cgaggtttcc ggcgaagcgg ttatcaactt cgcccgtgaa caggctaagg ctattgatgc 28080
ccagctggaa accgcgagca aaggcgtgga cgcgatggaa gcccgcgcac gtaacgcgat 28140
gaatgcattc cagctggcgt tagcggactc cggatatatc gatgcatacg ttcagctgct 28200
gcagaaggtc acggacttcc ttaatagctc ggatgggagg gaggccgcgg taaaactggg 28260
tgcggcattc agctacgtgg cggacactct agggtatctg attgacaacc tggacacggt 28320
tatcacggtg ctcggcgttc tggccggcct taaaatcacg cggatggttc tggggttagt 28380
cgggtccatc cgcacgatgt tgccgatgct gaaagaaggc gtcgttctca tccgcggggt 28440
atacactggc cttatgacat gggcgaccgg tcttgcgacg gttgaaggcg cggtcggact 28500
tctcggcgtc gcgttacgcg ggctgctgcg cgttatcccg tttgttggcg cagcgcttat 28560
cgcgtacgac atcgggtcga tcatgtacga ccagtcgtcg accttccggc agggcgttga 28620
cgaggtcatc cgggattaca aaaacctcgg caatcagctg ctggcggtcg gggagtccat 28680
cccgacgatg ctgtacgaca tcctgatcgg ctgggtacga cccgtaacga cgcaattcgc 28740
cacggccacg aagatgatca tgggttggat tgccaatgtg ttgcgcctga tccccggtgt 28800
cggcgaaacg ctggcgaact gggcggatac cctggccgaa gacatgacca aagagcaccg 28860
tgacttcctg gagtccacgg gcaaggtctg ggatgacgtc gataaaaaat gggccgagtt 28920
aaataaaaac atggtcgaca ccaacaagac tgcggtggat gttatccgtg gtcaggtggc 28980
gatgctgatg gccgatatta aggcgatcac aaaccctcaa ttccagtaca ccgctgaccc 29040
ggaaactgga gtcacccagc gcgaccgcga catcaaaggc atgacgaaag accttgccaa 29100
gatggaagaa caggcgaaaa aggctggcgt tgccgcgcag aaagcactgc agcgtaaaaa 29160
cctgccaggc cgcctggcga ttatcgatga ggaatttgcg ccgcagtacg cccgtgccaa 29220
gtcgatcggc ggtgacgaag gtgctgcgat gaccaagcgt ctcgacgcta ttgtggctgc 29280
gcggaagaaa gccgagacgg attcctataa cgccatggaa aacggcagca agggcagggc 29340
gaacgcggcg aagcgggagg aaaacgcgct ggcggcgctg acctctcagt atgaaaaact 29400
ggatgatgcc gttggcgtca agcagtcgaa ggtcgacccg aatgcctcgt ttgatgaccg 29460
actgcaggcc aaactgcagg ccgttaatac ccagtacgac cagctgatcg ccaaggcgaa 29520
aaaactcggt tcgggcgggg cagaactggc cggcaagttt gaagacctgc gcaagcggaa 29580
tctcgaatat gctaccacgc aggcgaagct ggaagagatc aagcgcgtgg aggaccagct 29640
taacgcggtc caggaaacga agaaaagcct gctggatgag ataaacgcca aacgtcaggc 29700
gggcattatc tccgaagatg aggcggtgaa gcagacgtcc gagctgtatg cgacgatgaa 29760
cgtgaacctg cagcagtcgg cgaacacact ggaccagctg gcgcagaaat tccgcaatgt 29820
tatgtcgccg gaagactatg cggcgctcat ggccaaaatt gcgcagatcc gcgcgggcct 29880
gaatgacgtc accggtacct ttacccagat ggatagtacg gtggtgcagg gcgttctgga 29940
tgggctggcg acgggtctac agtcggtcac ggatagcctt gtccaagtcc ttagtggcac 30000
gatgtccctg caggacgcat tccggagcct cggcgctacc gttaccaagt tcttcgcgga 30060
cttcctgatg aagattgcgc aggcgatcct gcagcagatg gtactaaact ccctggcggg 30120
aatgggcggc ggtatcggtg cagcagcggc atcgcttggc ggtgtagcag cgaaacacaa 30180
cggcggcatg gtcggcagca aaacgacggg cggccagcag cggaaaaact ccgtcagccc 30240
gtcgttgttt gtcggggcgc cgcgcttcca tgacggcggc ctgcccgggc ttaaatcgga 30300
cgaggtgcca atcatcgcgc agaaaggcga acagatcctg tccaaagacg acccgaataa 30360
tataatgaac caggggggcg gtagcggcag tggttccggg tcatctaatc tgcaggatat 30420
cagggtcatc aatgcgatag attcggcatc ggttgtcgcc gccgggctaa gtgctccgga 30480
aaatagtaaa gtggtcctca acttcatcaa ggccaataaa caggctgtta aacaaattct 30540
ggggtgatga atggcgagct taaccgacaa tgatgcactg gtcagcagtg atgggctggt 30600
agcgcacagc cttacggatt cgacgactga cgcatcgggc attaatccgg cggcgggaac 30660
gtcgtcggaa cagttccgga tggtgaccgg acttctgcgg gcgcaccgta ttgctccccg 30720
cccggcggcg gtacaactgg caaatcgcat cctgactgca gctgtatcct acctctaccg 30780
tggccagtcg tcagaagccg ggacgtttat cccacactat ctcgtcggcg tccgccataa 30840
cttcacgttg ggtaatggcg acgtggtgca gcccggagac gcataccgta tcgccccgac 30900
ggtggagatt gagccgagta ccgataccga ctcggaaaac catgctttcc gtgatgcgta 30960
tgaagccttc tcgatcggct ccgacgtaat gggggagaac gcctggacgc tcgcaaagga 31020
cgctaccgag cgccagatta aagggtcgat tcgatactcc gggttgtggt atacgccggg 31080
cgcggtaccg gtcattacgc agttcactcc gaatgataat gggtggcggc cgccggcgta 31140
cgttggtcgg cagatagggg cgcagtgggc gtcattcggg gatgcggaag ccaccgacaa 31200
taccgtgttc atgatgaacg acgcacagga cgcatggacc gcgcagaccg gaaaaatcga 31260
tggccttttc atgccggtgt tctacttcga ctctcccggg tcgacctcgt acggcccggc 31320
gaacacgttt gggtggaatg gccccttcga ctcacagagc atgtacgaac agctgtcggc 31380
gatgcgggat gccgttcgca tcgctacaca ggcaggcgag gcgggccgta aagcctacgc 31440
aacggctatc gctacccgtg cgcttaaatg gttcgggaat gaccgcaact ggatcccgtc 31500
gaacccgggc atcgcagacg cctggagcgc ggcgatccgc aaagcggccg ttctggggta 31560
ccaggagggg gataccgtta cgctgcctga actctggttc accgtcccga atcgcctgaa 31620
taccgatggc tcattcccga cgcctgtcta tgagccgggg ctactggcgg tggcgctgca 31680
ggcggcgatc gcggtggata agctgcagcg gccaaacaat gccgcaggtt cgctgtctac 31740
cgaagtggcg cgcgtggtag aaaagtgcat ccagatgttc gacttcacct acgtgaccag 31800
cggagtaatg gccggcacat tcagcccgga cccggcgaac cttaaatggc aagggcgctg 31860
gcatgcggaa ctgctgaatg ccatggtgga cctgtatgac tggtgtgggc agtcgaacaa 31920
taactacacc gccacgcggg cgaaggcgcg agagtggatt acggggctac tggactcggc 31980
ggaagcgcta tcggcagacc agtctggcgg attcatctat ggtcggtcta tgtggccgct 32040
gcagccaaac tggaaagacg gcatgacgga gtcgttcgaa ttttccacgc agatcatcac 32100
ggcggccagt ggcaaagagc agcgcttgtc ccgtcgcacc aaaccgcgcc gggcgctgtc 32160
catgcgccat acgctgacga cggcagacga ggcggcgcag tatcaggcca tcctccggaa 32220
gcgccagtgg cggccaatgc ttgttccgca gtggcacatg gcatcccgca cgctggtagc 32280
cgggaaagtc ggcgatacca ccctggtcct ggacaaagag ccgccggcca cctggggtgt 32340
ggtgaaagcg ctgtacctcg tatcagggga tgaccgccag ctgcttaacg tgctgcgggt 32400
atccgggtcg acggttatgc tgcgcgattc gctgacgttc ccggtaccgc gagggtcaga 32460
tattatgccg gtgcagtacg ggctgctgaa taacgacctg tcgtcttccc gggcgatctc 32520
caccacgatc gaagcgcagg tcggtttcac gatcctgccg cagacggact cgtttaccgt 32580
gccggcggta tcatcgtaca acgacctgat ttcgtttatc gcggaacagg gccatcgctg 32640
ggcgaaatat atccgacggg ccgccgcgct tgatcccgca gtatggccga cgtggccgcc 32700
aatgccgtcg aactatacga cgcgaatgac ctttgaactg aacggcgata cccgcatggt 32760
catcacccgt aaacctaact gggtatccgc ggtgacagtg gccgacgcct ggcagtacga 32820
cctgatcgac tattacaact cggcggttac gccggggtat gcggagaacg ccggacgccg 32880
tacattccag gcgcagtgga ccgcattcac gtatgatgag gttatcgata tcctcgcggt 32940
attctacgcg ctgcgtggta cgcaggtggc ctgctgggta ccatcgtggt cccacgacct 33000
gacggcggca gaggatatgc cggcgccgaa tcagttacga gtggagcgga acgccgtcat 33060
tgacgaagaa atattgcttg acgacccgag tatcgcattg atggttgaaa cgtttgatgg 33120
ccgcatgtat tgcgcggcgg ctaccggggt aacaacgtca gtcggggtat cgactatcac 33180
actggaccgc gagttcctca gcccgctcaa aaaggcggac atgatgcgga tcagcctgat 33240
gtaccgtgta cggcaggcca gtgattcggt ggaactttca tggcatgccc gcggcattgc 33300
cgaattgcag acggccttca tcaccgtcca ggagtaaaac gtgtcatatc ctcaacttga 33360
agacagcgtt gacagcggga aaccgctgta tttttacgag ttcatttacg gcgatgcagc 33420
gacgaatgcg taccgttatg tcgccgcact ggacctcact atctacggcg gccgcccatg 33480
gacccctttc ccgataaagc acagcgatat cgttacatcg gggtcactgg ataagcagac 33540
gctgacggtg acggcgcggg aggatattga tattaccgga ctggtagtga cccgcgcgcc 33600
aagccgggta acgatgctga atatctaccg cggccacgct ggcgatgatg acatgcggat 33660
ggtctggacc gggcgcgtcc tgtccggcaa catgatagag tcgtccgagg tggaactggc 33720
ctgcgagtcc ataagcacat cgcagctgaa tattggtctg cggcgtaagt atcaacgcgg 33780
atgcccgcac gccctttatg gtcgggcctg ttcagctgat aaggcgttgc attcggagac 33840
cggttcgtcc acggcggtcg ctaattcaat gacggtgtcc gttaccctga cgagtgaaga 33900
ccgcgggctg accgaggcta ccctaaccgg tggtatcttc cgcatcacgt tgaagaacgg 33960
cctgaccgaa atccgggcga tctcgtctgc gataaacaac ggcggccgca actggacgtt 34020
aaatatcatc gcgcctattt ccgacatgac cgccggccgt ccggtttctg tatcaaaagg 34080
ttgcctgcat acatacgatg cgtgtaaaaa cgtgtttaac aatgcggata actatggcgg 34140
atgtgccaat atccctatca aaaacccgtt caatgcaaac cagttctagg gggcgccatg 34200
ccagattggg tcgtctatat aattatttcc atcgcgatgt cgctggccag ttacgccctg 34260
actccgcgtg caaaaacgtc cagcgctaac cagtcaccgc agacggtcga cgtgccgacg 34320
gtcgatgcgg gccggtccat ccccgtagtc ttcgggacgg tgcgggtgaa atcgcctaac 34380
ctgttatgga tgggcggaca acggacaacg gagatcaaga aatgagtgat atccgcgtat 34440
tacctactga cctgccgacg gcgggtcttt gcgttaatgg cgctcgcgac tggttcgcga 34500
aacatgggct ggacttccgg gacttcatta agaatggcac tccagtagat gtcatgcggg 34560
cgaccggttg cccactggcg gaacgtgctt gccaggccgc cgagaagcgc gtcaacggag 34620
ataactgatg ggcgggaaaa gcaagaaaaa atcggtcgtc ggctataagt acaacatcgg 34680
cctgcatttc gccatttgtc acggtccgat cgccaagctg caggaaatct ggtgggcgga 34740
taaggtcgcc tggtccggca cgttgaataa ccccggggac gagtcgcagg ggcttgtggc 34800
ggtggacaat accggcctgt ttggcgggga ttcctccgaa ggcggcgtga aagggctggt 34860
ggaaatcggc ttcggtggat gggggcagcg ctgtatcggc gttggatccg acgggtcgta 34920
ttccgcgcca gccatcctgg cctggttcat ctccaaagga tacaactgga agccgcaggt 34980
taaggtgccg gacctcggcc tgaattaccg tgggctggcg gtcgcgctga tgcatgacca 35040
ctacatcggg aacaacgcct acctgaaaga cgtgtcgttc aaggtcagct gcttctgggc 35100
cgactggcac cctgaacttt gctacatcgg cgataacatg aacccggcgc acatcatccg 35160
cgaaggactg gtgaacacgg aatggggtct gggatacgcg ccagccacga tcgatgacgc 35220
cgcatatctt tctgccgcgc agactctgta taacgagggc ttcgggctat ccttcgtctg 35280
ggatgacgac aaagacctct acaccttcat tgacgaggtg aagtcatgca ttaacgccgt 35340
gacgtatctc gatccgcgtt ccgggctatg gacgattaaa cttatccgcg ctggcgagcc 35400
atcggcgctg accatcaacc ccgacaacgc cagcctgaaa tcctttaccc ggaaagcgct 35460
gggcgaaacg tacaacgaga taagcacgaa gtacacgaac ccggaaaacg aagagtacga 35520
gacagttacc gttcaggacc cggctaacat cgaggcgcag ggccgtgttg tgtcgacgac 35580
gaaagagtat gtcggcgtgc gggatgcaaa cctggccatc cggcttaccg aacgtgacct 35640
gcaggtggcc agcgcgcagc tgtgtacagc cgaggtgacg gtgaaccgcg aagcgtgggc 35700
catcgcgccg gggatgaacg ttaccttcaa ctggccgaga cacggcatct cgaacatgat 35760
catgcgtgtc gaagaggtga gcattgctgc tgtcggggat gactcgatct ccctgcgcat 35820
cgtggaggac gtcttctcgc gctcatcggc gaccttcgcc ggctcgcagg ataacggctg 35880
ggtcgacccg gcacaaccgg caacgttgtt cccgtaccgc cattcctggg agtatccgtt 35940
ctggtatctt attcgcgctg caggtctgcc agcagacgtc ctgccgacct tcgccggatt 36000
ctcgacggag attgctaccg gcggcaacga taacgcgcaa tcggtccagc tgttctccta 36060
catcaccacg gacgctggtc catcgtggca gctggtcgca gttggaccgc tgacgccgaa 36120
atccgcgttg tccgatgcgc tggttccgga aatcacctcc ctgatgaagc tgaatacgtc 36180
ggccagctac cgcctggcgg acatggagac gaacagtttt gcgcttctca cggatggtac 36240
caacgaagag atcgtccagg tgacgaactt cgcggatgtc gcgcagcagg cgaccattac 36300
ccgcggcctg atggacacac aaccgcgtaa ctggccggcg gggaccatcg tgtacttcat 36360
cggctccagt tccttcccgg aagacgagtc agtcaggtca ttcggcgaga cggtgcaata 36420
ccggccagtg atgcagacct ccattgacca gatggacatt aataacgttc cgacggatac 36480
catcaccctg cgcgggcggt acgagttgcc gtacccggtt gccaatgtga agatcggcgg 36540
cgcatactgg ccagtgtcgg taaacgtcaa tggcattgac ctcgccgtca cctgggccaa 36600
ccgaaaccgt ctgctgcagg acgcggctac ccaggtacca tgggacgccg gaaacatcat 36660
cccggaagac ggaaccacgg tgacgatcga gctgtggcgc agcggctcaa tggtgtacca 36720
gcagcaaggc atcaccggca cgtcgtttaa catccctgtg gatgccctgt cgaccggctc 36780
ccatgagatc cgcatttaca ccgtgcgcga cggccgccgg aactatacta atttccagca 36840
cacttttaac gtcgtactcc cgtctcgcga tacggggtat ggcaatagtt acggattcac 36900
ttacggagta taaccatggc gcagaaaacg gccccgaacc tgggcatgac ctacggctgg 36960
gatttaggcg aaagcgggtg gaagcctggt atggatgcca acatgaaaaa actggatgca 37020
attgtgggcg ccgcggtgct ggccattgcg aacagtccgt cagttacgga tgacggaacg 37080
cgctacattg tcgggacgtc gccgtccggc gcctttgccg gccaggcggg gaagctggcc 37140
gtacgtgttg aaggcgcatg ggaattctat acgccccggg caggatggtc cgtttacaac 37200
ctggcgaatg gcacggcgta ccggtacact ggttctgcat ggattatccc tgcgattgcg 37260
atccccgcac agccattcct ggaagtatct ggacccggta ccgaaacctt tgataatact 37320
gcgtgggtga aagttccgct gaccgtcatc gcgtcggata cggcagacgg gtgggatgca 37380
acggccaaca ccgactacat catcccgcag gccggcatgt accagattca ggggattgtc 37440
cggcccgcgc gaaccggaag caaccctttc ccggattcaa cggcattcgc cgttggggtc 37500
ggggccacgc cggcagacgg ggatgacgtg gcatgggcgg ttagcccgga cgtggccggc 37560
gcgcagttta ccctgcaggt agccgtattg cggcgctata atgtggggga ccgagtatcg 37620
ctttttgtga aacattctgc gacttctcct gtcgctattt cgcgcgcccg cttacgtgtt 37680
ttgcgtttaa cggattaaat gcgggatgct atagtgggca aacggttaat cgagggtaac 37740
taaaatgtca gatatggacc cgttgtatga attgatgaaa gactcagcgg aggatatgtc 37800
caaggctgtg gttgaaatga aggatatgat gacggaggac caaaacaccg acgtcgtcgt 37860
cgaagggtac ggcccgaagc cttcattcag caaacagata aaagagctgg tggccgggag 37920
gtcagaaggc atatttcggc tgtatgcgac attggccgag gcccaggcgg atatcgcgaa 37980
tacccctgtg gggtctgtaa cctatgtccg gggggcggat agcacgtccc tggccgatga 38040
gtatatcaac aatggcggca ccctaactgc gaccggacgg acgatgccat ccggggtcgc 38100
cgttgagatc atgtccgcta ccgtccagcg tttaatgacg gctttgcacg ttatggcgga 38160
gggcgacgcc ggttcggttt caggtattga cagcagcgat actgtgcagg gcttgatgac 38220
cggattcaac gtactggcgg agtcctttaa taacctttca gtggaaagtc agaaaaatgc 38280
ctccggcctg tccgccctgg tctcatccgt ccagatctgc actgaagcac tgaatacgct 38340
ggcggcccgg gtcgtgaccc cagacggcgc gtcgcagtat gactatatgg cattttccac 38400
gccaggtacc gtcaacgcca gtaacgggac gttcggtagc aacacccaat accgcaggac 38460
cgggatgatc ccggttcgca agggcgacgt tgtacgcctc accgttcaca ccgcaacgac 38520
agtcgcaggc cacgccgccg cattatatga cacagcggga acgtatgtgg gtcccctggg 38580
gatcatgtgc gggacgtatg cggcgtataa ggcgcggtat taccagtgtg aaattaccca 38640
ggatggattt gttgtcgcaa acacgctgga ccagagcgcg tccccttctg cagatgtaac 38700
aggtgcgtca ctgacgattg accatcgtct tcgtggccgg gaagcagaca cggttattaa 38760
gctgacaaag tctgatttga tcccggtccg cctggataac gggaacatca acgccagttc 38820
actcacccag gacggaatcg ttaactattc caccgggctg tattcctgca ccggcggcag 38880
actcctgttc agcggtttac ctgtggcctc atctccgggc cagagcagca gcctctacaa 38940
cgtcgtgttt tatgacgccg ctaaagcgct gatcgcgtac cgccccgtgt tctccagttc 39000
gggctatgtg gttatccccg aaaatgccgc gtactgggcg cagcagataa tcaccgacag 39060
aacacccaac tggtccgagg tctcgatagt ttattacaac tacgtctaca aggatgagtt 39120
gcataagcta ctgtcatcag aacgtgagcg cctcggacgt aactacccta acgaatattg 39180
gctgcaggat ttcagcggca ctaccgatat tgagtggatc cagaacgcaa tggactgggt 39240
gcatgatgct ggtggcgggt ggttgatact gtcatcggat tatgtgaaga aacagttcat 39300
catctccgaa gcggttatcc accgtagcaa tgtgtgggta gttctcgatg gtgtcgagat 39360
taaactgcag gatggcgtgc atgacaatct gtttcgtgct gccggggtta ttgtcaatcc 39420
tgacgacccg tttggtctgt gcctcgatct tgagataacc gacaacgttc gtctgattgg 39480
tacgggatat ccgaagttaa gtggtgccga tgtgccatat tatgccgata tccccgcagg 39540
aaccgggcca cgctactgga tcggcgacga atatggatgg cgaggtacgg ggctgattta 39600
ttatggtacg cagaattttg agatcggtgg ttttaaactc cagaacgtaa aaaactgggg 39660
tactgatttc gggtacggtt ctaaaaatgg ctatatccac gatatcgacc tgtggcagcc 39720
gaacaaaaac ggcgacggca tccacttcac taacggggcc agtcatatgc gcgtccgtca 39780
gattttcggc tatgcgcgcg atgactgcct agctatggtt aatagcgacg actccctggt 39840
ttacggcccg gacaaagtcc cgacaccggg gtcaattcgc cagtggatct accctacatg 39900
tccattctgg tatggttggg cgggaaatga ggccgtgggg accagtaacg acatccacga 39960
tatcgttgct acgaatatcg ggttaaccgg taacgagcag gtcagcacca ttctgaccac 40020
gcagtttaaa atctacaacg tgacaatcag cggtatcagc agcgtcaact atatgactcc 40080
aggccggggc tgggatgaag ttaatgcgat tctgaaatcg tatgcggcat ttggtgacgg 40140
ctccaggtat caggcaggaa atgtcagtaa catccgcatt aataacatca ttgagtgcgc 40200
atcaaaaaat tacagtatcg atataacgct ggaagggcgg gatatccgca tcaaccggta 40260
tatgaaactg gacacccgtg cgaaaacaaa aggcgcgctg aagatcagca gctcggcggc 40320
cccgtatgtg acaacctcta acatcgtgga ataagcagat gactatattg attcaggatt 40380
cattacgtcg cgccgttgaa gcggcctccc gcggtgcgca gactgtgctt tacacccggt 40440
cgggcgaccc gtcgtttgtg aatatcatcc ccaagtttga cgtcagcacg attgatgcct 40500
cgttggggtc tggaacgcat ccggcattta tcgttaacgg caccgaggtt agtcagattt 40560
tcgtcggcac ctaccccggc tgtattgtta acggccaact gctgtccctt ccggaccgga 40620
tacccgccac gtcggtggcc tatgatacgg gcatcggtct cgcccgggcg gccggcatcg 40680
gctggcacgc catgacaaac gcggaatggg cggcaatcgc tttgttgtgc tatgcacagg 40740
ggcaatcacc gcgcggcaat accaaccggg ggctgtcatc ggataacccc agcgagaagg 40800
ggcggcgggc agacgggctg gccgccggga ccgaatccgg aacgggtctg acgctgaccg 40860
gctccggtcc tgtcagctgg cggcacaacc gcgactatgc aggcattgca gacctggcag 40920
gcaacatttg ggagaccgtt accggggtcc gtttctgcgg tggcgagctg cagataatgg 40980
tcaataacga cgccgcgctt tacaccaccg accacacgtt atcctcaacg gcatggaaag 41040
ccgttagtgg tgtggatggg tctcttctta cgccgactgg caccggaacg ccgggaacag 41100
gttcatatgt tccaaccaca cctaactcag ttcgtatcgg cctttcgggg accgggaatt 41160
acacactgat ttatggtgaa aatacgctgt tcaccagtgc cacgaacccc ggggctacgc 41220
cggtatccga tgtcgcgcta agggtgctgc gccgactgat gttgttcccg ctgccgggtc 41280
tgatttccga cgacgcctta tcgtataaag cgggcgggga ggtcatgaca ctccgcggcg 41340
gggcgtatac caacggggct ggcgggggca tcaacgcgct actcgctaac cgtggacgta 41400
cttcagttgg tcgatctaac tctggtgtcc gtcctgttta ctacaagcct tgacattaat 41460
gcgccatacg gcgcatttct ttcctctttc ccggcgtggt gacagaagat gtttatgagg 41520
attagcttta aaaagtcgaa atggtccctc ttgttattta ttaaactgat caccgtggca 41580
gtattgacgc atttgttcgg tatcgggtgg gggcttctgg ctgtcgcggt ggtggagtct 41640
cttccatcca tcgagattaa gaggtcgatg tgaccgccgg gggtaagggg gccgccagac 41700
aaggcgcggg acccggtttt ttgttgacat caatagtgga actttccacc ggaaatgtcc 41760
agaatagtcc gaagcgatcc gctaccccga ctacaggaat attcatatga ctgaaccagt 41820
tatcaccggt accacgttga cgactgcggc tgccgtggtt ggcgccaccg gctggtgggc 41880
cggacttgac ccgggagtcg ctatcggggc tttctggggg gctatcttct ttgtcctgtc 41940
ttccaaggaa ttaacattaa ttgcgaaaac cggattcggg ggagtaagtt tctttttcgg 42000
aattatctgc gcgaattggg cggctgaatt gctaacatgg ggcgtacata agtttgcgtc 42060
aggcgccagc gatgcacccg ccgcaatggg ggccttcatt gcggccgccg tggcgatcca 42120
aaccctcatg gccatcacga cgaaagattt caccaaggcg ttgctcgacc ggttcctggc 42180
atggctgaaa agcgcgctgg tgaagactga tatcggagga ccgaaataat gtctgccttc 42240
gcattttcgg ataccatcat cacgaccttg ccggatagcc cggcattcct tttcatcacc 42300
catacattcg ctattttcaa cgttcttctc tgcctgtcta tcgtgtggcg gctgttcact 42360
ttccagcgga aaggggcgcg ccaccgttta gcaggcggcg tgatcgccat gttgctgatg 42420
gtcttttaca tgtggacacc gttccagttc gtgctgggac gcgtggccat tgtggactgg 42480
gcgaccgtcg gtattaactg catcgtcttc atcgcgatat tccgggcgcg gggaaatgtg 42540
atgcaactat tcaagtcgtg agggggcagc actatgtcgc tatcggatga cgagtaccag 42600
aaggccgcgg cgaagatcgg aatcagtgta cctgcgctgc gggcattcgc ggaagtggaa 42660
agcaatggca gcggctttat cgatggcaaa cggccaaaag ttcagtatga gccgcatgtg 42720
atgtatcagc ggctgaaaga gaacctcggg gttagcgttg ctaatggtgc gctgcggaaa 42780
tggcctgacc tggtggctac caaacccggc agctatcagt cgctgaacaa ggaagatcag 42840
gacatggacc gggcggccaa agagattgac cgcacaagcg cactggaggc cgccagctgg 42900
ggggcgtttc agattatggg ctaccactgg aagacttgcg gatacccggt gctgcaggca 42960
ttcgttaacg cgcaatactc cgaggctggg cagctggaca cactggtccg gttcctgcgt 43020
gcatcgccgg ccatcgtatc tgcggtcaaa agcaagaact ggtcgaaggc ggcgcagctg 43080
tacaatggcc cggcgtataa gaaaaacgcg tacgacgata aactggcgaa ggcatataaa 43140
aaatacgggg gtgtgtgatg cttacgccta ccgttaaaac tgtagtggcg gctatcatgg 43200
ccgccgctgt tatcttcgcc ctggtgtggc tgcataactc gctggccgag cgccactacc 43260
agcctaccat cgatagcctg aataaaacgc ttggcagcgt gaagcagcac aatgccggtc 43320
tgactgccca gctgcaggcg caaaacgctg ccatcgcgtc tatggcggta cagagcgaga 43380
aagataagca acgtatcgcc gaactggaga aagccgcgca gcggggcgct ggcgaggaat 43440
acggcagggc caatgaagtc ctgcaggaac gcaccaccgg ttccgacgtc tgccgggcgg 43500
ccagtgatgc cttcgacgcc gagctgcgga aggagcgggc aaaatgagaa agctgatcgt 43560
gaccatggtc atgctgcttg tcggctgttc cgcccgaacc gaaacgccgc cggccgtcgt 43620
ggaagtcaaa gtgccggtgc tgcagaagtg cgatatccgc cagcctgacg cgccggcgtt 43680
cgcggtggac gcattacctg tcggtgcgcc gatcgatgcc cagatgcgcg ccctgcgagc 43740
ggaacggcac caacggcagg ggtacgagat attactgcga gccgagatag acaagtgcaa 43800
aaagtaagcc cgggaaaccg ggctttttcg ttactggggt ttgcgtttac gccgctggcg 43860
catccggtat ttgaactcgt cccatcccca ctggattaag accagcatta tcgccagcgg 43920
ccaaaagata accgcgaaga accgaccgac tgactcgtcc tctgacgtta tgccggccat 43980
gagcgccata cccagaatcc agaccaccac taacatgatg tcattcagca ttctttaccc 44040
tccacgcgcc gcataacgac tttgaaaatt tcagcgtagt ggtagcgttc ggatgtaccg 44100
ttagcccagt tcaacttaat gattagacca tcaagctgtt cggtgctgtt aacgacatcg 44160
ccgctactta acacgtcgcc cgggcgcagg ttaactgcgg cgacaggggt ttcagttaat 44220
gtcgccagta cacggtcttc cagtttggag aattcatgta cggtcaaagg cccatcggta 44280
tcccacgcct tacctgcgcc cggagacatt tgcatgaaac gccggtgggt ttcttcttcg 44340
ttacggcgca ggagttcata cattccctgt agtccggtac ggtccgggag gatcagctga 44400
atcggcagac ggacgacctg gttttgctgc gcggcccggc gtaacgcgtc aaaactgcgg 44460
tatacctgga tgcccagctg gtacgcgcgg tggacttccg cctttgtgcc ggtgcttacg 44520
acgtccgcgt ttggcatggt tagcagtacg gcgtcgcaac gttccagcat ggccatcgtt 44580
ccgtccaaga aatactggtc gtcgttttgc ttcgcctgat tttcgaagtc ccgggtattg 44640
agatgcggca ccaccgggaa cagtccgaga tggccaagcg tatctaccag gtgaacggcg 44700
gtaagttcgg cgatgctgat attatgggca gtatcgacta acgcgccgca ggcgttggtg 44760
taagggcggt acggcccggc aatgtagatc agtttcattg gctttcccca ttaattcgtt 44820
tcgaacttaa ctttgtccat gtacttgtcg cggaaaggtc cattgcgcac agttcgtctt 44880
cgttgtttaa aaacagaacc cagttacgtt ccgccatttc agcagatatt tcggcgatga 44940
attcgtcggt gatctttaat cgtccggata tatcccgtag ggtattccgg gagaatttat 45000
atcggtttat ctcgcgccct ttctctgtgc cgtatgcatc cgcgttggaa attatcagat 45060
tggcaacgtg acgcgcgccc ctgaccgcca tcatttcata cctttgaagt ttttaggatg 45120
gccgatgtta ctctgaacat cgatagtaat ttcatccatg aagcagggca cgcggacccg 45180
caccagtgtt tttgcgttta ccatgtccac caggcaagtc gtttgcccgg ccactgctgc 45240
gttaacccgt tcatgccctt tcgccttcgc taactcgcta tacgccgcaa ccgtatcggc 45300
gaccatattg gccatgaagt cccactgggc ctcgtttatc ttccgctgga tgtcgtgggg 45360
gatgaccgct ttattcgctt tgaacatatt atttcctccc catggggcga tgtgagccga 45420
tccctttctg gtggccgatg tggatcttgc cgcacagttt gcagtggtag gcatccatcg 45480
gcccgctgta cccgtacgtc cgcttgatat accggatgcc tgccagagcg gccgggatgt 45540
ccggataacg ttgcttcccc tcgcatgact tccggcgcag tctgcgctta ctggccatcg 45600
ttacaggctc cagttaggca ggatgcccat ggcggccagg atggctgcga tgacgaacag 45660
cgcagacagc aggcagcaga taaatccggt gcggcggttc gtcttgtcgc cctccagcgg 45720
caacgactcg atatactctt ccgccttctt acggcctgcc tcccagcgcc agtatgcccg 45780
gcatttcgcc ccggtaccgt tagttgggtc gctgtacggg ttgctttttt cggtggcgcc 45840
ctgcaggccc gccagcacac cttctgcttc ttccagagta cgggccggga tgaattcatg 45900
cgcgccgggt accggtactt cgtagccttt ctcgctttct ttgatcatgg gttaaccctc 45960
gtagttcatg ttaaaggtga tgcgtattac tgacttaata cccaggtgat cggtaatcgc 46020
caggtaattt ggtggctcgc tcatcatggc gaattctttt accgccatat acccgggact 46080
taacggtctc cccctggctt tcatcccggt ttcataggcg gagacgaacg ctttggcgct 46140
gacgacctta cggtccagca caaatcccca ttccatgagc aaggggtaac gcggtggtgc 46200
agttttggcc gttggcttat cagcgaatct acggctgctg cgataaatgc cctgcgggat 46260
ggggtacacc cgacaaaccc cgtgatagcg ccccagttct tccagcccat agaaggtgtt 46320
gcagcggata tcgtattcgc gttcgccgtc cattaatgcg gcaactgcgg ctttcagttc 46380
gtagtaatac tggaaccact ggtggtggcg gttgaccacg cccgaaatga tctgctggtc 46440
aatccggtga acaatctggc tcataatgaa aaactcccgt cgttgccttc gggagtaata 46500
ttagttgcac acgaatcgta tgtcaaacag ttttttaagt tattcaggtt caggttttag 46560
ccgcgggaat ctttccagcc agccgtgatc gataatcacc atatacgcct ggcggtaggc 46620
atcccgtatg gcagtgtgtt gcgctaacgg gcagcgcgct tccgcctgtg cgtcagcgag 46680
ttcccacagg ccgccttctc ccggacggag acggtcccac cgcttcatta gcgtgcgggt 46740
atcgttctca tcccgaaagt cccacggacc ttttccctct ccgccaaaca gcccgttttc 46800
cagttggata atatccacgc gtggtgcatg cccccaaacc tgcgggcgga attcttccca 46860
tgcttgatag aggcccatgt aacccagttc atcctgaccc ggggagcaca tgtattcttt 46920
aagcgcctgg tgtacccagc tcatgaaggt gatacgagcg tcatcgatcg aaaccggttc 46980
agcatcttcc ttcgcgaaaa acgcttccat tgcggcttcc gggttttgca tcgcctgact 47040
gacccaccac ttaaccgttt cagggtcaat gtcgccccgg cggcgacgac cggcaccctt 47100
ggctaacgta acgctgaact cgcggaacca gccttcgtcc gcgtggaaca tgacgcacgc 47160
gaatgacaga aggtagccgt cggtcttgca tgacaggttt tccacgtcga atacgaggtg 47220
gattttgccg atgtgttctg gttttgctct cataggtgtt cctcttcttt ggtccattct 47280
ccgctgccgt cggcgcgggt cactttaata atttcgtctt tttccacgtg catcaccggc 47340
agcggtggaa atgctacggt accgtcggtg tggcataccc gcacttccac ccgccagggc 47400
ttccagaaaa cgggtatcca gtcgcaatgc tcaatcacga tgccggagta ttcccggcca 47460
ttgcatttat cccggaagcg gaccatgtcc ccgtagagcg ggtaatcagg gtccggcggg 47520
agggcggcat atttatccgc aattgatctg caaacgtcat acattgacat attaatcccc 47580
cataaaaggt tcgcagctcg ccgcgcaacc ttcgtaatct tccggagcgt cttcacgaac 47640
cggcactgtc aggtcgaaac tggcgatcag ctgctgcgta tttcggtatc cccggaagaa 47700
gacccgtggg tcgtctacct ttaccccttt gaccatgttg tcgccaacgc ggccatagcg 47760
ttcttccatc tcccgcgtcc actcgaagaa gtccagcacg tccagcttgt cagtcgggaa 47820
ccagtcgatc agcgggtaca cgcggacctg gcccgtctga cggctaaccg tggtcttctt 47880
acgctgcagt tcgtccgtac gaatgccgat cgccgtctgg taggtgccgc gcttccagcc 47940
gatggaccgc atgtacgagt ggatcacgtt ctccttcaat tcccgggtgc aatggatgta 48000
gtttttgttc gggatgccgt actttttgag catctcttcg aacaccctgc cttcccggtc 48060
cgccgtctcg tacgagatga cccgatgggt acagccgcgc tttttgccgt ggtgaacaac 48120
cgcttccagc cataccgtgt tgaagccgaa gtgctggtcg cagtctcgta cgaagtccag 48180
cgtttccgga ttctcacggc cggtattggc gaagcacacg ataatctcgt acttatcggc 48240
gtactctttc aggatccggt aggtcatgta agcggaggtg cgccccccgc tgaacagcac 48300
cagtaagcgc ggctttgcca ttagaaatcc ccgtctaact cgcccaggtc atcggcacgg 48360
ccatacagct cttcgaacag gatcatcgct gcggcgtaca ccagcgtccc gcgaagttcg 48420
ttgatccggg cctgtttagt cggcagcgtg cgggcctcaa tggttttctt gataacctgc 48480
tgcgccaggc cggcgtcgct gtccagcata tgcgccatgg tcagaatcgg ctgttcgata 48540
aacggcaggt cattggcgtg acgctcacgg cctttaccgt acgccgcctg ttccagcgcg 48600
ccgaggaagg tgcgcagcag cggcaggtag tcatcacggt ctttctcgtt tttgaaccgg 48660
aacaaggtcg accggatgcc ggaatcatcg gcgaccatag tcaggtccag gtcgtcatta 48720
gtatccgtgg ttgatgggcg taactccgga gcgaactttt catactctat gccctggcaa 48780
tcctctgctg ccttatcgta cgcagaagcc aggccactcc atttcagttc ttcaaccgca 48840
cctactggca gtgtcacgtg aggccatttt gcaccagcct taatcttgat gcgttgttcc 48900
ggaaacaggt ccggagcggc ttcgtttttg atagtcacgg tatttttagc atgagtgttt 48960
ctacccgcat cggcggactg gcgggcttcc ggttccactg gccggggggc gacgagcgta 49020
tcgatcgctg acaggatgct ttcgtctgac gattcgaaat caagttttaa cgtcgctgca 49080
atcgtttcca aggttgtttg gtgttcaaac gcctgcgcat tcacagcgcc taccatggcc 49140
agcatttcgt cccagctgcg gcctgtaaca cccagcgcgt tcgccagctg gtcacgcatt 49200
tgcgaatcaa tgctgaccgg ttcgtcaatg gacgggttac gcagcgaaag gagtttatgc 49260
ccgttgagat gcgcgaacat gagatagttc atcgcgtcga tcaacttacc cttggccagc 49320
gaatcgcgaa tgcaggtacg gcattcatgc tcggtcagtt ctttccatgg ttcagcggtc 49380
gcccagcctt tgcgcttatc cgcgccgtag taaagacgac caagcatctc atcgaagacg 49440
cctttaactg aggtcaggaa cgcttcattc aataaattgc tatggaaggg cggccagcgg 49500
agttcggttc tcgggtgaac gattctgttt ttggccggca tttctttatt ctctgacatg 49560
gtatatctcc gggttgtttt gttgttcgat tagaatacta gctgcacacg ttttgtgtgt 49620
caaacgtttt ctagaaaatc tacagttccc accataaagt ttcggatgaa ctgggcgccg 49680
acttgaggga cgattgcatt gccgtatccg cgcagtcgca ccactcgggc gggtacccca 49740
ttagccaacg ggaaaacgcc ggatccaacg ggcctgaact tcccatcccg gcatagcagc 49800
cagtcagcat ttgaccacgg gccgtgatcc tgatcgggaa gtcgggggca ggcgtacact 49860
tctccatgcc cttccggtag ctccccgata gctgccccct cgatgccggc gagtccggta 49920
ctgtcagcgg tgtcgggtag ctggcgagac gaaccgcgcc gcccagggtc gtcgaccgat 49980
ccggatggcc cgctgcgccc gcctccccgc gtacctgatt gttgtcgatc gtcgtcaccg 50040
ttggccaggt cgccagctgc gccgccacgt ccagccggtc gacggatagt ttgccattcc 50100
ttatccgccc acccgcgtag ccgcctttcc agtccgtcgc tgacgaggtc ggccaggtcg 50160
atagcgccaa agaaaaggcg atctctttta tgcggggcgc cgacgctgca cgctggcaat 50220
actgccgacc cgcaggcgta accttcttct tccagctcaa cgaatagagc atcgagccac 50280
aattctttaa ttgctgcgct aacctgttcg ccaaaaataa ctggaggtcg cagctctgcg 50340
atgaggtcga gaaaggccgg agccaggtga cgggagtcgt cccgcccgcc tcgttttcca 50400
gccacactaa aaggctggca cggcggactt cccgtacaca ctggcgcata cgccggccat 50460
ccggcgagtt taagggccag cggccatccc ccgataccgg cgaagaagtg ccactgacgg 50520
aaaccccgga ggtcttccgg ggcgacttcg gtgattgatc gttcatcgac aattccatct 50580
ggcaggtggc cgcgcctgat tagttcacga agccacgctg cggttttagc gtcccactcg 50640
ttgtagtagt ggaacggttt agagccgttt atgtatgcca ttctgcgcct tcttctcttc 50700
gcgtcttttg accgcacaat cggcatggat cgtagtccac gttccggacg cagacctttc 50760
aagatacccg gcgccggccg gcactggctt tttgcagtag caacacatag ccacgtattt 50820
atttctggcc atctttgacc ctcgcgaaac aggcatacgg gccatcgaat tccgtcggcg 50880
ccgtatacag gagaaaccag ccggacccgt taagcgacgt cgggcgcggc atccaggtac 50940
gcagcacaga ggcgcgcatc tcgtccgtct tcgcgttgtc gtacgccacc cgcagcggca 51000
cttccagcgc tcgcggatag ccttcgccca ggtagaatcc ctcgcactcc aggttgtatg 51060
catccagcag cgcgtcgaga ttggacccat catagttatt actggcgtgg aagaagacgg 51120
gatggtagta ccaggcgtcc gggtcatacc cgtccgccag gcttacctgc tcgccaatta 51180
cgccatcgtt atacacgttt ggctttggca ttcttccctt cctcttcggc aactgaccag 51240
acgacctcgg tgaacgggtc agggttgatc gtcttcccga ccttattctg gtcgaggtac 51300
cagtcgtcgc cgcaccacag tttgacgccg tgggcatccc ggcggacttc aacgtcgaac 51360
gttttcactt cggtgatctt gccgttacgg gttacagttt tggttaattt catggtcttg 51420
gcctcacgtt tatgaacacg aacctgtttc atgggtcatt ccccgaggta attcatggcg 51480
ccgcaatccc ggcatacaac ttcacgcggt ttcccttccc acgtccattc cgtcacatcg 51540
cattgatagt gactacagct atcctgaatg cgctgcgttt cctgccgttg cgcttcgtat 51600
ttagcgtcct gctcggcgcg gcgttcatcc cgtaaacgct gcttgcgttg ttttgatgat 51660
tcgaatgtca ttgctatacc tcgtcccact gggcgatcca cttctcgcgg acgtcctgca 51720
tgatgttggc catgggcagt ccgatgtcca tgagcgcttc ccgggagatg tactccgggg 51780
catgtttttc ttcgtcttcc ggatcgaaga tgactatcgc ggcgccgaag cccgcggacg 51840
ttgcacctgc ggcgcccgtc ttcgctttga accataccgg cggttcgaaa ccgatacgcc 51900
ctttgatgaa tatggtgcgc gtggcgatgg tatctggcca ccatgtttca gcggtagccg 51960
ctttgatcac ccagaccgta cccgcgcctt tcttccgttc ctcttccgcc ttggccatga 52020
tgttgaccat gccggtcagc ggcacttcca cagcacggtt acggctgtat ggcgggttgc 52080
cgaaacccca tacccgccga acgtggtcgg cgacatcgta cacttccgcc tcggcctcca 52140
gttccgcctg tatccttttc agccggcccg cccagtcctg gcgcagcgcg ttgtcctcgg 52200
cggtgtaata gcgcgtgcat ttggcgttct ggccatcggt gaacaggtcg agcaccagcg 52260
ggccgaacag cttgtccagc gcgaagaaca gccagtcggg tgttcgccac tggtcgccta 52320
tctctttcag gtcatgcgct tcccgggctt tcagcgcgat gaggttgtca acgtattcac 52380
tcacaaatta gcctccatgt atggacttgg tcgccctggg tgatgagatt cacaatgata 52440
aagccgcctt ctttttccat tcgcgcttta tccgcgaatg ccggaattgc ggcaaggaag 52500
tctttccatg gcagggggtt aaacgcgcca atggctaccg agatttccag gtttttattc 52560
ccaccggcct tgtgggaaac gcagcaaagg ctggttccgg ttttatcccg cagccaacgg 52620
tctacgctcc ggaggaattt cccgtctccg gcggttaaaa tgtcgcactg gacaacgata 52680
tttgtcacgt cactcatggc cttttctccg ctaaaaattc gcgtaatacc ttttccatgg 52740
ccaattcgtt tgccgcagcg ccaggccatt taccgagaag ccgcgcatta ttcggtacgg 52800
tctgcatttc cacaagacag actttgttac ccaactcatt gcgagaatgg ttgatactca 52860
ggctgtaaat gctgacgtcg tccgggccat cccataggtc ttttcggata ttaagatatg 52920
cctgaatatt acctgcatcc gggatcgcac ctgcgctcat aatatctacg cacatttcct 52980
ggatgacctt ttggtcgtta attacgtttt tcatttccgt ttttccttct gtcgtgacac 53040
gaactggact ggggtgacga cctcaccgaa attcgggtaa cggctgcgca ccagctcaag 53100
ggtcagcggg ttgatctccg cacgcggcgt cttcacgtcg tacgcgcggt ccgggatgtc 53160
gatgcggcgc atgtacgtcg gtcgcatccc gacgcgtacg gcgtagttat acgcttcctt 53220
cgggccgttc gcccagacca cgaagccgac cccgcggcgc tgcagataat atgcctgcgc 53280
cgtattggag tcatcgcgag gcagattttg tggtatcgcg ggaaaacggg cgctacttcc 53340
tttcacggtt cctgtatacc aattggtcga agcatggcgt tcttccgaac actccggcgg 53400
gtacgggtca ttgatatccc acgtctttcc gcaccaggaa cagaacacct ggtccgattg 53460
ctggatagcg tttttgtggc cgttagtttc catcggtgtc ctccatcatc caggacggcc 53520
atacgccatc gcggatcatc tggcgctggg ccttccagtc ggcctgcgcg agttctttaa 53580
ctcgggtccg gatgacagcg tcgggcataa acgccgtcat tactttcgtc aggaaaactt 53640
tgttgtaggg gtcctccacg cggcagttta acgcccgggc gcaggactgg atcgccgcct 53700
tatcattgcc gtgttctttc atgcacagca tgagcgtaac gatcatgtct atcgcctcgg 53760
cgatatcccg gcacgctttc ttttctggcc cgtggacctc aatggaaata ctggtcgccg 53820
ggaataacag gtggtctttg tacgggcgca gccagtccgc tttcgcccgg tcttctgcgc 53880
tggtggtcat acttcgatgt cctcttcccg gatcagctgc agggcgttgc cgttcactgc 53940
ccacggttgc cacacgtcca ccaccagcgc cgcacggaat gaccggttga agcagttctc 54000
gatcatcgcc cagttatcgt ccggacggtc tgacgcaatg ccattgcgtt cccagtgcca 54060
ctggcgaggc gcctgggcca gctcgcggag gggcgggcgg gggtgtgagt agggattgca 54120
caggccggaa cgcagcaggc cacgctggag ccatgagcgc tgccaccaga ggtcacagcg 54180
ggtcgacccg acggcgtatt cctcttccag catgccgcac atgatcagcg cgcacacagt 54240
atcgcgtggc gccggcgcac cgatgaggtc gaaatcctcc agcctcttcg ccaggcggtc 54300
ggcggaccct tcgtcctgcc cgttgccgtc ggtacggtca tgcagaatta catcgaggat 54360
gatggccgga aaaacgactt gtttgccgtt gcgggtaaag cgggggtccg gctcattgaa 54420
gagggcgtga tacagccgcc cgaaccactc cgacaggtca ggcacgaagt cggcgatatc 54480
cggccagctg cgttcctctg tgttgtggat gcgcacggac gtctcttcct ctatcgggtc 54540
gtactcgacg cggacgatgc agcgcgggcc gtgcgggagg ggaaaaatgt agatggtctg 54600
tttgccgatt cgattctggt caaagcggcc aaacgacatt agatgcttct tcatgggatg 54660
ttcctttttg tggactccca agaaatgtag ctgaacacga ttcgtgtgtc aaacgctttc 54720
tgcaggcaaa aaagaagccc ggacaaagcg tgccgggctt taatgtcagt ggaacaccga 54780
gcatgaagat ttcatcccat gtcccgatca ctatacgtca ggattgcgat aaatcaaatc 54840
ccagtaggtg aatgtttcca ggtcgacttc cgtccagtcc gggtcgtcca ggtacgacag 54900
gcaggtgccg gcatcctcgg cgcagacctg cccggcggcc gcattatgca gcaggcggac 54960
ttcccggaaa tagatgaacc actcgcggca tggcgtatag gactcgggct gacgggtctt 55020
gatgatctgg cccgtctttt tgtcctgcca gtacgccgtc cgtttcttcg ccaggtagcc 55080
catatcagcc caccctcatg acgcgggatc ccatgcggcc gtaaatcggg tcgcgcagca 55140
cccagcggat agccagctta taccccaact ggtaccccag gcgccgcacg tagcccaggt 55200
ccgcaggccg cttgccgctc acgaagaagg actcgccgac agccatagcg ccaagcaggc 55260
gtttatgctc ggcgatatgg gggttcggtt tagcgtgttt acggcctgcc atgtcacacc 55320
tcgtcgtcgt cttccagctg cgcgtcgacc tcaaccgtga tgtccatctt atcgcggaag 55380
acgtcaatga cgtcctgcag cgacagcacc gtctggaaca ggttggccat gtaggtcagg 55440
aacgtaccgc tgtcattgtt gtagcgctcc agcgtggctt cgtagttggc gtcaacatcc 55500
gcctcgccga tgtggatccc ggagatgatc gccttgtcgg taaggcggaa gaacacgttg 55560
cccacgcccg ggcgcatctc gccttcgtcg attcgcatgt tcagcgcccg aaccgtgtaa 55620
tgccgcgcca ggtagtcgag gaccacttcg tccttgtgga tgtcaatgtc cttgaacttc 55680
acgtcatcgc catcgtcgtg cttgatgtgg atgaagtcct cgccggtgac accctcgatg 55740
tcgccgcgta cgaccttctc cattgactga cgcagcacga agtcattgat cagcaggtgt 55800
tccactggcc aggtaccgaa cgcggcacgc agtagggagt taatctcttc ggcggtcctg 55860
gcgctggtgg tgaacacgta gacgtacggg acggcgatga tcacgttgta gcgggtcggg 55920
cggataggcg cggttttcag catttcggct tcaacatcgt ctttcagctg cgcccagtct 55980
ttccgggtcg gctcccagcc ttcaatctct ttctcgcgcc aggtgtccat acgcttcgtc 56040
acttcgttgc gcacgctgac gccgggcagc acgcgttcac gcttttcggc ctgcagcacg 56100
atggcgttag tacccgggat gcccatggca aacttgccgc ccacgtagtc cgcgtacggc 56160
gcaaagccaa tcgtcttata gccgatcggg tctttcactt catgcttcgc cagcagatcg 56220
ctcacacggc cggcggcgaa ttcatggacc gacatttcgt ccatgttcgg cgtgttcagc 56280
agcgtgcggt ggaaactttt taccgacttc tcgccagcgt ttgcggcgcc aaagagcgcg 56340
ccgagatgca gaatgatgac tttctcaaag cctttaactt tcattggggg tatctccgtt 56400
tgcaaacaga ttcaggaatg gcgcacgcac aagggcggcg gttagatggg ccagcagcac 56460
acggttcgtc tcccgggcgc tacgcaggtc tgccgccatt tcggcatact ctttatcgac 56520
tttgacaaag gcaccttcgt cagcgtcagg gtcgaccatc gtgttgccga ggacttcggt 56580
atacacccgg gtcgcttcat cctcgatgtc ggcgataatg ctgttcagga tggcgatctt 56640
actgcgtacc tggtcgagcc ggtcagcgcg ggtcgtcgcg tacgctttca gcagttcagt 56700
gttcatccgc gtgctctctt ttcgttacgg cggcgctggc gctcatcctt gcgcttctcc 56760
acctgtgcat tccagcggtc gcgttcctct gactccgccc ggttcttgag ccagagttcc 56820
tcccgttcgc caagcgcttt actgaccgca ccgtcaataa cttccgtggc ccggaccagc 56880
tcgtcttccg tcatttcagc ggcagagcac ttcccgatct ccgtctgcag caaacggaca 56940
acggcagaga tgccgatcgc gtcgatggcg atacgggcct tttgcgcata cagcagtctt 57000
tggttaaccg gcatcatttc acccccgttg tcaggacgac atagaggacc gccacgcagg 57060
cgaccagctc gatcagcacc atgaacagga tggacgccag cagcagtttc gcaaatgacg 57120
gcaggtatgg agtaaggcgt atgcgagcat gaccgtccag ctctttgtgc ttcattggtc 57180
ggcggttacg tttggtccag cggcgtatcc agttttcgcc gcggcggtgt acgaggctat 57240
cattcatcac ggttccctcg catggcatcg cgcaggtctt tcggcgggta gattttattg 57300
acgccatcac cttcacgcag gaaacggatt aacatggcca gggtctgcac gatctcttct 57360
tcgacatgga cccaggtatc acggcgctcc gcgtaatgca ctgctgcctt gatcacctcg 57420
ccggcctctt ccgagaattt cagcatggtg taattcggct gcgggtattt ttcgatagcc 57480
cgggccgatt cggctcgtgc ctggtcgacg aggatatcga aataatcggc cttcgcttcc 57540
gcctgcgaat tcatctgcag gtaaaagatg gccagcgtcg tgaggaattc cgggctggcg 57600
aaagtgatgt ccccacggcg taccgcatcg cgataccggg cgacgctttc cgggttgact 57660
tctctgaact cattttcatt tgacatgggg tttccttctt agtgtttttc gccagcaatc 57720
tccgccagta cggcagcgac ttccggcgtt ggcatgtggg tgttagccca gtacagcagc 57780
ccgatgatgt agtggatcat ctgaccgacc tctgccgcgc cgcgggcttt tccgcctttg 57840
gctttcgcat aatcgccttc gctgaacagc actttgccgg taccgcggta gccaacaatg 57900
gccgaaccgg tatgcgtgac gtaaatggcc acggcgtatt tgtcttccag ggatcgaaac 57960
gccgggccag cgtcgagtcg tttgcgcggc gccgcaacgc ggttcaccgc cagcgcgaca 58020
ttactcggtg tcgggttttc cattgagcgg ctctccgttc agggtgtaga tgacgacgcc 58080
cggcacgctg acgtcgatcg acagcgatgg cacaaagccg gacatgacgt tctgcggggt 58140
gatggtggcg cgtttcaggc cgttctcgta catgatgttc gcgatgcctg ccatgacgga 58200
cttctccacg atgttctggt tcgtctcttc gcgcatggtc agcagctgtt tcaactcttc 58260
gacttcattt ggaatgtcaa aggtatgctg taacatccgg ataagcgtaa tggcatcatc 58320
acgggtgatc ggggtcagta gctgggcata agcagggtca atatggtcga tcatgatctc 58380
gccatcctgc tgtcctggct tacggtaggt atgcaggact cgcgctaact cagggtagcc 58440
gggcataatt tccgacgttt tcctttggtc atcatatgac atagggtgtc tccgggtgaa 58500
aagggtggta cggcaaaaaa gaggtgccgc gtcctacagg attaaacttc gtcgtcttcc 58560
ggtgtgccgg cgccgtcatc aacgcgcttg atcgccacct ggataaacgc acggcccgac 58620
gggtacatga ccagcgccgt ttccagtgag aactgactat tgcaggcccg tttggcgtta 58680
cgcagggaag acgacacgcc gttacgcatt ttgtagcgca gcgccgtggc ttcggtctgc 58740
aggtctgcca gcgccttgct gctgtccagc tcctgcgcat aaacgtagac ctcgcccggc 58800
ttgaggccga tcaggttgcc agtgatactg ttagcccgga tacctgacgg cagttccacg 58860
tccgtctcca tggtcatcat ggccggcgtc aggtcatcca ggataatcgc gtcgttcatc 58920
ggtattctcc gtcgttaaat ttgcgtatct gtcacgctga aagatagttg catacgttcc 58980
gtgtgtcaat cgttttcact gaacgacaac ctgccagctt tttcaagtaa gaaatttcag 59040
ccggctaact ttttgaagta agacccgaac cgctatggcg ccggccatgg ttattacggg 59100
59100
<210> 2
<211> 333
<212> DNA
<213> Unknown
<220>
<223> Klebsiella pneumoniae bacteriophage YMC15/11/N54_KPN_BP ORF 48
<400> 2
atgtctgcct tcgcattttc ggataccatc atcacgacct tgccggatag cccggcattc 60
cttttcatca cccatacatt cgctattttc aacgttcttc tctgcctgtc tatcgtgtgg 120
cggctgttca ctttccagcg gaaaggggcg cgccaccgtt tagcaggcgg cgtgatcgcc 180
atgttgctga tggtctttta catgtggaca ccgttccagt tcgtgctggg acgcgtggcc 240
attgtggact gggcgaccgt cggtattaac tgcatcgtct tcatcgcgat attccgggcg 300
cggggaaatg tgatgcaact attcaagtcg tga 333
<210> 3
<211> 585
<212> DNA
<213> Unknown
<220>
<223> Klebsiella pneumoniae bacteriophage YMC15/11/N54_KPN_BP ORF 49
<400> 3
atgtcgctat cggatgacga gtaccagaag gccgcggcga agatcggaat cagtgtacct 60
gcgctgcggg cattcgcgga agtggaaagc aatggcagcg gctttatcga tggcaaacgg 120
ccaaaagttc agtatgagcc gcatgtgatg tatcagcggc tgaaagagaa cctcggggtt 180
agcgttgcta atggtgcgct gcggaaatgg cctgacctgg tggctaccaa acccggcagc 240
tatcagtcgc tgaacaagga agatcaggac atggaccggg cggccaaaga gattgaccgc 300
acaagcgcac tggaggccgc cagctggggg gcgtttcaga ttatgggcta ccactggaag 360
acttgcggat acccggtgct gcaggcattc gttaacgcgc aatactccga ggctgggcag 420
ctggacacac tggtccggtt cctgcgtgca tcgccggcca tcgtatctgc ggtcaaaagc 480
aagaactggt cgaaggcggc gcagctgtac aatggcccgg cgtataagaa aaacgcgtac 540
gacgataaac tggcgaaggc atataaaaaa tacgggggtg tgtga 585
Claims (15)
- 카바페넴(Carbapenem) 내성 클렙시엘라 뉴모니아(Klebsiella pneumoniae)에 대하여 특이적인 세포 사멸능을 갖고,
서열번호 1로 표시되는 유전체로 이루어지며,
명칭은 YMC15/11/N54_KPN_BP이고, 기탁번호는 [KCTC18572P]인 박테리오파지. - 삭제
- 삭제
- 삭제
- 삭제
- 제 1항에 있어서,
상기 박테리오파지는 시포비리데(Siphoviridae)에 속하며, 전체 게놈 크기가 59100bp인, 박테리오파지. - 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 제 1항 또는 제 6항의 박테리오파지를 유효성분으로 포함하는 항생제.
- 제 1항 또는 제 6항의 박테리오파지를 유효성분으로 포함하는 소독제.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170077538A KR102011956B1 (ko) | 2017-06-19 | 2017-06-19 | 항생제 내성을 갖는 클렙시엘라(Klebsiella)속 균을 용균하는 박테리오파지 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170077538A KR102011956B1 (ko) | 2017-06-19 | 2017-06-19 | 항생제 내성을 갖는 클렙시엘라(Klebsiella)속 균을 용균하는 박테리오파지 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20180137813A KR20180137813A (ko) | 2018-12-28 |
KR102011956B1 true KR102011956B1 (ko) | 2019-08-19 |
Family
ID=65008883
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020170077538A KR102011956B1 (ko) | 2017-06-19 | 2017-06-19 | 항생제 내성을 갖는 클렙시엘라(Klebsiella)속 균을 용균하는 박테리오파지 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102011956B1 (ko) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000508322A (ja) | 1996-04-15 | 2000-07-04 | エヌワイエムオーエックス コーポレーション | バクテリオファージを含有する組成物および感染症を治療するためのバクテリオファージの使用方法 |
JP2015523850A (ja) | 2012-05-04 | 2015-08-20 | バイオコントロール リミテッドBiocontrol Limited | 治療用バクテリオファージ組成物 |
WO2017081709A1 (en) | 2015-11-09 | 2017-05-18 | Universita' Degli Studi Di Siena | Bacteriophage able to lyse klebsiella pneumoniae expressing a cpskkbo-4 capsular polysaccharide and related medical uses thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1487273B1 (en) * | 2002-02-13 | 2009-01-21 | Immunology Laboratories, Inc. | Compositions and methods for treatment of microbial infections |
-
2017
- 2017-06-19 KR KR1020170077538A patent/KR102011956B1/ko active IP Right Grant
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000508322A (ja) | 1996-04-15 | 2000-07-04 | エヌワイエムオーエックス コーポレーション | バクテリオファージを含有する組成物および感染症を治療するためのバクテリオファージの使用方法 |
JP2015523850A (ja) | 2012-05-04 | 2015-08-20 | バイオコントロール リミテッドBiocontrol Limited | 治療用バクテリオファージ組成物 |
WO2017081709A1 (en) | 2015-11-09 | 2017-05-18 | Universita' Degli Studi Di Siena | Bacteriophage able to lyse klebsiella pneumoniae expressing a cpskkbo-4 capsular polysaccharide and related medical uses thereof |
Also Published As
Publication number | Publication date |
---|---|
KR20180137813A (ko) | 2018-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7674467B2 (en) | Salmonella bacteriophage and uses thereof | |
EP3253215B1 (en) | Novel shigella bacteriophages and uses thereof | |
KR101261873B1 (ko) | 식중독을 유발하는 살모넬라에 특이적 사멸능을 갖는 박테리오파지 | |
KR101822812B1 (ko) | 신규한 엔테로코쿠스 패슘 박테리오파지 Ent-FAP-4 및 이의 엔테로코쿠스 패슘 증식 억제 용도 | |
KR101609111B1 (ko) | 신규한 에드와드시엘라 타르다 박테리오파지 EdW-TAP-1 및 이의 에드와드시엘라 타르다 균 증식 억제 용도 | |
KR20130087118A (ko) | 그람 음성균에 대해 세포 사멸능을 갖는 포도비리대 박테리오파지 | |
KR101915486B1 (ko) | 신규한 비브리오 파라헤몰리티쿠스 박테리오파지 Vib-PAP-7 및 이의 비브리오 파라헤몰리티쿠스 균 증식 억제 용도 | |
KR102073086B1 (ko) | 신규한 스트렙토코커스 수이스 박테리오파지 Str-SUP-1 및 이의 스트렙토코커스 수이스 균 증식 억제 용도 | |
KR102011956B1 (ko) | 항생제 내성을 갖는 클렙시엘라(Klebsiella)속 균을 용균하는 박테리오파지 | |
KR102011965B1 (ko) | 항생제 내성을 갖는 클렙시엘라(Klebsiella)속 균을 용균하는 박테리오파지 | |
KR102041109B1 (ko) | 신규한 살모넬라 하이델베르그 박테리오파지 Sal-HEP-1 및 이의 살모넬라 하이델베르그 균 증식 억제 용도 | |
KR20180137814A (ko) | 항생제 내성을 갖는 클렙시엘라(Klebsiella)속 균을 용균하는 박테리오파지 | |
KR102012227B1 (ko) | 신규한 에로모나스 하이드로필라 박테리오파지 Aer-HYP-3 및 이의 에로모나스 하이드로필라 균 증식 억제 용도 | |
KR101789877B1 (ko) | 항생제 내성을 갖는 슈도모나스 균속을 용균하는 박테리오파지 | |
CN114703152B (zh) | 类鼻疽伯克霍尔德菌噬菌体vB_BpP_HN01及应用 | |
KR101940019B1 (ko) | 항생제 내성을 갖는 클렙시엘라(Klebsiella)속 균을 용균하는 박테리오파지 | |
KR101824778B1 (ko) | 항생제 내성을 갖는 슈도모나스속 균을 용균하는 박테리오파지 | |
KR102193101B1 (ko) | 항생제 내성을 갖는 클렙시엘라 속의 균을 용균하는 신규한 박테리오파지 | |
KR101788401B1 (ko) | 항생제 내성을 갖는 슈도모나스 균속을 용균하는 박테리오파지 | |
KR20170061553A (ko) | 항생제 내성을 갖는 슈도모나스 균속을 용균하는 박테리오파지 | |
KR101915493B1 (ko) | 신규한 비브리오 파라헤몰리티쿠스 박테리오파지 Vib-PAP-8 및 이의 비브리오 파라헤몰리티쿠스 균 증식 억제 용도 | |
KR102646232B1 (ko) | 항생제 내성 슈도모나스균 특이적 박테리오파지 | |
KR102720036B1 (ko) | 신규한 살모넬라 엔테리카 특이 박테리오파지 opt-sal01 및 이를 포함하는 항균 조성물 | |
KR102269089B1 (ko) | 항생제 내성을 갖는 아시네토박터 속의 균을 용균하는 신규한 박테리오파지 | |
KR20230159558A (ko) | 장독소원성 박테로이데스 프라길리스의 증식을 억제하기 위한 조성물 및 방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |